Glossary of Key Terms
The following glossary provides definitions for common terms related to transgender identities and experiences, drawn from clinical sources such as DSM-5 and ICD-11, and general usage. Note: These terms primarily describe self-reported gender identities or umbrella categories. They are distinct from biological sex, which is defined by the type of gamete (sperm or ova) the reproductive system is organized to produce (see Biological Sex section).[1]- Transgender: An umbrella term that became established in the late 20th century (building on earlier medical terms such as transsexual) for people whose gender identity and/or expression differs from their biological sex (or sex assigned at birth on the basis of observed sex characteristics). Not all people described as transgender seek medical transition. Used in clinical, research, and advocacy contexts; some restrict it to cases involving dysphoria or medical change, while others treat it as a self-identified category. (Not itself a DSM-5 or ICD-11 diagnosis.)[13]
- Cisgender: Term for individuals whose gender identity corresponds to their biological sex. Coined in the 1990s as an antonym to transgender (Latin cis-, “on this side”). Used in advocacy, academic, and research contexts (e.g., comparison groups). Critics argue it is a neologism that presupposes gender identity as primary over biological sex.[14][15]
- Non-binary: An umbrella term originating in late-20th-century activist and academic discourse for people whose gender identity does not fit exclusively within the male/female binary; may include identities like genderqueer, agender, or genderfluid.
- Gender dysphoria: Clinically significant distress or impairment resulting from a mismatch between one's experienced gender and sex assigned at birth (observed on the basis of biological sex characteristics) (DSM-5).[16]
- Gender incongruence: A marked and persistent mismatch between experienced gender and sex assigned at birth (observed on the basis of biological sex characteristics) (ICD-11), not necessarily requiring distress.[3]
- Trans man: A person of female biological sex who identifies and lives as a man (often described clinically as assigned female at birth).[17]
- Transition: The process (social, legal, medical) of aligning presentation, documentation, or physical characteristics with identified gender. Clinical sources (DSM-5/ICD-11 related criteria, WPATH-type guidelines) frame medical steps as treatment for incongruence; evidence quality, risks, and use especially in youth remain contested.
- Detransition: Ceasing or reversing a gender transition (hormones, social presentation, or surgery where possible), for reasons including resolution of dysphoria, comorbidities, or identity change. Prevalence, causes, and implications are debated.
Common Self-Reported Identity Labels Under the Transgender Umbrella
Transgender serves as an umbrella term encompassing various specific self-reported identities. Common self-reported identity labels that some individuals place under the transgender umbrella include:- Trans man / Transmasculine: Individuals whose biological sex is female who identify as men or on the masculine spectrum (sometimes described in clinical/advocacy literature as “assigned female at birth”).[17]
- Trans woman / Transfeminine: Individuals whose biological sex is male who identify as women or on the feminine spectrum (sometimes described in clinical/advocacy literature as “assigned male at birth”).[17]
- Non-binary: People whose gender identity is neither exclusively male nor female; may use terms like enby.
- Genderqueer: An identity rejecting traditional gender distinctions, often overlapping with non-binary.
- Genderfluid: Gender identity that shifts over time or depending on circumstances.
- Agender: Absence of gender identity.
- Bigender: Identification with two genders.
- Pangender: Identification with all or many genders.[18]
- Demigender: Partial identification with a gender (e.g., demiboy, demigirl).
- Gender non-conforming: Expression or identity that does not align with societal expectations for assigned sex, though not all GNC people identify as transgender.
Definitions and Terminology
Core Definitions and Distinctions
Biological sex refers to the binary classification of organisms as male or female, defined by anisogamy: the production of small, motile gametes (sperm) by males and large, nutrient-rich gametes (ova) by females, which determines their reproductive roles.[24] Primary sex characteristics, present from birth and including gamete production, gonads, and reproductive anatomy, form the basis of this classification. In humans and many other animals, this is typically determined by chromosomal pathways (XX for females, XY for males). Secondary sex characteristics, such as those developing during puberty (e.g., body hair distribution, breast development, voice pitch), are additional dimorphic traits influenced by sex hormones but do not redefine biological sex, with rare exceptions in disorders/differences of sex development (DSD). While the classification of biological sex remains binary based on anisogamy, other sex-linked biological traits—such as neuro-functional networks and hormonal profiles—exhibit a bimodal distribution rather than a strict binary, with most individuals clustering at the ends of the male-female spectrum. Biological sex at the systemic level represents a composite of multiple variables, which in rare cases of biological incongruence (e.g., DSD) can develop in divergent directions.[25] In biomedical research, particularly under the NIH's Sex as a Biological Variable (SABV) framework, sex is treated as a key biological variable influencing physiological traits and research outcomes.[26][27][28] Biological sex is observed and recorded at birth primarily on the basis of external genitalia (with rare DSD exceptions requiring further evaluation).[29][30] The phrase "sex assigned at birth" is widely used in clinical guidelines (e.g., DSM-5/ICD-11) and advocacy contexts to distinguish natal sex from later gender identity in medical and social discussions, without altering the underlying biological binary defined by anisogamy. Critics of the phrasing contend that sex is observed or recognized at birth on the basis of biological markers rather than assigned, and prefer “sex observed at birth,” “sex recorded at birth,” or simply “biological sex.”[31][32] Two broad approaches to the concept of gender appear in the literature. In gender studies and many contemporary clinical guidelines, gender is described as encompassing socially constructed roles, behaviors, expressions, and identities that may or may not align with biological sex.[33][34] In evolutionary biology, medicine, and sex-realist perspectives, gender is treated as the social and behavioral expression of the binary biological sexes, with gender identity understood as a psychological phenomenon whose etiology and relationship to biological sex remain debated.[35][36] Gender expression involves outward presentation through clothing, behavior, and mannerisms, while gender roles refer to societal expectations associated with gender. Related concepts include gender dysphoria, defined in the DSM-5 as a marked incongruence between one's experienced/expressed gender and assigned gender (the terminology used in the manual), accompanied by clinically significant distress or impairment.[2] In contrast, the ICD-11 defines gender incongruence as a marked and persistent incongruence between an individual's experienced gender and assigned sex, focusing on the mismatch itself without requiring distress, and classifies it outside mental disorders.[3][33][34] Transgender is an umbrella term, originating in mid-20th-century medical literature and later expanded in advocacy contexts, for individuals who report a gender identity or expression that differs from their biological sex.[37] Some seek social, legal, or medical changes so that their presentation, documentation, or secondary sex characteristics more closely resemble those typical of the identified gender (or of the opposite sex), though not all do so. Common terms include "trans man" (biological females who identify as men) and "trans woman" (biological males who identify as women). The term’s scope and the relative priority of identity versus biological sex remain subjects of debate. By contrast, transsexual is a narrower term historically applied to those seeking or undergoing medical interventions like hormones or surgery to modify secondary sex characteristics, emphasizing physical transition over mere identification; "transsexual," once medical-focused, has largely been replaced by the broader "transgender" in contemporary usage.[33][38] Advocacy and professional organizations such as GLAAD, the APA, and WHO typically define the term using "sex assigned at birth." According to GLAAD, transgender refers to a person whose gender identity differs from the sex assigned at birth.[22] The APA describes it as an umbrella term for persons whose gender identity, gender expression, or behavior does not conform to that typically associated with the sex assigned at birth.[39] WHO defines gender identity as a person's deeply felt, internal and individual experience of gender, which may or may not correspond to their designated sex at birth, and describes transgender as an umbrella term for people whose gender identity and expression does not conform to the norms and expectations traditionally associated with the sex assigned to them at birth.[40][41] Other medical and scientific sources define transgender identification as a mismatch between psychological gender identity and biological sex, emphasizing that medical interventions modify secondary characteristics but do not change sex defined by gametes or chromosomes.[1][42] Transgender experiences differ from intersex conditions. Under strict developmental definitions requiring inconsistency with binary gamete production or chromosomal-phenotypic alignment, DSDs occur in approximately 0.018% of births;[4] broader estimates including milder variations reach ~1.7%.[5] Transgender identification occurs independently of detectable DSDs in the large majority (>98%) of cases.[43] DSDs are medical conditions within the binary framework of anisogamy and do not constitute a spectrum of sex that undermines the male/female classification.[1] Intersex conditions involve biological variations such as atypical chromosomal, gonadal, or anatomical development at birth—for instance, congenital adrenal hyperplasia. These individuals typically identify with one of the binary sexes following medical evaluation.[44] Cross-dressing or gender nonconformity in expression, such as through clothing or mannerisms, is generally distinguished from transgender identity in the absence of a persistent internal sense of belonging to the opposite sex.[33] Gender incongruence, as defined in ICD-11, is a descriptive diagnostic category based on self-reported persistent mismatch between experienced gender and assigned sex, without requiring distress and lacking any established biological marker (in contrast to DSDs). In over 98% of cases, transgender identity presents independently of detectable biological anomalies like DSDs. Historical studies of clinic-referred childhood gender dysphoria (pre-2010 cohorts, mostly early-onset and male-predominant) showed high desistance rates (often 60-90%) under watchful-waiting or exploratory approaches.[45][46] Later cohorts have shown different demographics (sharp rise in adolescent females) and different treatment pathways; long-term desistance/persistence data under current affirmative protocols remain limited and debated.[10][47] For phenomenological parallels with other conditions involving incongruence between body and self-identity (e.g., body integrity dysphoria), see Comparative Phenomenology with Analogous Conditions.Relation to Sexual Orientation
Gender identity and sexual orientation are conceptually distinct. Sexual orientation refers to patterns of sexual attraction relative to biological sex (androphilia, gynephilia, or both); some contemporary sources also frame it relative to gender identity.[48][49][50] In early sexology, figures such as Magnus Hirschfeld often conflated gender variance with non-heterosexual orientations, studying transvestism and homosexuality as related forms of "sexual inversion."[51] Later clinical research has described distinct developmental pathways (e.g., early-onset same-sex attracted versus later-onset opposite-sex attracted presentations among natal males, with parallel patterns reported among natal females), though the validity, prevalence, and implications of these typologies remain debated.[52][53] Self-reported non-heterosexual sexual orientation labels are reported at substantially higher rates than in the general population.[54] In the non-probability 2015 U.S. Transgender Survey (n=27,715), a purposive online convenience sample with limited generalizability, 15% identified as heterosexual, 16% as homosexual (gay, lesbian, or same-gender loving), 14% as bisexual, 21% as queer, 18% as pansexual, and 10% as asexual.[55][56] Similar patterns appear in other convenience samples. More recent data from the 2022 U.S. Transgender Survey (n=92,329 total respondents, including 84,170 adults), a community-based non-probability online survey, and associated reports continue to document this diversity in sexual orientation labels among transgender individuals, though specific percentage breakdowns are detailed in topic-specific releases.[57][58] Population-based surveys also find elevated rates of non-heterosexual identification among people who identify as transgender, though absolute percentages vary with sampling method and question wording. Complementary analyses of prior surveys and international data, such as from the 2019 Canadian Health Survey on Children and Youth, a nationally representative probability sample, show similar patterns of variability, often with higher rates of non-exclusive opposite-gender attraction compared to non-transgender peers.[59] These findings indicate heterogeneity in sexual orientations without implying causation or uniformity. Self-reported sexual orientation changes have been documented in multiple studies (e.g., ~33% of natal males and ~22% of natal females in one clinical sample), sometimes preceding hormones or surgery.[60][61] Changes frequently involve shifts toward bisexual labeling; the relative contributions of identity redefinition, hormonal effects, social factors, and genuine fluidity remain under study. Self-reported labels are commonly applied relative to gender identity (for example, a natal male attracted to females may identify as lesbian after living as a woman). When attraction is classified relative to biological sex, clinical and survey cohorts frequently show elevated rates of same-sex attraction compared with the general population, consistent with historical sexological observations of overlap between gender variance and non-heterosexual orientations.[62]Evolution of Key Terms
Terminology related to gender variance has evolved across medical and social contexts, reflecting changing understandings of sex, identity, and behavior.Selected Chronology of Modern Medical, Social, and Legal Developments Related to Cross-Sex Identification and Transition
| Year | Event | Description |
|---|---|---|
| 1919 | Institute for Sexual Science founded | Magnus Hirschfeld opens the first sexology institute in Berlin, providing early counseling, hormones, and surgeries; the institute is raided and its library burned by Nazis in 1933.[63] |
| 1930 | Lili Elbe surgeries | Danish painter undergoes a series of experimental sex-reassignment operations in Germany, among the earliest documented cases; dies of complications in 1931.[64] |
| 1952 | Christine Jorgensen's sex-reassignment surgeries | Christine Jorgensen (born George William Jorgensen Jr.) underwent hormonal treatment and surgeries in Denmark, receiving extensive media coverage as one of the first widely publicized cases of male-to-female sex-reassignment surgery in the United States.[65] |
| 1966 | Johns Hopkins Gender Identity Clinic opens | First U.S. university-based clinic offering sex-reassignment surgery after psychiatric screening.[66] |
| 1966 | Compton's Cafeteria Riot | Patrons including transsexuals, transvestites, drag queens and hustlers clashed with police during a raid at the cafeteria in San Francisco's Tenderloin district.[67] |
| 1969 | Stonewall Riots | Figures including Marsha P. Johnson and Sylvia Rivera (who contemporaneously self-described as gay men, drag queens, transvestites, or street queens) played roles; they have later been described as trans women of color, though their self-identification, specific roles, and the era's terminology remain subjects of historical debate.[68][69] |
| 1977 | Renée Richards v. U.S. Tennis Association | Richards (born Richard Raskind), a male-to-female transsexual who underwent sex-reassignment surgery, wins legal right to compete in women’s tennis, prompting debates over fairness; Richards later stated that male puberty confers lasting physiological advantages.[70] |
| 1979 | Johns Hopkins Gender Identity Clinic closes | Follow-up study of clinic patients concludes surgery conferred no objective benefit in social rehabilitation; the clinic ceases offering the procedures.[71] |
| 1999 | Transgender pride flag introduced | Designed by Monica Helms. |
| 1999 | Transgender Day of Remembrance established | Established to commemorate transgender-identified people killed in violent incidents, beginning with the 1998 unsolved murder of Rita Hester; motives and classification of such cases remain subjects of discussion.[72][73] |
| 2015 | Caitlyn Jenner's public transition | High-profile visibility in media and sports. |
| 2020 | Finland restricts youth medical transition | After evidence review, COHERE recommends psychotherapy as first-line care for minors; puberty blockers and hormones limited to exceptional cases.[12] |
| 2021 | Laurel Hubbard at Olympics | First openly transgender woman (male-to-female) to compete in the Olympic Games (weightlifting), prompting debates over retained male physiological advantages in female categories.[74] |
| 2022 | Lia Thomas NCAA swimming championships | First transgender woman (male-to-female) to win a Division I title, prompting debates over retained male advantages and fairness in female categories.[75] |
| 2024 | Cass Review published | Independent UK review finds evidence for puberty blockers and cross-sex hormones in youth “remarkably weak”; NHS England ends routine use of puberty blockers.[10] |
Related Identities and Practices
Non-binary identities encompass gender experiences outside the male-female binary, such as agender (absence of gender), genderfluid (gender varying over time), and bigender (identification with two genders). Some definitions and communities include non-binary identities under a transgender umbrella when the person’s gender identity differs from their sex observed at birth; others do not. Not all non-binary people identify as transgender.[81][84][85] Additional terms that have gained common usage include "transfeminine," typically referring to people whose sex was male (observed or recorded at birth) who identify with or present predominantly feminine characteristics (an umbrella term that can include binary trans women and some non-binary people), and "transmasculine," similarly referring to people whose sex was female (observed or recorded at birth) who identify with or present predominantly masculine characteristics (an umbrella term that can include binary trans men and some non-binary people).[86][87][88][89] Terminology for natal sex varies: “sex assigned at birth” (AMAB/AFAB) is common in many clinical guidelines, advocacy materials, and community usage, while “sex observed/recorded at birth” or direct biological descriptors (male/female) are used in other clinical, scientific, and some advocacy contexts; critics of “assigned” language note that sex is determined by reproductive anatomy and gametes and is observed (not arbitrarily assigned) at birth in typical cases.[81][31][32] Transgender experiences are distinct from practices such as cross-dressing, where individuals wear clothing typically associated with another gender without necessarily identifying as that gender or seeking medical interventions. Cross-dressing (historically termed transvestism by Magnus Hirschfeld in 1910) involves wearing clothing associated with the opposite sex. Hirschfeld's original usage covered a diverse range of phenomena later understood separately as recreational or fetishistic cross-dressing, aspects of homosexuality, and presentations subsequently classified as transsexual or transgender. It is distinguished from transgender identity, which entails a persistent internal sense of gender incongruent with biological sex, rather than mere expression or behavior. Motivations vary (recreational, situational, erotic, or occasionally identity-related). Terminology shifted toward "cross-dresser" in community usage partly to reduce associations with older psychiatric classifications; some forms remain diagnostically relevant when associated with distress (transvestic disorder in DSM-5-TR). ICD-10 categories of dual-role transvestism and fetishistic transvestism were removed in ICD-11.[90][91][92][33] Similarly, drag performance involves exaggerated gender presentation for entertainment purposes, as seen in drag queens (typically male observed at birth presenting femininely) or drag kings (female observed at birth presenting masculinely), and is generally not linked to a persistent gender identity differing from sex observed at birth. Drag refers to theatrical performances featuring exaggerated clothing and characteristics of a different gender, such as drag queens or kings, primarily for entertainment. Unlike transgender identity, which is an enduring sense of self, drag is performative and temporary. While some transgender people have participated in drag, the majority of drag performers do not identify as transgender, and conflating the two is generally rejected by both communities.[81][93]Biological Sex
Primary and Secondary Sexual Dimorphism
Humans exhibit binary sexual dimorphism at the level of reproductive roles (anisogamy: small/mobile vs. large/nutrient-rich gametes), with no third gamete type.[94][1] Many other sex-linked traits (hormone levels, brain structure, muscle mass distributions, etc.) show bimodal rather than strictly binary distributions, with substantial overlap between the sexes. This dimorphism arises from genetic mechanisms at fertilization: XX chromosomes typically yield female development via ovarian formation, while XY prompts male development through the SRY gene, whose expression is epigenetically regulated, triggering testicular differentiation around week 6 of gestation. Resulting traits include average differences in size, muscle mass, bone density, and post-pubertal hormone profiles (testosterone dominant in males, estrogen/progesterone in females).[95][96][97][98][99] Primary sex characteristics, present from birth or early development, encompass reproductive organs (gonads and genitalia) and the capacity for gamete production. Secondary sex characteristics emerge at puberty and include developments such as body hair distribution, breast growth, voice changes, and differences in muscle mass and fat deposition. Primary biological sex characteristics, as established by genomic and developmental processes, are not altered by current medical interventions. Current medical interventions do not change chromosomal sex, gonadal type, or the capacity to produce the opposite gamete; males cannot be made to produce ova nor females sperm.[100][101][1] Chromosomal sex persists lifelong, gonadal tissue retains its type despite removal or hormones, and gamete production is not reversed. Cross-sex hormone regimens induce measurable changes in secondary sex characteristics and certain systemic parameters (lipid profiles, hemoglobin, bone mineral density, muscle mass, etc.).[102] These shifts move some values toward the statistical ranges of the opposite sex but do not eliminate sex-based differences in skeletal structure, organ size, or reproductive anatomy, nor do they create a third sex. Gross skeletal geometry, whose macroscopic features such as overall frame and pelvic geometry are largely determined by the hormonal environment during puberty,[103] is not reversed by later cross-sex hormone therapy, while aspects of bone health such as bone mineral density (BMD), cortical thickness, and trabecular microarchitecture exhibit ongoing plasticity under cross-sex hormone therapy.[104][105][106][107][102] Interventions such as hormones or surgeries primarily modify secondary sex characteristics. Long-term cross-sex hormone therapy (exogenous sex steroids intended to produce secondary characteristics of the opposite sex; commonly termed gender-affirming hormone therapy or GAHT in some clinical guidelines) alters secondary sex characteristics and induces systemic phenotypic adaptations in physiological profiles such as lipid metabolism, cardiovascular risk factors, muscle protein synthesis, hormone levels, hemoglobin/hematocrit, and certain blood chemistry parameters toward ranges typical of the opposite sex.[108][109][110][111][112][113] Sexual dimorphism also extends to pharmacogenomics; for example, the liver enzyme CYP3A4—which exhibits female-predominant expression, metabolizes approximately 50% of clinical drugs, and is regulated by circulating sex hormones—can have its activity influenced by such hormone regimens.[114][115][116][117] This influences clinical diagnosis and treatment protocols in medicine and pharmacology but does not change primary sex characteristics or fundamental chromosomes (typically XX or XY).[118][101][119][120] Rare disorders of sex development (DSDs, ≈0.018% under strict definitions) involve atypical chromosomal, gonadal, or anatomical development but still align with binary classification by gamete potential and do not create a third sex (see Disorders/Differences of Sex Development subsection).[4][121][95][122][100][101]Disorders/Differences of Sex Development (DSDs) and Relation to Transgender Identities
Disorders (or differences) of sex development (DSDs), also referred to as intersex conditions in some advocacy and popular contexts, arise from atypical chromosomal, gonadal, or hormonal development. Prevalence estimates range from approximately 0.018% under a strict clinical definition limited to conditions with chromosomal–phenotypic inconsistency or unambiguous ambiguity[4] to as high as 1.7% under a broad definition that includes many conditions not regarded as intersex by most clinicians.[5] Examples include androgen insensitivity syndrome, congenital adrenal hyperplasia, and Klinefelter/ Turner syndromes; these produce verifiable ambiguities in reproductive anatomy or gamete production pathways. Transgender identification occurs independently of detectable DSDs in the large majority of cases (>98%). Studies of gender-clinic populations report a low but clinically relevant prevalence of DSDs (approximately 1.5–2% in some pediatric series).[43] Mainstream medical bodies (e.g., Endocrine Society, WHO) classify DSDs as disorders or differences of sex development that occur within the binary framework of anisogamy; no third gamete type is produced.[121][123][124][125][126] Some advocacy and academic perspectives interpret the existence of DSDs as evidence that sex is a spectrum and use this to support self-identification models. Critics of that interpretation argue that DSDs are rare developmental variations that do not undermine the binary classification and that conflating them with transgender identity risks inappropriate medicalization or neglect of DSD-specific clinical needs (e.g., cancer surveillance, fertility counseling). Policy implications appear in legal recognition (some jurisdictions exempt DSDs from standard transition pathways) and sports (case-by-case evaluation). Both framings appear in the literature.Forensic and Legal Markers Post-Transition
Chromosomal analysis (XX/XY), skeletal metrics (pelvic inlet, brow ridge, long-bone density), and DNA profiling remain highly reliable primary methods for biological sex determination and are not altered by hormones, surgery, or appearance.[127][128] Forensic anthropology and pathology routinely identify biological sex from remains or crime-scene evidence using these markers; soft-tissue changes or hormone-induced voice/fat redistribution do not alter them.[129] Soft-tissue changes, hormone-induced redistribution of fat or muscle, and surgical alterations can affect visual or secondary assessments but do not change chromosomal, skeletal, or DNA-based sex determination.[130] In legal contexts, this has implications for cold-case resolutions, inheritance disputes, and criminal profiling (e.g., offender databases retaining biological-sex patterns).[131] One set of arguments holds that chromosomal, skeletal, and DNA markers of biological sex are irrelevant to lived identity and civil rights once legal recognition has occurred. A contrasting set of arguments maintains that these markers remain necessary for accurate forensic identification, criminal statistics, prison placement, sports eligibility, and other contexts in which biological sex has material consequences.[130] Both perspectives appear in forensic science literature and case law; the distinction underscores that while social and legal recognition can evolve, biological sex determination in forensic contexts continues to rely on these markers.Historical Context
The 17th and 18th centuries featured documented instances of women adopting male presentation for exploration, military service, economic independence, or personal autonomy in Europe and emerging colonial societies. These cases, recorded in personal memoirs, trial transcripts, and colonial dispatches, highlight pragmatic motivations amid expanding global mobility and rigid gender expectations. In Britain, Mary Hamilton (also known as Charles Hamilton, active 1746) married a woman while presenting as a man, working as a quack doctor and laborer. Convicted in 1746 for "fraudulent" marriage and vagrancy, she was publicly whipped and imprisoned; court transcripts describe her use of male clothing, posture, and a fabricated backstory, sensationalized in pamphlets as a cautionary tale of deception.[132] Other military examples include various "female soldiers" in European armies and navies. Accounts from the War of the Spanish Succession (1701–1714) and later conflicts note women enlisting as men for pay or escape from poverty, with some serving undetected for years.[133] Colonial contexts added layers: In Dutch and French settlements, reports from the 1600s–1700s describe women adopting male roles in trade or defense, sometimes marrying women or owning property under male names. These instances reflect early modern Europe's complex negotiation of gender—often pragmatic rather than ideological—with exposure typically framed around fraud or immorality rather than inherent identity.[134] In the Spanish Empire, Catalina de Erauso (c. 1592–1650), known as the "Monja Alférez" or Lieutenant Nun, fled a convent in Spain, assumed male attire and identity, and served as a soldier/conquistador in the Americas (Peru, Chile, Mexico). Her autobiography details battles, duels, gambling, and administrative roles while maintaining male presentation for over two decades; injured and revealed in 1624, she received papal permission to continue living as a man and later became a celebrated figure upon return to Spain.[135] The 19th century produced extensive newspaper, court, and personal records of individuals living long-term in a social role different from their recorded sex at birth, particularly in the United States, United Kingdom, and parts of Europe.[136] Primary sources most frequently record practical motivations—access to male-dominated occupations, military pay, marriage, or personal safety—rather than statements of an innate cross-sex identity.[136][137] Modern readers sometimes interpret these lives through the lens of gender identity; historians caution that such readings project later concepts onto earlier evidence.[77] These cases often involved women adopting male presentation for economic opportunities, military service, or marriage, with public exposure typically occurring through legal troubles, accidents, or deathbed revelations. Cases of men presenting as women were rarer in documentation, likely due to greater social/legal risks. In the United States, "female husbands" (a contemporaneous press term for women living as men and marrying women) appeared in reports: Joseph Lobdell (born Lucy Ann Lobdell, 1829) lived publicly as a man for decades, worked in manual trades, married a woman, and faced institutionalization later amid family and legal disputes—accounts described a life blending independence and hardship.[138] Charley Parkhurst (born Charlotte, c. 1812) worked as a California stagecoach driver during the Gold Rush, voted in elections before women's suffrage, and was only identified as female after death in 1879, with obituaries noting community acceptance as male.[139] During the American Civil War, over 200 women enlisted as men in the Union Army, such as Albert Cashier (born Jennie Hodgers, 1843), who enlisted in the 95th Illinois Infantry, fought in over 40 battles from 1862 to 1865, received a full military pension postwar, and lived as a man in Illinois until an injury in the 1910s led to revelation and institutionalization.[140] Frances Thompson (c. 1840s–1876), a Black person who presented as a woman and escaped slavery, testified before Congress in 1866 about violence during the Memphis riots, including her assault, but was arrested in 1876 for "cross-dressing" while working as a sex worker.[141] In 1895, the Cercle Hermaphroditos formed in New York as an informal club for androgynes (a contemporaneous self-description used by some male-bodied individuals who adopted feminine presentation, attire, and roles) providing mutual support and defense against harassment, involving Jennie June (Earl Lind, 1874).[142] European cases include newspaper accounts of "female husbands" in Britain and France, where women married women and lived as men, often exposed via medical or legal events.[143] These stories reflect Victorian-era fascination with and regulation of cross-dressing and opposite-sex role adoption through anti-cross-dressing ordinances (from 1850s U.S. cities onward)[144] and sexology precursors (e.g., Havelock Ellis's "Eonism" term in 1928, but rooted in 19th-century observations of Chevalier d'Éon legacy).[145] Such documentation highlights practical motivations (work, marriage, survival) alongside emerging public discourse on such presentations, setting the stage for 20th-century medical and activist frameworks without formal terminology. By the late 19th century, advances in medicine and emerging sexology began distinguishing forms of cross-sex presentation and inversion from homosexuality or pathology. In 1864, German writer Karl Heinrich Ulrichs articulated concepts of an innate "female psyche in a male body," laying groundwork for later distinctions.[146] Austrian endocrinologist Eugen Steinach's early 20th-century experiments on sex hormones (building on 1890s–1910s research) provided biological insights into sexual differentiation, influencing subsequent medical approaches to gender incongruence.[147][148]Historiographical Revisionism and Anachronistic Interpretation
Contemporary scholarship sometimes reinterprets historical figures (e.g., Elagabalus, Joan of Arc, or Chevalier d'Éon) through a transgender lens based on cross-dressing or gender-nonconforming behavior. One scholarly approach treats such behavior as evidence of transgender identity across time. A contrasting approach emphasizes the risks of presentism and anachronism, arguing that 21st-century identity categories, medical frameworks, and concepts of gender dysphoria cannot be straightforwardly applied to earlier periods whose primary sources usually explain such behavior in terms of religion, ritual, economics, politics, or same-sex attraction.[77][149] Primary sources and period scholarship rarely support modern identity claims; such reinterpretations more often appear in secondary literature than as archival consensus. Both approaches appear in the historical literature; careful scholarship prioritizes contemporaneous terminology and documented motivations while noting the range of modern interpretations.Pre-modern cross-sex roles, clothing, and burial practices
Archaeological and textual records document individuals who performed roles, wore clothing, or received burial treatments that mixed male- and female-associated attributes. These roles were frequently tied to religious, ritual, or social functions (e.g., Mesopotamian gala priests, South Asian hijra traditions, certain Indigenous North American roles (later labeled ‘Two-Spirit’ by some modern activists)).[150][76][151] Modern scholars offer differing readings: some interpret them through the lens of contemporary transgender or non-binary identity frameworks; others emphasize that the categories operated within culturally specific cosmologies and did not correspond to contemporary Western notions of an internal gender identity independent of social role. Primary sources rarely supply first-person identity statements of the modern type.Prehistoric and Early Civilizations (c. 3500 BCE–500 BCE)
Some modern scholars interpret the following archaeological and textual indications as evidence of gender variance; others caution that the data are consistent with ritual, status, or mythological practices and do not demonstrate an internal gender identity of the modern type. Primary evidence is limited and open to multiple readings. Prehistoric and early archaeological indications (c. 3500 BCE onward): Clay figurines from the Valdivia culture in Ecuador (c. 3500 BCE) and Late Bronze Age Knossos in Crete combine physical traits and clothing markers that some modern scholars interpret as departing from typical male/female depictions (e.g., breasts depicted with male-associated attire or absence of breasts with female-associated features). Similar ambiguities appear in figurines from other regions, including Tumaco-La Tolita and Bahía cultures in South America. A burial near Prague in the Corded Ware culture (c. 2900–2500 BCE) contained a biologically male skeleton interred with objects conventionally associated with females; interpretations range from ritual practice or social status to gender nonconformity, but remain speculative given limited context.[152] These artifacts have been taken to indicate that cultural depictions of gender may have allowed for variation beyond strict binary norms, though interpretations remain limited by sparse contextual data and risk of modern projection. Mesopotamia and Sumer (c. 3000–2000 BCE): Among the earliest written records are Sumerian cuneiform texts referencing ritual specialists in the cult of Inanna (later Ishtar) who performed feminine roles, adopted feminine names, spoke a distinct dialect, and mixed male- and female-associated attributes in cultic contexts. Texts describe Inanna's ability "to turn a man into a woman and a woman into a man." Other terms such as assinnu, kurgarrû (Sumerian kur-ĝar-ra), and ur.sal appear in religious contexts, often linked to androgyny, castration, or ritual transformation. These roles were integrated into temple practices and held social/religious significance. Scholars sometimes describe them using the modern label of gender variance, though exact equivalence to modern gender identities is debated.[153] Ancient Egypt (Middle Kingdom onward, c. 2000 BCE): Execration texts from the Middle Kingdom list categories including t3y (male), ḥmt (female), and sḫt (sekhet, often translated as "eunuch" or a third category). The sekhet term appears in lists of people and may refer to eunuchs, intersex persons, or those with non-conforming social functions. Scholarly interpretations differ on whether it denotes a social role, physical condition, or something else; evidence is scarce and ambiguous before the Late Period.[154] Mixed-Attribute Burials and Ritual Roles in Ancient Andean Societies: Pre-Inca and Inca Cultures (c. 2000 BCE–1530s CE). Archaeological findings from the Andean region, including Moche (c. 100–700 CE) and Chimú (c. 900–1470 CE) societies along the Peruvian coast, reveal burials and iconography showing mixed male- and female-associated attributes. Moche ceramic figurines and tomb assemblages occasionally show males interred with feminine grave goods (e.g., spindle whorls, weaving tools, and jewelry typically associated with women) or vice versa, suggesting social recognition of statuses that mixed male- and female-associated attributes in certain ritual or status contexts. In the later Inca Empire, chroniclers such as Garcilaso de la Vega (early 17th century, drawing on oral traditions) described individuals referred to as "hombres-mujeres" or effeminate males serving in ritual capacities or as attendants in temples, though colonial Spanish accounts often framed these through a lens of condemnation. These patterns indicate culturally specific ritual and social roles involving mixed attributes linked to cosmology, labor division, and religious functions. Mixed Attire and Ceremonial Roles in Prehispanic Mesoamerica: Concepts in Ancient Mesoamerica (Formative to Postclassic periods, c. 1500 BCE–1500s CE). Archaeological and iconographic evidence from Mesoamerican civilizations, including Olmec, Maya, and Aztec societies, indicates ritual uses of mixed masculine and feminine elements. Classic Maya rulers (c. 250–900 CE) sometimes depicted themselves in blended attire combining masculine and feminine elements, such as mixed regalia or performing roles associated with both in ceremonial contexts, for ritual or political authority. Burials and figurines from sites like Playa de los Muertos (Honduras) show individuals with ambiguous or combined sex-associated markers in grave goods or body adornment.[155] Scholarly analyses interpret these as reflecting performative and contextual roles influenced by cosmology, kinship, and social status rather than fixed internal identity, though direct personal narratives remain absent from surviving records. Gender-Variant Roles in Zapotec Society: Muxes in Indigenous Zapotec Culture (Isthmus of Tehuantepec, Oaxaca). Among contemporary Isthmus Zapotec communities, muxes (pronounced mu-shay; from Spanish mujer) are typically natal males who adopt feminine dress, occupations (embroidery, cooking, childcare), and social positions and are locally recognized as a third-gender category. Ethnographic studies document participation in festivals, family economies, and community life within this matrifocal setting. Some scholars infer pre-colonial continuity from broader Mesoamerican evidence of ritual gender-crossing in Spanish chronicles and from cultural persistence despite colonial pressures, though direct pre-Hispanic Zapotec texts or archaeology naming a muxe category are lacking.[156][157] Pre-Colonial Indigenous Gender-Variant Roles in the Americas: Colonial-era ethnographic and historical accounts document individuals in various Indigenous societies of North and Central America who combined or crossed masculine and feminine traits in dress, labor, or ceremonial roles. The pan-Indian term "Two-Spirit" was coined in 1990 by Indigenous activists.[151] Anthropologist Will Roscoe identified records of alternative male gender roles in over 150 tribes (with female counterparts in about one-third); roles and status varied by group, including occupational specialists or (in some cases) spiritual/mediator functions, rather than a uniform institution of high-status visionaries equivalent to modern gender identity. Early European accounts include Vasco Núñez de Balboa's 1513 expedition in Darién (Panama), which reported executing around 40 individuals accused of sodomy, some described as adopting female roles, illustrating Spanish colonial responses to indigenous sexual and gender practices.[158] South Asia: Roots of hijra traditions (ancient to medieval): Ancient Indian mythological and ritual narratives involving transformation or androgyny from the Vedic to classical periods (c. 1500 BCE–500 CE) appear in Vedic and epic literature such as the Mahabharata, featuring characters with gender transitions or ambiguity, including Shikhandi (born female as Shikhandini, raised as male, later obtaining male physiology via a yaksha exchange to act as a warrior) and Arjuna’s year as Brihannala (a eunuch-like dance teacher in feminine guise). Classical texts reference categories such as kinnara (celestial androgynous beings) and napumsaka (impotent, non-procreative, or third-nature persons) in grammatical, legal, medical, mythological, and ritual contexts. These illustrate frameworks that accommodated ritual gender-crossing, cosmic androgyny, and a recognized “third nature” (tritiya-prakriti) in certain settings. Scholars caution that while later communities cite these texts, they do not establish unbroken continuity of a specific hijra institution of the modern type.[159][76] The hijra (kinnar) community of South Asia—typically individuals assigned male at birth or intersex who adopt feminine presentation, often undergo ritual castration, and form guru-chela groups with ritual functions such as blessing births and weddings—traces some cultural roots to these traditions as well as later Puranic and medieval (including Islamic court-eunuch) practices. Modern hijras frequently invoke epic figures and a folk episode they attribute to the Ramayana in which a group neither men nor women remain to await Rama and receive powers to bless; this narrative is a later oral tradition, not present in the core Valmiki text. The organized community with its distinctive structure is more clearly attested from the medieval period. Under Mughal rule (1526–1857), eunuchs (khwajasara) served as harem guardians and in some administrative roles. Pre-colonial sources show variable integration into Hindu and Muslim socio-religious life. British colonial authorities targeted the community via Part II of the Criminal Tribes Act, 1871, which mandated registration and control of “eunuchs,” restricted public dress and performance, and aimed at suppression.[160]
Classical Antiquity and Regional Traditions (c. 500 BCE–500 CE)
Classical antiquity: Greece and Rome (c. 5th century BCE onward): Greek and Roman sources describe ritual roles of castrated males who adopted feminine clothing and presentation, notably the galli (or gallae), eunuch priests of Cybele (Magna Mater) in Rome and Anatolia. Biological males who underwent castration, adopted feminine clothing and presentation, and lived in service to the goddess. Roman writers referred to them as a "third sex" (tertium sexus) or ambiguous category outside male/female norms. In Greek literature, Plato's Symposium includes a myth of primordial three-sexed beings (man-man, woman-woman, androgynos). These roles were tied to religious devotion and often marginalized in civic life. In Roman Britain, a 4th-century CE skeleton at Catterick was buried with ornamental jewelry typically associated with women, possibly indicating a gallus or eunuch priest.[168] In ancient Greek contexts, women occasionally crossed gender boundaries for social or professional roles, such as Agnodice, who disguised herself as a man to study and practice medicine, and Axiothea of Phlius, who attended Plato's lectures in male attire.[169][170] Philo of Alexandria (1st century CE), in On the Special Laws, referenced individuals who "change artificially their nature as men into women," including those who remove their penises and adopt feminine presentations.[171] These instances illustrate culturally sanctioned forms of opposite-sex presentation and role adoption in ancient contexts, often linked to social, religious, or survival necessities, as documented in archaeological and textual evidence. In ancient Phrygia and later Rome, the galli served as eunuch priests to the goddess Cybele from around the 3rd century BC. These men voluntarily underwent castration and adopted female clothing, makeup, and ritual performances including dances and self-flagellation. Primary sources such as Lucretius and Juvenal describe the priests' foreign origins and bodily alterations as sacred yet contravening Roman norms of masculine virtus.[172][173][174] Indigenous North American societies recognized social and ritual statuses that mixed male- and female-associated attributes from pre-colonial to early contact periods. Many Indigenous societies in North America recognized individuals who embodied both masculine and feminine qualities in spiritual or social roles (later termed Two-Spirit by some modern Indigenous activists; a pan-Indian term adopted in the late 20th century to replace colonial-era labels like "berdache"). These roles varied by tribe: for example, the Navajo nádleehí, Zuni lhamana (notably We'wha, 1849–1896, who served as a cultural ambassador in Washington, D.C., in the 1880s while presenting femininely and performing traditional crafts), and Crow batée (or "woman chief" figures renowned for hunting and leadership). Such individuals frequently held spiritual, mediatory, or ceremonial positions, such as healers or mediators. Acceptance was typically tied to fulfillment of specific community, spiritual, or economic roles within societies that otherwise maintained strong sex-based divisions of labor and status. European colonial accounts from the 16th century onward (e.g., Álvar Núñez Cabeza de Vaca's 1528–1536 observations) documented such figures, often with misunderstanding or condemnation, contributing to later suppression under missionary and governmental pressures.[175][176] In pre-colonial Southeast Asia, the Bugis people of Sulawesi (Indonesia) recognized five genders in pre-Islamic traditions, including calabai (males who embodied feminine roles) and calalai (females who embodied masculine roles), alongside bissu (androgynous spiritual shamans occupying a culturally specific ritual category who performed rituals and mediated between genders). These were documented in oral traditions and early European contact records (from the 16th–18th centuries) and reflected social structures with strong binary sex-based distinctions for the majority (oroané men and makkunrai women) plus limited exceptional ritual, occupational, and spiritual categories influenced by kinship and performance. Later colonial, missionary, and Islamic influences often recategorized or suppressed these exceptions rather than imposing binary distinctions where none had existed.[177] In Polynesia, fa'afafine in Samoa and māhū in Hawaii and Tahiti occupy culturally recognized roles combining masculine and feminine labor or traits, often raised from childhood in the opposite-sex social role and fulfilling family or ceremonial functions. Primary sources and ethnographic accounts for these and analogous phenomena (galli, certain Indigenous North American statuses, Bugis categories) almost never describe a persistent internal cross-sex identity of the contemporary psychological type; they were typically role-, ritual-, status-, or kinship-based. Modern labels such as “non-binary” or “third gender” are interpretive anthropological or activist categories rather than native terms, and their application remains contested. These examples illustrate how such presentation and social roles were often integrated into cultural or religious systems rather than conceptualized through modern medical or identity frameworks.[77] Similar role-based or ritual categories appear in other regions (e.g., certain Indigenous North American statuses later termed two-spirit, fa'afafine in Polynesia), typically tied to spiritual or social duties from pre-colonial periods rather than to an independent gender identity. In ancient Indigenous contexts in California (c. 500 BCE), archaeological evidence has been interpreted as indicating individuals in specialized intermediate social or ritual roles at rates comparable to later ethnographic practices in the region.[178][179] In Thailand, kathoey (effeminate males or males who adopted feminine presentation and roles) have long held visibility in entertainment and daily life, with cultural tolerance linked to Buddhist views accommodating certain forms of gender-crossing presentation, though employment stigma persists outside certain sectors.[180] In pre-colonial sub-Saharan African societies, gender diversity was incorporated through roles with social or spiritual functions. Among the Langi (Lango) of Uganda, effeminate males were socially treated as women in marriage and labor, permitted male spouses. In the Buganda kingdom (pre-colonial Uganda) and other groups, cross-gender practices were documented in royal courts or ritual contexts. In West African traditions, biological males presenting femininely as spiritual leaders held revered positions as mediators or diviners. These roles often intersected with kinship systems, spirituality, and community harmony, contrasting with later colonial-era pathologization or criminalization under European influences.[181]Medieval and Early Modern Periods (c. 500–1800 CE)
Beyond monastic hagiography, medieval gender variance appeared in courtly, legal, and non-Christian contexts, often reflecting institutional roles or social negotiations rather than individual devotion. In Byzantine courts (c. 500–1453 CE), eunuchs—castrated males serving as administrators, chamberlains, or clergy—occupied a distinct social and institutional category due to infertility and physical modification, between full adult males and females in court, administrative, and ecclesiastical roles. Sources describe them with feminine titles, attire, and mannerisms; some rose to high power (e.g., as regents or patriarchs). Some contemporary scholars interpret this as a "third gender," though the category was based on functional roles rather than personal identity. This contrasted with Western views, where eunuchs were rarer and more stigmatized.[182] Legal records from Western Europe occasionally document gender nonconformity outside religious frames. For instance, 13th–14th-century French and English court cases involved accusations of cross-dressing for fraud or immorality, such as men adopting female disguises for access to women or vice versa, though outcomes focused on deception rather than identity.[183] Tournament accounts (e.g., Philip of Navarre's eyewitness reports) describe knights performing as "dames" or "nounains" in mock battles, blending play with gender inversion.[184] Byzantine and Islamic Worlds (c. 500–1500 CE): In the Byzantine Empire, eunuchs, often castrated before puberty and serving in courts or church, occupied a distinct social and institutional category due to infertility and physical modification; saints like Ignatios of Constantinople (9th century, eunuch who became patriarch) highlight their prominent roles. Hagiographies sometimes portrayed eunuchs as spiritually elevated or as occupying a special status that set them apart from typical adult male and female roles.[182] Eunuchs held prominent roles in courts and religious institutions. They served as administrators, guardians of harems, and chamberlains, occupying a social position distinct from typical male roles. In some contexts, they adopted feminine presentation, and some primary sources described them as neither male nor female or as an intermediate category, reflecting a functional rather than identity-based status.[185] Islamic medieval societies (c. 700–1500 CE) featured mukhannathun (effeminate males) as musicians and entertainers in early periods, later regulated or suppressed amid hadiths cursing effeminate men and occasional caliphal orders of banishment or castration; jurists distinguished innate from willful traits and imposed restrictions on mixing or ritual roles; Ottoman köçek (young male dancers in feminine attire) continued this tradition into early modern times, often in court or public performances.[186][187] These examples illustrate gender boundaries as context-dependent—tolerated or institutionalized in some imperial/ritual settings, policed in others—highlighting medieval diversity in imperial, ritual, and religious contexts. Religious and legal texts occasionally referenced mukhannath (effeminate men or those adopting feminine mannerisms) in early Islamic tradition, though attitudes varied by era and region. These roles were frequently tied to court service, performance, or spiritual functions rather than personal transition. Medieval Europe (c. 500–1500 CE): Medieval Christian hagiography frequently depicted biological females adopting male monastic identities through ascetic practices, clothing, and behavior, often celebrated as paths to spiritual perfection closer to a masculine divine ideal. These narratives, while not using modern transgender terminology, illustrate recognized forms of gender presentation shift for religious devotion. Hagiographies and saints' lives include figures like St. Marinos the Monk (early Christian tradition, possibly 5th–6th century), born female but living as a male monk in a monastery until death, when her biological sex was discovered. In Coptic and Byzantine traditions, Anastasia the Patrician (6th century) fled court life in Constantinople under Justinian I, adopting male monastic attire and living as a monk (Anastasius) in the Egyptian deserts for 28 years until death; sources portray her full acceptance as male within the community.[188] Beyond these, figures like Hilaria (5th–9th centuries, Coptic/Egyptian traditions), daughter of Emperor Zeno, disguised herself as a man to live as a monk named Hilarion, using extreme asceticism to suppress feminine traits (e.g., reduced breast size, ceased menstruation) and gain integration as male among monks.[189] Similar accounts include Eugenia of Alexandria (3rd–4th century, but influential in medieval retellings), who disguised herself as a monk named Eugenius to study philosophy and enter a male monastery; after false accusations of assault, she revealed her biological sex to defend her chastity, yet sources emphasize her masculine virtues and acceptance as a holy figure.[190] Apollinaria/Susanna (5th century, Egyptian desert tradition) fled marriage, lived as a male hermit Apollinarius, and was accused of fathering a child but maintained silence to preserve her male monastic identity until death revealed her sex.[191] In Western European contexts, Pelagia the Penitent (5th century, but medieval versions widespread) transitioned from courtesan to male hermit Pelagius in Jerusalem, achieving ascetic transcendence through masculine presentation and labor.[192] Margaret/Pelagius (similar variant traditions) lived as a monk, with hagiographies highlighting masculine traits from extreme deprivation. Other figures include Matrona of Perge (5th century, Byzantine), who adopted male attire as Babylas to join a Syrian monastery,[193] and Theodora of Alexandria (6th century), who lived as Theodore after entering a male community to atone for past sins.[194] These narratives often frame crossings as temporary or miraculous, valorizing movement toward masculine spiritual ideals (typically under extreme asceticism and revealed posthumously) while condemning reverse shifts. Unauthorized male-to-female presentation was frequently treated in canon and secular law as deception, sodomy, or heresy, drawing on Deuteronomy 22:5, as in Joan of Arc's trial. Scholars note these tales reflect medieval views of gender as malleable through piety, with biological females frequently canonized as saints for such transformations—contrasting with rarer documented male-to-female cases, which faced greater social/legal stigma.[195] In Western Europe, Gregory of Tours' 6th-century History of the Franks describes accusations during a convent revolt that the abbess kept a childhood-castrated man who dressed in women's clothes at the monastery of the Holy Cross in Poitiers.[196] Sworn virgins in the Balkans, from the 15th century onward in Albanian and Montenegrin societies with possible earlier roots, took vows of chastity, dressed and labored as men, used masculine pronouns, and functioned as a third-gender role, considered a pre-Christian survival in some analyses.[197] Scholars interpret such narratives as reflecting possible gender-variant experiences, though framed within ascetic or miraculous religious storytelling. Legal documents from late medieval England, such as the 1394 case of Eleanor/John Rykener (arrested in London while presenting as a woman and engaging in sex work), describe a biological male who lived and worked in feminine roles; the trial record uses feminine pronouns and attire references, leading some historians to view it as an early documented instance of gender nonconformity. In the early 15th century, Joan of Arc wore male attire to lead military efforts, with heresy charges emphasizing violations of dress norms. Literary works portrayed gender transformation in divine or heroic contexts, such as the 13th-century French romance Roman de Silence, where the protagonist, assigned female at birth, is raised as a knight and minstrel, embodying masculine traits through clothing and deeds; the 14th-century chanson de geste Tristan de Nanteuil, featuring Blanchandin, physically changed from female to male by angelic intervention to fulfill paternal roles; and Christine de Pizan's Livre de la mutacion de Fortune (1403), which employs the Ovidian Iphis myth to metaphorically depict a protagonist's transformation from woman to man, reflecting themes of gender mutability tied to fortune and divine will.[198] Jewish texts include Kalonymus ben Kalonymus's poem in Even Boḥan (Provence, 1322), which laments being born male, describes male anatomy as a defect, and expresses a desire to be female. In medieval Jewish communities (e.g., Provence/Spain, 12th–14th centuries), beyond Kalonymus, rabbinic texts occasionally addressed androgynous or tumtum (indeterminate sex) individuals under halakha, assigning conditional gender roles for marriage/ritual obligations—reflecting awareness of biological variance without modern frameworks.[199][200] These accounts, embedded in piety and survival narratives, show medieval societies negotiating gender boundaries through religious frameworks, with crossings toward masculinity often valorized while reverse shifts faced greater scrutiny or condemnation. These examples appear in religious, legal, and fictional sources, often without a unified concept of transgender identity. In pre-modern Ryukyuan society, indigenous religious specialists such as noro (priestesses) and yuta (shamans/mediums) were overwhelmingly female, reflecting the onarigami belief associating spiritual power with women. Male yuta existed in small numbers but were generally less trusted. A 20th-century ethnographic study documents a case of a biologically male youth presenting as female to be initiated as a shaman, gaining legitimacy in a female-dominated spiritual domain.[201] No historical evidence supports a specific pre-modern ritual called winagu nati for male shamans adopting female roles. Korean shamanism (musok), with roots in ancient times, features predominantly female mudang, with male shamans (baksu or paksu mudang) as a minority. Ethnographic research indicates that some male shamans adopt feminine dress, makeup, and mannerisms, particularly during possession by female spirits, and a subset live in feminine social roles; these behaviors are often the initial signs of a shamanic calling and are framed as spirit-driven rather than personal identity.[202] Such practices have been noted in the tradition for centuries, though most detailed accounts postdate the specified period and were sometimes viewed through colonial or modern lenses. Wakashu in Edo-Period Japan: The Wakashu Role in Early Modern Japan (Edo period, c. 1603–1868). During Japan's Edo period, adolescent males who had reached puberty but not yet undergone the genpuku coming-of-age ceremony were categorized as wakashu ("beautiful youths"), recognized as a distinct social and aesthetic category with androgynous presentation. Wakashu maintained specific hairstyles (long forelocks), clothing, and manners that blended masculine and feminine attributes, and they were socially permitted as objects of desire for both adult men and women within established hierarchies. This role appeared in ukiyo-e prints, literature, and theater, reflecting temporary gender ambiguity tied to age and transition to adulthood. The category declined in the late 19th century amid Western-influenced modernization and stricter binary norms.[203][204] Cross-Gender Performance in Chinese Opera Traditions: Gender Roles in Chinese Theatrical Practices (Ming to Qing dynasties, c. 1368–1912). In imperial Chinese opera, particularly during the Ming and Qing periods, all-male troupes (due to gender segregation policies) featured male actors specializing in dan roles, portraying female characters with stylized feminine dress, movement, voice, and demeanor.[205] These performers, known as nandan, trained extensively to embody idealized femininity both on stage and sometimes in related social contexts, such as courtesan-like interactions.[206][207] While primarily performative, such practices allowed sustained cross-gender expression within culturally sanctioned artistic frameworks, contrasting with stricter prohibitions on non-theatrical cross-dressing under certain laws.[208] Related phenomena included boy actresses in regional theaters who adopted female presentation for extended periods. Early Modern Europe (Renaissance to 18th century, c. 1400–1800 CE): Early modern Europe saw documented cases of individuals who adopted the clothing, names, and social roles of the opposite sex, often discovered through legal or social scrutiny. The Public Universal Friend (born Jemima Wilkinson, 1752–1819, in colonial America) rejected gendered pronouns and birth name after a religious experience, presenting as genderless and leading a religious community; they refused classification as male or female. In France, the Chevalière d'Éon (1728–1810) lived publicly as a woman after earlier years as a male diplomat and soldier; their gender presentation shifted over decades, culminating in legal and social recognition as female later in life. Cross-dressing women (sometimes interpreted as transmasculine figures) appear in military or adventure accounts, such as Hannah Snell (England, 1723–1792), who served as a male soldier and sailor before disclosure. These examples often involved practical disguise for social mobility, military service, or personal autonomy, with varying degrees of permanence. Colonial encounters in the Americas and elsewhere documented Indigenous third-gender or two-spirit roles (e.g., in North American tribes), though European observers frequently pathologized or suppressed them. European records note isolated cases of cross-living, such as the Chevalier d'Éon (1728–1810), a French diplomat and soldier who lived publicly as a woman from 1777 following a royal decree that officially recognized and deemed d'Éon legally a woman. English courts also recognized this status. Postmortem examination confirmed male anatomy.[209] Enlightenment-Era Shifts in Individual Identity: During the 18th century, Enlightenment emphasis on personal autonomy, self-knowledge, and empirical observation of human variation contributed to more documented cases of individuals who lived in the social role of the opposite sex from that recorded at birth. Notable examples include the French diplomat Chevalier d'Éon (1728–1810), who lived publicly as a woman after 1777 under a royal decree, prompting widespread debate in European salons and medical circles about the nature of sex and gender presentation.[209] Pre-20th century cultures include accounts of individuals or groups exhibiting cross-gender expression or role adoption. These behaviors were often linked to religious rituals, social functions, or individual eccentricity. Such contexts generally lacked medical or identity frameworks distinct from biological sex and embedded gender variance in cultural, devotional, or elite contexts.Medicalization and clinical history (20th century)
Medical conceptualizations of cross-gender identification and transvestism (later termed transsexualism and subsequently subsumed under the broader transgender category) emerged in early 20th-century European sexology, distinguishing such phenomena from homosexuality.[210] Magnus Hirschfeld coined “transvestite” in 1910 (Die Transvestiten), describing individuals driven by an innate urge to live as the opposite sex, often without sexual motivation, and classified them as natural variations on a continuum of sexual intermediaries.[90][211] Other contemporaneous clinicians framed the same presentations as psychopathology or inversion requiring psychiatric management.[212] His Institute for Sexual Science (1919–1933) provided early counseling, hormone treatments, and surgeries (e.g., Dora Richter, 1931). Havelock Ellis introduced “Eonism” (1928), emphasizing aesthetic and psychological cross-gender expression.[213] In the United States, David O. Cauldwell used “transsexual” (1949) for those seeking bodily change, framing it as a psychopathological condition to be managed psychiatrically rather than through surgical intervention.[214][215] Lili Elbe underwent a series of highly experimental sex reassignment surgeries between 1930 and 1931 following examination by Magnus Hirschfeld. The first procedure (orchiectomy) occurred in Berlin; subsequent operations, including penectomy, ovarian transplantation, and a final uterine-transplant attempt with vaginal construction, were performed by German gynecologist Kurt Warnekros in Dresden. She died on 13 September 1931 from complications including infection and organ rejection.[64][216] Sporadic surgical efforts continued in Europe into the 1930s until the Nazi regime raided and destroyed the Institute for Sexual Science in 1933. Publicized cases such as Lili Elbe’s surgeries and Christine Jorgensen’s highly reported 1952 transition brought international attention to medical possibilities. Harry Benjamin’s work from the 1940s onward, culminating in his 1966 book The Transsexual Phenomenon, synthesized clinical observations from several hundred patients and proposed a Sex Orientation Scale—a seven-point continuum from transvestism to intense transsexualism. Benjamin argued that hormonal and surgical treatments should modify primary and secondary sex characteristics to resemble those of the opposite sex in order to match the patient’s self-reported identity rather than relying solely on psychotherapy, and that transsexualism stemmed from biological-psychological factors.[217] His work influenced the first U.S. gender clinics (e.g., Johns Hopkins, 1966) and laid groundwork for later standards of care. These early studies, based on small case series and lacking modern controls, conflated aspects of orientation and identity while pathologizing variance. They established medical approaches over purely psychiatric ones, shaping subsequent frameworks despite methodological limits. This period also saw the opening of specialized clinics such as the Johns Hopkins Gender Identity Clinic in 1966, which formalized multidisciplinary evaluation and treatment protocols.[218][219]
Notable Individuals
The following are illustrative examples of individuals who have identified as transgender or undergone medical transition and who have achieved significant public visibility or influenced related policy debates.- Lili Elbe: one of the earliest documented recipients of experimental genital-reconstruction surgeries, 1930–1931.[64]
- Christine Jorgensen: 1950s media figure whose highly publicized 1952 surgeries and subsequent coverage brought widespread attention to sex-reassignment procedures in the West.[229]
- Alan L. Hart: American physician who underwent hysterectomy in 1917–1918 as one of the earliest documented surgical transitions in the United States and later pioneered mass X-ray screening for tuberculosis.[230][231]
- Virginia Prince: mid-20th-century activist who advanced terminology and community organizing.[232]
- Laverne Cox (biological male, identifies as a transgender woman): gained recognition as an actress and advocate.[233]
- Elliot Page (biological female, identifies as a transgender man): Academy Award-nominated actor who publicly transitioned in 2020 and became the first openly transgender man to appear on the cover of Time magazine.[234]
- Caitlyn Jenner (biological male, identifies as a transgender woman): Olympic athlete and public figure.[235]
- Jazz Jennings (biological male, identifies as a transgender woman): media personality who publicly documented a childhood and adolescent medical transition.[236]
- Ben Barres: neuroscientist who transitioned mid-career.[237]
- Laurel Hubbard (biological male, identifies as a transgender woman): first openly transgender athlete to compete in the women’s category at the Olympics in 2021 and a focal point in ongoing debates over fairness, safety, and retained physiological advantages after male puberty.[238][239]
- Lia Thomas (biological male, identifies as a transgender woman): swimmer who won an NCAA Division I title in 2022 and a focal point in ongoing debates over fairness, safety, and retained physiological advantages after male puberty.[240][241]
- Sarah McBride (biological male, identifies as a transgender woman): U.S. Representative.[242]
- Various elected officials in Europe: have been elected to public office.
- Keira Bell: former Tavistock clinic patient whose judicial review contributed to later restrictions and reviews of youth gender services in the United Kingdom.[243][244]
- Chloe Cole: testified before U.S. congressional committees about her medical transition as a minor.[245][246]
- Ritchie Herron: British adult who underwent genital surgery and later initiated legal action against NHS gender services.[247]
Diagnosis and Prevalence
Diagnostic Criteria and Classification
The term "transgender" refers to individuals whose personal sense of gender identity differs from their biological sex. Unlike formal diagnoses, this label does not require clinical distress, impairment, or medical intervention. Thus many individuals who identify as transgender do not meet criteria for either gender dysphoria or gender incongruence.[2][3] Clinical diagnoses evolved across systems. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV, 1994) defined gender identity disorder (GID) as a strong and persistent cross-gender identification, persistent discomfort with one's sex or sense of inappropriateness in the gender role of that sex, and clinically significant distress or impairment; it was classified under Sexual and Gender Identity Disorders.[248] The DSM-5 (2013) replaced gender identity disorder with gender dysphoria to focus on distress arising from incongruence rather than identity itself; the revision committee stated this would reduce stigma associated with pathologizing identity.[249] Placed in its own chapter apart from paraphilic and sexual dysfunction disorders, it requires incongruence manifestations—distinct from gender nonconformity alone—causing distress or impairment for at least six months. Diagnosis requires a marked incongruence manifested by at least two of six specified indicators (adolescents/adults) or six of eight (children), lasting ≥6 months, and associated with clinically significant distress or impairment. The DSM-5-TR clarifies that individuals who identify as transgender but do not meet criteria for gender dysphoria fall below diagnostic thresholds.[250] DSM-5 uses “assigned gender” and ICD-11 uses “assigned sex” (commonly phrased “sex assigned at birth” in guidelines), referring to the initial clinical observation of external genitalia rather than the underlying biological sex defined by gamete type.[251][2][252] The International Classification of Diseases, Eleventh Revision (ICD-11, effective 2022) terms the condition gender incongruence and relocated it from mental disorders to a sexual-health chapter with the stated aim of reducing stigma.[3] It demands marked, persistent incongruence between self-perceived gender and assigned sex (sex observed/recorded at birth)—typically over two years—often with a desire to transition or change sex characteristics, but without requiring distress or impairment. The incongruence must be marked and persistent (typically ≥2 years), accompanied in many cases by a desire to transition, and is not diagnosed on the basis of gender-variant behavior or preferences alone. Gender-nonconforming behaviors alone do not suffice, and codes differ for adolescence/adulthood (HA60) and childhood (HA61).[253][23] Critics of both the DSM-5 and ICD-11 changes argue that removing or de-emphasizing a distress requirement risks medicalizing self-reported incongruence without clinically significant impairment and may complicate differential diagnosis of co-occurring conditions.[254][255]Reception and Critique
Reception of the diagnostic changes has been mixed. The DSM-5 retained a psychiatric diagnosis (Gender Dysphoria) focused on distress rather than identity itself, in part to support access to medical care under insurance systems, while ICD-11 moved Gender Incongruence out of mental disorders into a sexual-health chapter with the explicit aim of reducing stigma; neither diagnosis is based solely on gender-variant behavior.[20][3][256] Advocacy groups and many clinicians, including the World Professional Association for Transgender Health (WPATH), welcomed the DSM-5 emphasis on distress and the ICD-11 relocation as steps that reduce stigma and facilitate access to care.[20][257] Critics from multiple perspectives have argued that DSM-IV’s Gender Identity Disorder pathologized identity, that DSM-5 still frames incongruence within a psychiatric manual and retains a distress criterion partly for insurance reasons, and that ICD-11’s removal of a distress requirement may expand eligibility to individuals without clinically significant impairment or adequate differential diagnosis of comorbidities.[251][258] Additional critiques have focused on conceptual coherence of the incongruence model, the continued need for differential diagnosis of co-occurring conditions, and the relative weight given to stigma reduction versus evidence of long-term outcomes.[254][10]Demographic Trends and Increases Among Youth
Referrals to specialist gender identity clinics for youth with gender dysphoria have increased substantially in multiple countries over the past decade. In the UK, annual referrals to the Gender Identity Development Service rose from about 210 in 2011–2012 to over 5,000 in 2021, a more than 20-fold increase.[259] Referrals among adolescent girls surged 4,000% over an eight-year period ending around 2019.[260] In English primary care records from 2011 to 2021, gender dysphoria diagnoses among children and adolescents climbed from 0.14 to 4.4 per 10,000—a 50-fold rise—though absolute numbers remained low at about one in 1,200 by 2021.[47] Denmark saw similar growth, with referrals increasing from 97 in 2016 to 352 in 2022.[261] In the US, population surveys show rising self-reported transgender identification among youth. The CDC's 2023 Youth Risk Behavior Survey found 3.3% of high school students identifying as transgender and 2.2% questioning their gender.[262] Approximately 724,000 youth aged 13–17 identify as transgender, equating to 3.3% of that group.[6] Earlier data from 2014–2015 reported lower rates of around 0.7% for young adults aged 18–24.[263] Recent population-based estimates in the United States indicate approximately 0.8–1% of adults and higher proportions among youth (around 3% for ages 13–17), with generational differences showing rates around 2% among Gen Z adults, totaling roughly 2.1–2.8 million adults and youth overall, with distributions often approximating balance across categories such as transgender women, transgender men, and non-binary or gender-diverse identities (e.g., around one-third each in modeling from behavioral risk factor surveys). Demographic breakdowns from earlier population surveys indicated higher identification rates among some racial and ethnic minorities; for example, 2016 estimates showed approximately 0.8% of Black adults identifying as transgender compared with 0.5% of White adults. More recent estimates indicate that the racial and ethnic distribution of those identifying as transgender is similar to that of the U.S. population, with differences not statistically significant.[264][265] Some more recent U.S. college and young-adult surveys have reported continued rises or possible plateaus/declines depending on the dataset and year; longer-term trends remain under study.[266][267] Demographic shifts include a focus on adolescents over prepubescent children. In specialist clinic-referred samples in the UK, Europe, and elsewhere, the sex ratio has reversed from historical male predominance among children to 60–70% or more observed female at birth among adolescents. In one UK sample of referrals from 2017–2020, 82.7% involved adolescents and 71.4% were individuals observed female at birth (biological females).[268] Gender dysphoria in children historically affected more biological males (observed male at birth), but recent adolescent clinic data show 70–71% of referrals from biological females.[269] Female predominance reaches up to 70% in some European cohorts, contrasting prior male-heavy patterns and aligning with adolescent-onset cases.[261][270] Some population surveys of self-identification report different ratios, including more balanced or male-predominant patterns among youth, and higher rates of non-binary identification.[271] Absolute prevalence of clinic-diagnosed gender dysphoria remains low. Worldwide prevalence estimates vary by measurement method and cultural context, ranging from 0.3 % to 1.2 % in adult populations according to population-based surveys and health-system records, with higher figures in jurisdictions offering legal gender recognition and lower figures where stigma or limited access reduces disclosure. Methodological differences — such as self-report versus clinical diagnosis, lifetime versus current identification, and inclusion of non-binary categories — account for much of the observed variation; studies that rely solely on clinic referrals or youth samples often overestimate persistence rates compared with representative household surveys. These discrepancies underscore the challenge of establishing a single global figure and highlight the influence of social and legal environments on reported identification. Clinic referral data show large increases in youth identification and a shift toward adolescent-onset cases with female predominance in those samples, while population surveys document rising self-reported identification with more variable sex ratios and substantial non-binary categories. Proposed explanations include greater societal visibility and reduced stigma, social and peer influences including online communities, changes in diagnostic practice and survey design, and possible cohort-specific factors. These have been discussed in advocacy and public-health sources, parent-report studies[272], and independent reviews such as the Cass Review[10]. Longitudinal and representative data capable of distinguishing these accounts remain limited. These demographic shifts occur against a background of elevated psychiatric comorbidity in clinic samples and differing persistence rates between childhood-onset and adolescent-onset presentations (see Comorbidities with Mental Health Conditions and Evidence on Treatment Outcomes sections).[273][45][10]Comorbidities with Mental Health Conditions
Individuals with gender dysphoria (particularly in clinic-referred samples) and self-identified transgender individuals exhibit substantially elevated rates of comorbid mental health conditions compared with the general population, including depression, anxiety, suicidal ideation, self-harm, autism spectrum disorder (ASD), and post-traumatic stress disorder (PTSD). These elevated rates may be partially confounded by higher rates of sexual-minority orientations among transgender-identified people (approximately 70% LGBQ vs. ~8% in non-transgender adults), as LGB populations themselves show 2–3× higher depression and anxiety.[274][275] These conditions often co-occur with gender-related distress in clinic-referred populations.[276][277][278][279][280][281] Pooled data from systematic reviews and a 2023 meta-analysis indicate an 11% (95% CI 8–16%) ASD diagnosis rate among transgender individuals, versus 1-2% in the general population;[282] transgender individuals are 3 to 6 times more likely to meet criteria than non-transgender individuals.[8] Clinic-based estimates are higher (e.g., roughly one in three young referrals at the former Tavistock Gender Identity Service exhibited moderate to severe autistic traits; ranges of 20–50% reported in some minor cohorts), reflecting differences in assessment methods, screening tools, diagnostic criteria, and referral patterns. The Cass Review highlighted the high rate of comorbid neurodevelopmental conditions, including ASD, among referred youth and emphasizes the need for holistic assessment.[283][284][285][286][287][288] PTSD prevalence in some self-identified transgender surveys reaches approximately 42%, compared to 6-7% in the general adult population. Meta-analyses indicate roughly 2.5 times higher risk, though survey methodologies vary. Adverse childhood experiences, including trauma, occur at elevated levels in gender clinic referrals.[289][290][287] The following table summarizes prevalence ranges from heterogeneous sources, varying by population (e.g., clinic-referred gender dysphoria vs. self-identified transgender individuals), setting (e.g., specialized clinics vs. population surveys), and measurement methods.| Condition | Cohort Prevalence | General Population | Key Sources |
|---|---|---|---|
| Depression | 28-64% (primarily clinic samples) | ~7% | [279] [280] |
| Anxiety (moderate-severe) | 50% (youth cohorts, clinic and survey samples) | ~18% (lifetime) | [280] |
| Autism Spectrum Disorder | 11-50% (pooled and clinic estimates) | 1-2% | [284] [285] |
| PTSD | 42% (self-identified transgender surveys) | 6-7% | [289] [290] |
Etiology and Explanatory Frameworks
The etiology of transgender identification and gender incongruence, including gender dysphoria (GD), is multifactorial and not fully elucidated, encompassing potential biological, psychological, developmental, social, and environmental influences. Proposed frameworks include biological factors (genetics, prenatal androgen exposure, neurodevelopmental differences), psychological and developmental factors, and social/environmental influences; no single factor has been shown to be necessary or sufficient.[10] Twin and family studies suggest moderate heritability estimates, often in the 20–50% range in some analyses, with substantial non-shared environmental contributions and high variability across studies (including near-zero in certain designs). High-quality evidence remains limited for most proposed mechanisms.[297][298][299][300][10][301] Large-scale surveys show elevated rates of transgender identification among individuals reporting autism-spectrum traits, histories of childhood adversity, and (in some Western samples) certain racial or ethnic minority groups. Class and educational attainment show mixed associations. International datasets reveal that urban, higher-education, and digitally connected populations consistently report elevated prevalence. These are associations; causal direction and mechanisms remain unresolved. These patterns are documented without implying uniform explanatory mechanisms across groups.[8][302][265]Biological Hypotheses
Some evolutionary hypotheses frame transgender identification as a potential developmental mismatch: human sexual dimorphism evolved under selection pressures favoring reproductive specialization, yet brain-behavior plasticity allows adaptation to diverse ecological and social niches. Rare persistent reported gender identity incongruent with biological sex may reflect trade-offs where neural mechanisms supporting social cognition or self-representation occasionally decouple from reproductive anatomy, persisting at low frequencies due to kin selection or balancing selection, though empirical data remain sparse. In Samoan culture, fa'afafine—males adopting feminine roles—display elevated kin-directed altruism, aligning with the culturally specific "super uncle" hypothesis of kin selection, which is not generalizable. Yet gender variance lacks simple adaptive explanations and fails to account for transgender dysphoria in Western contexts. These views remain speculative.[303][304][305][306] Twin and family studies suggest moderate heritability estimates, often in the 20–50% range in some analyses, though systematic reviews report wider variation (including near-zero in certain subgroups or designs) and highlight that non-shared environment typically accounts for most variance. A 2022 Swedish register-based study found no concordant same-sex twin pairs with gender dysphoria; opposite-sex dizygotic twins showed 37% recurrence versus 0.16% in non-twin siblings, which the authors interpreted as reflecting shared intrauterine influences. Discordant monozygotic twins indicate genetics do not determine outcomes alone. A 2025 systematic review of the twin literature found genetic contributions to gender identity ranging from 0.00 to 0.84 and non-shared environmental contributions from 0.15 to 0.96, with high variability across studies. No specific genes consistently emerge; genome-wide association studies and candidate gene analyses of hormone receptors or steroidogenesis pathways yield no replicable causal variants.[307][308][309][300] Epigenetic mechanisms, such as DNA methylation, regulate the phenotypic expression of sex-linked traits in a tissue-specific manner. Preliminary epigenome-wide association studies have reported distinct global CpG methylation profiles in hormone-naïve transgender individuals compared with same-sex (biological-sex-matched) controls, with differentially methylated genes involved in brain development and neurodevelopment. These findings are limited by small sample sizes, require independent replication, and do not establish causality.[310] Prenatal androgen exposure may shape gender identity through atypical brain sexual differentiation. In congenital adrenal hyperplasia (CAH), elevated prenatal androgens in genetic females are associated with increased male-typical behavior and modestly elevated rates of gender dysphoria or gender-atypical identity in some cohorts (estimates often cited around 5%, with a 2019 review reporting declared gender dysphoria in 9% of female-raised 46,XX cases; higher in severe or poorly treated cases). The vast majority of 46,XX individuals with CAH raised as female develop a female gender identity. Diethylstilbestrol (DES)-exposed cohorts have been linked in some reports to higher transgender identification. These associations are correlational; hormone assays and animal models do not reliably predict individual human outcomes.[311][312][313][314][315][316][317][318] The organizational-activational hypothesis offers a standard neuroendocrinological framework for brain sexual differentiation, whereby early organizational effects of prenatal hormones permanently structure neural circuits, potentially mismatched with gonadal sex and leading to gender identity divergence in some cases; these circuits may then be activated by later hormonal influences. Diffusion tensor imaging (DTI) studies have identified white matter microstructure differences in transgender individuals. Findings are mixed (intermediate, sex-typical, or unique patterns), effect sizes are small, and limitations include hormone-therapy confounds and correlational designs.[319][320] Neuroimaging studies report mixed structural and functional differences versus same-biological-sex controls. Some find intermediate or partially identity-congruent patterns in specific regions or networks even in hormone-naïve samples; others find patterns closer to biological sex or mosaics that do not reliably classify individuals. A 2020 machine-learning analysis of structural MRI data showed increased misclassification of biological sex in transgender women, revealing deviations from both biological sex and identified-gender patterns. A 2021 ENIGMA mega-analysis of 803 hormone-naïve participants found a variety of region- and measure-dependent patterns, confirmed volume and surface-area differences but not cortical thickness, and concluded that transgender persons present with unique brain phenotypes rather than a simple shift toward identified gender. Effect sizes are typically small relative to within-sex variation. Sample sizes are often small, designs are cross-sectional, and confounds (sexual orientation, psychiatric comorbidities, neuroplasticity from distress or social factors, and prior hormone exposure) are difficult to isolate. One interpretation is that these differences support an innate neurobiological contribution to gender identity; alternative interpretations emphasize that brain sexual dimorphism is probabilistic and mosaic and that observed differences may be secondary or non-specific. No reliable individual-level diagnostic biomarker exists.[321][322][323][324][325][326][327][328][329][330][331][332] From an anthropological perspective, gender-variant roles in non-Western societies (e.g., hijra in South Asia, two-spirit in Indigenous North American groups) often involve ritualized liminality mapping onto social functions such as mediation, performance, or spiritual roles. Traditional hijra practices frequently include ritual castration (nirvan), a non-Western form of body modification, while two-spirit roles typically do not involve bodily alteration.[76][151] These observations raise questions about whether contemporary medicalized transgender experiences in industrialized societies represent a culturally specific expression of embodied incongruence, amplified by modern individualism, digital communities, and access to endocrinology, into a medical-therapeutic paradigm. Neuroanthropological inquiry examines how such experiences emerge at the intersection of neural plasticity, cultural scaffolding, and evolutionary legacies of sexual dimorphism. Neuroanthropology integrates neuroimaging, cross-cultural ethnography, and evolutionary anthropology to examine how embodied experiences of gender incongruence emerge at the intersection of neural plasticity, cultural scaffolding, and evolutionary legacies of sexual dimorphism. Human brains exhibit sexual dimorphism in structure and function (e.g., greater male-typical gray matter volume in regions linked to spatial processing, female-typical in language-related areas), though with substantial overlap and individual variability. Postmortem studies have reported that the central subdivision of the bed nucleus of the stria terminalis (BSTc) in some male-to-female transsexuals more closely resembles female-typical volume and neuron numbers, while MRI studies have identified mixed or intermediate cortical thickness and white-matter patterns in some hormone-naïve samples. These findings are limited by small samples, heterogeneity, and confounds such as sexual orientation, hormone exposure, and neuroplastic changes from chronic distress or social factors; some interpret them as possible innate predispositions.[333][334]Cross-Species and Evolutionary Analogues
Sequential hermaphroditism and sex reversal occur widely in non-mammalian species, sometimes cited as evolutionary parallels or contrasts to human gender incongruence. Clownfish (Amphiprioninae) exhibit protandrous hermaphroditism: the dominant individual becomes female upon loss of the breeding female, with rapid hormonal and behavioral shifts.[335] Bluehead wrasses and some parrotfish change from female to male (protogyny) triggered by social hierarchy.[336][337] Certain amphibians (e.g., Rana temporaria frogs) and fish display environmentally induced sex changes via temperature or pH.[338] Some authors interpret these as evidence of natural plasticity in sex determination that supports broader views of sex variability or gender fluidity.[339] Others emphasize that the changes remain strictly binary (production of either sperm or ova), are adaptive reproductive strategies triggered by social or environmental cues, and lack a direct analogue in mammals, which have fixed chromosomal sex determination and internal gestation.[340][341] In these species the transition produces functional gonads of the opposite sex and is an evolved reproductive strategy, not an expression of psychological gender identity.[342][343] Comparative biologists generally treat the phenomena as informative about evolutionary pressures on sex differentiation while cautioning against direct equivalence to human gender dysphoria.[341]Psychological and Developmental Explanations
Psychological models propose that gender dysphoria may emerge from underlying mental health dynamics, such as dissociation or attachment disruptions. Some researchers (e.g., Blanchard and followers) propose that in a subset of cases—particularly late-onset male-to-female presentations—sexual arousal patterns involving the fantasy of oneself as the opposite sex (autogynephilia) may contribute to the desire for body modification or social-role change. This remains a contested minority framework.[52] Studies show elevated rates of personality disorders, including borderline personality disorder and other Cluster B disorders, among individuals with gender dysphoria. One multicenter European study found lifetime psychiatric comorbidity rates of nearly 70% (current Axis I diagnoses in 38%, mainly affective and anxiety disorders) among transsexual individuals, with personality disorders diagnosed in 15%.[344] Assessments of transgender patients reveal higher diagnoses of Cluster B disorders. DSM-5 criteria for gender dysphoria require a marked incongruence between experienced/expressed gender and assigned gender of at least 6 months’ duration, associated with clinically significant distress or impairment in functioning; a specifier notes when the condition exists with a disorder of sex development.[249] Clinic and population studies consistently find elevated rates of psychiatric comorbidity—particularly autism-spectrum traits (3–6× general-population rates), personality disorders (especially Cluster B), anxiety, depression, and histories of adverse childhood experiences—compared with the general population or with other clinical groups.[345][346][297][347][8] Developmental factors include the process by which individuals become aware of a transgender gender identity, which is highly individual and can occur at any age, from early childhood to adulthood. Many individuals who later identify as transgender retrospectively report an early and persistent sense of incongruence between their experienced gender and their biological sex, often becoming more evident during puberty or through life experiences. Realization may be gradual, involving self-reflection and exploration, or sudden, triggered by exposure to gender-diverse information or social contexts. Not all transgender people experience gender dysphoria, but awareness typically involves recognizing incongruence between one's experienced gender and their biological sex.[33] Adverse childhood experiences (ACEs), such as abuse or neglect, reported at rates up to twice the general population average among those with gender dysphoria. These may foster dissociative coping mechanisms. Clinical observations link early familial instability or sexual trauma to later gender incongruence. Longitudinal studies indicate developmental fluidity. Older clinic-based longitudinal studies of prepubertal children with gender dysphoria reported desistance rates of approximately 60–90% by adulthood in the absence of social or medical transition.[45][46] More recent studies of youth who have already socially transitioned (e.g., Olson et al., 2022) report high short-term persistence (~97% after ~5 years).[348] These two sets of findings are not directly comparable because of differences in sample composition, diagnostic thresholds, and follow-up length; long-term data on persistence after early social transition remain limited. Persistence into adulthood occurs at rates of 2.2–50%.[349][350][351][352][353][330][354] Ray Blanchard's typology distinguishes "homosexual transsexuals," who are early-onset androphilic males exhibiting feminine behaviors from childhood, from "autogynephilic" types, who are late-onset typically gynephilic males motivated by sexual arousal from envisioning themselves as women. Surveys report autogynephilic ideation among non-homosexual male-to-female transsexuals correlating with transition motivations. MRI studies describe distinct neural patterns aligned with this classification. Functional MRI studies on own-body perception tasks have found that transgender individuals exhibit brain activation patterns in self-referential networks, including the default mode network (e.g., posterior cingulate cortex and precuneus), that align with their gender identity rather than their biological sex.[355] Data from multiple cohorts describe autogynephilia as a paraphilia in a subset of cases. Clinical evidence includes phallometric testing to assess arousal patterns. Critics, such as Moser (2009), have applied Blanchard's autogynephilia scales to cisgender women and found that a significant majority (93% in one study of 29 women) report experiences that would classify them as autogynephilic under the same criteria, suggesting these traits may reflect normative aspects of female sexuality rather than a unique paraphilia driving gender dysphoria in males. The World Professional Association for Transgender Health (WPATH) objected to the inclusion of autogynephilia as a specifier for Transvestic Disorder in the DSM-5 through their consensus process, arguing against pathologizing such arousal due to insufficient evidence.[356] The typology remains a minority but actively researched framework within sexology; it does not command consensus and is rejected by many affirmative clinicians.[52][357][358][359][360][361][362][363][364]Social/Environmental Hypotheses
Social contagion theory describes clusters of behaviors attributable to direct social influence, homophily, or shared environments.[365][366][367] Post-2010 trends show natal female adolescents disproportionately seeking gender-related interventions, correlating with online visibility; recent referrals comprise 60-90% adolescent females, contrasting historical patterns. Gender dysphoria diagnoses have risen sharply, such as UK referrals increasing 4,000% from 2009 to 2018.[368] Parent reports describe increased social media engagement, friend-group clustering of identifications, and sudden onset without recalled childhood indicators in many adolescent cases. Proponents of applying this framework to transgender identification, particularly among adolescents, posit spread through peer networks and online communities, akin to patterns observed in eating disorders or self-harm. The "rapid-onset gender dysphoria" (ROGD) hypothesis refers to sudden identity declarations amid online exposure and peer clusters, without prior childhood indicators. Clinical literature recognizes adolescent-onset gender dysphoria as a distinct trajectory from childhood-onset cases, based on differences in recalled prepubertal incongruence and emergence timing.[369] While social hypotheses like ROGD emphasize sudden onset without prepubertal history, the mere absence of early indicators does not conclusively prove social causation, as other developmental factors may contribute. Lisa Littman's 2018 study, based on parent reports from 256 cases of adolescents and young adults, reported that 86.7% had an increase in social media/internet use, belonged to a friend group in which one or multiple friends became transgender-identified, or both; in 36.8% of the friendship groups described, a majority of members became transgender-identified; 62.5% had at least one prior mental-health or neurodevelopmental diagnosis.[272] A 2023 study by Diaz and Bailey of 1,655 parent surveys found that 60% of natal females and 38% of natal males had at least one friend who declared a transgender identity around the same time, with parents reporting an average of 4.5 hours per day of internet and social-media use prior to onset.[370] The paper was retracted from Archives of Sexual Behavior over consent documentation and subsequently republished in the Journal of Open Inquiry in the Behavioral Sciences.[371][372] The ROGD hypothesis and social contagion concepts remain debated in the scientific community. The Cass Review (2024) documented a marked increase in adolescent referrals, a reversal of the historical sex ratio, and evidence of social influence and peer clustering, while stating that there is no simple explanation for the increase and that it results from a complex interplay between biological, psychological and social factors; the evidence base for social contagion as a sole or primary driver remains limited and multifactorial explanations are required.[10] No large-scale prospective, controlled studies have confirmed social contagion as a primary driver of adolescent gender identification increases, and the absence of such studies likewise precludes ruling it out as a contributing factor; ongoing research gaps underscore the need for direct youth-reported data to complement parent observations. Critics of the ROGD hypothesis argue that methodological limitations, such as reliance on parent reports and non-probability sampling, undermine its validity. Littman’s sample was recruited partly via parent forums concerned about rapid-onset cases, raising the possibility of selection bias toward those parents; parallel limitations apply to clinic- or advocacy-recruited samples that may under-represent desisters or parental concern.[373] ROGD is not a formal diagnosis in DSM-5 or ICD-11 and is not endorsed as an etiology by WPATH or the APA. Nonetheless, the underlying observations of sudden adolescent-onset clusters, peer contagion patterns, and sex-ratio shifts remain subjects of active empirical investigation. Critics attribute rises in identifications to greater visibility, reduced stigma, and evolving diagnostic practices rather than contagion. Subsequent analyses and publisher notes on related studies (e.g., correction to the 2018 Littman study by PLOS ONE) have raised concerns about selection bias and called for caution in interpreting findings as evidence of causation.[374] Some longitudinal studies provide context for persistence, such as Olson et al. (2022), which followed 317 youth who had already socially transitioned (mostly with prepubertal onset and parental support for the transition) and reported a 7.3% retransition rate after an average of 5 years; the design does not address desistance rates among non-transitioned or less-supported cohorts, and follow-up was short relative to the full developmental window.[375][376][377][378][374][10][379][380][348]Comparative Phenomenology with Analogous Conditions
The experiences labeled gender dysphoria (DSM-5) or gender incongruence (ICD-11) share descriptive features with other conditions involving persistent incongruence between experienced sense of self and physical body, such as body integrity dysphoria (desire for amputation of healthy limbs), species dysphoria, or certain presentations of anorexia nervosa involving distorted body perception. In each case, individuals report intense discomfort or alienation from observable anatomical traits, often accompanied by requests for medical modification. Some clinicians and researchers have drawn phenomenological analogies to body integrity dysphoria and anorexia nervosa, noting similarities in onset during adolescence, comorbidity patterns (including neurodiversity and trauma history), and debates over medical versus exploratory psychotherapeutic approaches.[381][382] Phenomenological parallels include intense rejection of healthy anatomy, requests for irreversible medical alteration, adolescent-onset clusters, and elevated rates of autism-spectrum traits and trauma history.[381] Key differences include the social and legal recognition afforded to gender identity claims, the existence of large-scale medical pathways for transition, and the relative rarity and lack of institutional endorsement for surgical responses to body integrity dysphoria or species dysphoria.[383] Diagnostic classification, treatment pathways, and evidence standards remain distinct for each condition. DSM-5 gender dysphoria requires marked incongruence plus clinically significant distress or impairment; ICD-11 gender incongruence focuses on the mismatch itself without requiring distress. Some clinicians and researchers treat the phenomenon primarily as an identity issue; others emphasize distress, comorbidity, or developmental factors.[2][3] Unlike the affirmative medical pathways available for gender incongruence in many jurisdictions, medical interventions for body integrity dysphoria (e.g., elective amputation) remain exceptional and ethically contested, and treatment of anorexia nervosa prioritizes correction of the perceptual distortion rather than affirmation of the desired body state.[354][381][383][384][385] Contemporary models increasingly integrate biopsychosocial factors: genetic/epigenetic predispositions interact with prenatal hormonal environments, early trauma/comorbidities, and adolescent social influences (peer groups, online communities). Persistence rates appear higher in youth who have undergone social transition (changes to live as one’s identified gender, such as adopting a new name and pronouns, altering clothing and hairstyles), though long-term data remain limited. Individualized assessment is emphasized over universal explanations. Several questions remain subjects of active investigation: the relative contributions of genetic, prenatal, and post-natal social factors to persistence versus desistance; the optimal duration and design of longitudinal studies tracking mental-health trajectories over decades; and the development of improved methods for distinguishing primary gender incongruence from secondary presentations linked to neurodiversity or trauma. There is a need for larger, higher-quality cohorts with minimal loss to follow-up to refine causal inferences and inform individualized care pathways.Treatment Approaches
Non-Medical Interventions and Resolution Without Medical Intervention
Two primary non-medical clinical approaches are used for children and adolescents with gender dysphoria. Social transition involves changes in name, pronouns, clothing, and social presentation to match the individual’s self-reported gender identity, such as adopting a new name and pronouns, altering clothing and hairstyles, and informing family, peers, or institutions; it can occur at any age and is often accompanied by family and school support.[386] Watchful waiting or exploratory approaches involve comprehensive psychological assessment, monitoring of symptoms over time, and treatment of co-occurring conditions such as anxiety, depression, autism-spectrum traits, or trauma, without immediate social or medical transition.[387] Proponents of each approach cite different evidence and ethical priorities. Systematic reviews, including the Cass Review (2024), find that high-quality comparative data remain limited and that the evidence for long-term benefit from either approach is of low or very low certainty.[388][389][390] Psychological therapies for gender dysphoria include gender-affirmative approaches such as transgender-affirmative cognitive-behavioral therapy (CBT), which support the stated gender identity and aim to reduce distress associated with incongruence by addressing maladaptive thoughts, enhancing coping skills, and exploring gender-related concerns.[391] Exploratory psychotherapies examine possible underlying factors such as comorbidities, trauma, or social influence, while remaining open to the possibility that the gender identity is persistent and may warrant later social or medical steps.[392] Both approaches are described in the clinical literature; high-quality evidence comparing long-term outcomes remains limited.[390] Support groups, including organizations like PFLAG, provide peer support and family education.[393] Voice and communication therapy is a non-medical intervention offered to modify speech patterns, pitch, resonance, and nonverbal cues toward those typical of the opposite biological sex; WPATH standards describe this as aligning communication with gender identity. Many participants report improved social confidence and reduced dysphoria, with measurable changes in listener perception ratings.[394] Therapy is typically short-term and reversible. Critics note variable outcomes depending on starting voice characteristics and age, and some individuals experience limited benefit or choose not to pursue it. Guidelines recommend it as an optional component of care when desired.[395]Pharmacological Interventions (Puberty Blockers and Hormones)
Surgical Interventions
Multisensory and Proprioceptive Changes Associated with Transition
Bodily modifications associated with medical transition can trigger sensory and proprioceptive recalibration processes that alter how the brain integrates visual, tactile, vestibular, and interoceptive signals. Whether these changes produce a stably coherent sense of self remains an open empirical question. Neuroscience experiments using rubber-hand illusions, full-body ownership paradigms, and virtual-reality embodiment demonstrate that the brain’s body map can be updated through repeated congruent stimuli, producing measurable changes in perceived ownership and agency.[426][427] These laboratory paradigms demonstrate short-term plasticity of body ownership in non-clinical samples under controlled multisensory conflict. Their relevance to the longer-term, hormonally and surgically induced changes experienced by people with gender dysphoria is plausible but not yet firmly established; most studies remain small, cross-sectional, or limited to healthy volunteers.[428] Some post-hormone or post-surgical individuals report subjective shifts in gait, voice resonance, temperature sensitivity, and genital schema.[322] Objective longitudinal data on the frequency, magnitude, and durability of these changes—and on their relationship to residual incongruence—are limited. These processes illustrate the known plasticity of multisensory body maps.[428][429] At the same time, clinical and phenomenological reports document persistent mismatches between the altered body and the experienced sense of self in a non-negligible subset of cases.[430][431] Research remains exploratory and does not demonstrate that medical transition reliably produces full resolution of incongruence.[10]Healthcare Access Barriers
Access to specialized gender services varies widely. Reported barriers include long waiting times in public systems, variable insurance coverage, and limited provider numbers. In the U.S., federal regulations under the Affordable Care Act’s Section 1557 have been interpreted by some administrations and courts as prohibiting discrimination on the basis of gender identity in covered health programs; state-level rules and specific coverage exclusions vary, and the interpretation remains subject to legal and regulatory change.[432][433] Some clinicians and systems restrict or decline certain interventions, citing limited high-quality evidence of net benefit, irreversibility of effects, high rates of co-occurring mental-health conditions, and the need for thorough differential diagnosis.[434][435][436][12] Advocacy groups and some guidelines attribute many refusals to bias, insufficient training, or discrimination and advocate expanded access to affirmative care.[55] Globally, limited specialist capacity, rural access limitations, and cultural, legal, and religious factors (in addition to stigma) in low-resource settings, particularly in low-income countries in Africa and Southeast Asia, affect both demand and provision, with limited services reported by WHO and UNAIDS; WHO recommendations emphasize training to improve equity.[437] Wait times in systems such as the UK NHS have lengthened amid large increases in referrals (particularly among natal-female adolescents, many of whom present with significant comorbidities) and, in some jurisdictions, after policy shifts toward more comprehensive assessment following systematic reviews that rated evidence for medical interventions as very low certainty; as of 2025, waits averaged over five years for a first appointment in adult services, with over 40,000 people waiting.[434][438] Post-COVID-19, telehealth utilization has increased, facilitating virtual consultations and hormone management, thereby enhancing access for some transgender individuals while raising questions of assessment quality and continuity of care.[439] Both the access-expansion literature (WHO, advocacy groups) and the evidence-caution literature (Cass Review, European national health authorities, systematic reviews rating evidence very low) appear in policy debates.Evidence on Treatment Outcomes
The evidence base for medical interventions (puberty blockers, cross-sex hormones, and surgery) consists almost entirely of observational studies. Independent systematic reviews commissioned by health authorities in the UK (Cass 2024, NICE), Sweden, Finland, and the United States (HHS 2025) rate the certainty of evidence for psychological and quality-of-life benefits as very low and note physical risks including infertility, reduced bone mineral density, and possible cardiovascular effects.[10][440] Observational studies frequently report short- to medium-term improvements in self-reported distress and well-being among individuals with persistent gender incongruence who undergo these interventions; these findings are subject to the same methodological limitations (lack of randomization, high attrition, confounding). Professional associations including WPATH, the Endocrine Society, and several national pediatric and endocrine societies continue to recommend access to these interventions for carefully selected patients despite the low certainty ratings assigned by the systematic reviews.[398][11] Clinicians and researchers who interpret the available observational data plus clinical experience as justifying individualized medical interventions under multidisciplinary care (often termed the affirmative model) also cite an ethical obligation to relieve suffering and note that several large medical associations judge benefits to outweigh risks in selected patients. Clinicians and researchers who apply evidence-based-medicine standards and the precautionary principle, prioritizing minimization of irreversible harm (often termed the exploratory or cautionary model), argue that apparent benefits may reflect concurrent psychotherapy, social support, or natural maturation rather than the medical treatments; they therefore recommend psychological care as first-line, especially for minors.Evidence quality
The evidence base for medical interventions in gender dysphoria relies primarily on observational studies, cohort analyses, and few randomized trials. Systematic reviews consistently highlight methodological weaknesses, including lack of randomization, small sample sizes, high attrition, inadequate comorbidity controls, short follow-ups, and publication bias toward short-term positives. Major reviews affirm low evidence quality. The Cass Review (2024), analyzing over 100 studies, rated most as weak and found limited evidence of long-term improvements in dysphoria, mental health, or body satisfaction from puberty blockers or cross-sex hormones.[10] The UK's NICE evidence reviews (2020) reported "very low certainty" for psychosocial or dysphoria benefits from puberty blockers.[441] A 2024 Archives of Disease in Childhood review of 50 studies noted inconsistent short-term psychological effects and limited long-term data.[397] Miroshnychenko et al. (2025) in Archives of Disease in Childhood conducted GRADE-assessed meta-analyses of puberty blockers and cross-sex hormones (termed gender-affirming hormones in the source) in individuals under 26, rating evidence very low certainty for psychological outcomes (gender dysphoria, depression, global function), bone mineral density, and other endpoints due to risk of bias, imprecision, and lack of comparators; one pooled analysis found 92% of puberty-blocker recipients progressed to hormones within 12–36 months (very low certainty).[442][443] The authors concluded that benefit or harm cannot be excluded and called for rigorous prospective studies. Sweden's 2022 youth hormonal treatment review identified insufficient high-quality evidence for benefits.[444] Finnish and Cochrane reviews highlighted elevated post-transition suicide risks unaffected by interventions and absent randomized hormone trials. A 2025 US HHS report on pediatric gender dysphoria treatments emphasized limitations in systematic reviews and low-quality evidence for intervention benefits.[445] Systematic reviews assessing interventions for gender dysphoria in youth—particularly puberty blockers and cross-sex hormones—have consistently applied the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework or equivalent tools to rate evidence certainty very low to low. These downgrades stem from pervasive issues in primary study design, such as reliance on uncontrolled or weakly controlled observational data, short follow-up durations relative to intervention irreversibility, high attrition rates that compromise representativeness, and challenges in disentangling intervention effects from maturation, comorbid conditions, or concurrent psychosocial support. Risks of bias (e.g., lack of randomization, inadequate controls, confounding), imprecision from small samples, inconsistency across studies, and indirectness when outcomes rely on proxy measures rather than direct clinical endpoints further contribute to low certainty for benefits on key domains such as psychological functioning, quality of life, and long-term health, with similar limitations applying to safety profiles (e.g., bone density, fertility, cardiometabolic effects). Proponents of models involving affirmation of gender identity recognize these GRADE limitations but contend that the framework may apply overly stringent criteria in a field constrained by ethical barriers to randomization and long-term experimental designs. They argue that consistent directional signals in observational cohorts, combined with clinical consensus from major associations, offer practical warrant for individualized care despite formal downgrades, and that alternative appraisal approaches prioritizing patient-centered proxies or real-world applicability could yield higher perceived certainty. Critics emphasize that very low certainty indicates significant uncertainty, warranting caution especially for irreversible interventions in minors, and highlight recurring methodological issues including selection bias, missing data, and limited long-term follow-up. GRADE downgrades remain a point of contention, with debates over whether observational designs can achieve higher ratings absent RCTs and whether alternative frameworks better capture patient-centered outcomes. Overall, the preponderance of formal evidence-quality assessments using GRADE or similar methods rates the body of evidence as very low to low for both benefits and harms of medical interventions in youth, sustaining calls for improved study designs (e.g., prospective registries with minimal loss to follow-up, objective markers) while contributing to international practice variation. Observational studies like deMayo et al. (2025) on the Trans Youth Project cohort (N>900, followed 2013–2024) report over 80% of early socially transitioned transgender youths maintained stable gender identity across childhood to adolescence, a rate statistically indistinguishable from non-transgender siblings and matched peers, with changes predominantly to nonbinary identities rather than reversion to identification with natal sex.[446] Wright et al. (2024, Journal of Paediatrics and Child Health) synthesised available data to argue that treatments are associated with reported improvements in appearance congruence, social recognition, and self-reported distress, with some associated mental-health improvements in some cases and low regret rates (0.5–2%). They noted that physical risks are documented but often manageable.[447] Proponents of models involving affirmation of gender identity interpret the stability data and reported improvements in appearance congruence and social recognition as supporting timely intervention in persistently incongruent cases, especially where family support is present. Critics maintain that very low certainty in the intervention reviews—particularly the high progression rate and absence of robust comparators—underscores the need for caution, arguing that observational persistence in supported cohorts does not demonstrate causal efficacy of medical pathways over psychosocial approaches alone. These additions illustrate ongoing divergence: rigorous syntheses continue to rate evidence quality as very low, while longitudinal cohorts in environments that affirm the identified gender show higher persistence than historical clinic samples. The following table summarizes key findings from major systematic reviews and guidelines:| Review/Guideline | Evidence Quality Rating | Key Findings on Long-term Outcomes | Youth Treatment Recommendations |
|---|---|---|---|
| Cass Review (2024) | Weak/low | Limited evidence of long-term improvements in dysphoria, mental health, or body satisfaction | Restrict routine use of puberty blockers and hormones due to uncertain benefits and risks |
| NICE (2020-2021) | Very low certainty | Inconsistent or absent benefits for psychosocial functioning or dysphoria | Limited evidence supports puberty blockers; further research needed |
| Swedish National Board of Health and Welfare (2022) | Insufficient high-quality evidence | Uncertain benefits outweighing risks for hormonal treatments | Restrict non-experimental use of hormones in youth |
| WPATH SOC8 (2022) | Primarily observational | Short-term reductions in distress and improved quality of life in affirming models | Recommend puberty blockers and hormones for eligible adolescents under multidisciplinary care |
| Endocrine Society (2017, updated) | Low to moderate based on available studies | Alleviation of dysphoria and mental health improvements | Support puberty suppression for Tanner stage 2+ adolescents with persistent dysphoria |
Professional guidelines and organizational positions
Independent systematic reviews using GRADE or equivalent methods, commissioned by national health authorities in the United Kingdom (Cass Review 2024 and associated NICE/York assessments), Sweden, Finland, Norway, and the 2025 U.S. HHS report, have concluded that the evidence for puberty blockers and cross-sex hormones in adolescents is of low or very low certainty. These reviews find very weak evidence of benefit for alleviating gender dysphoria or improving mental-health outcomes (including suicidality) and identify risks that include infertility or sterility, sexual dysfunction, impaired bone-density accrual, and uncertain effects on cognitive and psychosexual development. The reviews have led those jurisdictions to restrict routine use outside research protocols.[390][451][452][453] Different bodies respond differently to this shared low-certainty evidence. WPATH SOC-8 (evidence graded informally rather than by GRADE), the Endocrine Society, AAP, APA, and AMA recommend protocols that include puberty blockers and cross-sex hormones for eligible adolescents, citing observational evidence of reduced distress and placing greater weight on clinical consensus and access to care.[395][385][454][455][456] The World Professional Association for Transgender Health (WPATH) Standards of Care Version 8 (2022, with later clarifications) and the Endocrine Society Clinical Practice Guideline (2017, updated) recommend social transition, puberty blockers for eligible adolescents, cross-sex hormones, and surgery where indicated, stating these interventions alleviate gender dysphoria and improve mental health outcomes including reduced suicidality (low-certainty evidence per GRADE ratings in Cass/NICE reviews).[385][457] Additional endorsements include the American Psychological Association (2024 policy statement), which supports unobstructed access to evidence-based clinical care (which it describes as affirming care) for transgender, gender-diverse, and nonbinary individuals of all ages and opposes legislative bans;[455] the American Medical Association, which affirms coverage for medical and surgical treatments for gender dysphoria and gender incongruence (which it terms gender-affirming care) as medically necessary and opposes criminalization;[456] and the American Psychiatric Association (2025 position statement), which endorses the full range of treatment options (which it describes as affirming) decided by families, youth, and physicians.[458] The World Health Organization’s ICD-11 (2019) depathologized gender incongruence by removing it from mental disorder classifications.[3] The American Academy of Pediatrics (policy statement 2018, reaffirmed) similarly supports a gender-affirmative care model and opposes restrictions on care.[454] These positions are followed in parts of the United States and some other countries. For adults, observational evidence is more extensive than for youth (with remaining long-term uncertainties documented in the Adult outcomes and Evidence quality sections) and access remains broadly available in many jurisdictions. The divergence reflects differing thresholds for acting on low-certainty evidence (access and observational signals versus precaution and restriction of routine use) rather than organizational endorsement implying high-certainty evidence.Youth outcomes
Independent systematic reviews, including the Cass Review's University of York evidence reviews (2024) and NICE assessments (2020–2021), rate the evidence for social transition, puberty blockers, and cross-sex hormones in youth as low- or very-low-certainty. They find no reliable evidence of benefit on gender dysphoria, body satisfaction, mental health, or psychosocial outcomes, and uncertain or unknown effects on cognitive development, fertility, bone health, and psychosexual development.[10][388][397][401][453] The Cass Review found that puberty blockers do not appear to “buy time to think,” as most who start them continue to cross-sex hormones (typically exceeding 90% in clinic follow-up), and there is no clear evidence of reduced suicide risk.[10] For a comparative overview of major reviews, see the summary table in the Evidence quality subsection. Pre-2010s longitudinal clinic follow-ups of children with gender dysphoria (typically referred before puberty and managed without social or medical transition) reported desistance rates of approximately 60–90% by adolescence or adulthood. Steensma et al. (2013) followed 127 children referred before age 12 and classified 80 (63%) as desisters in adolescence; intensity of childhood dysphoria, social role transition, and natal sex (higher persistence among natal females) predicted persistence.[45] Singh, Bradley and Zucker (2021) reported desistance in 122 of 139 (87.8%) clinic-referred boys followed into young adulthood.[46] Recent large administrative datasets likewise show low diagnostic stability: German statutory-insurance data covering youth aged 5–24 found that only 36.4% of those with a confirmed F64 gender-identity diagnosis retained it after five years (27.3% among 15–19-year-old females).[459] These historical data primarily describe childhood-onset presentations; contemporary cohorts, which are predominantly adolescent-onset and natal-female, lack equivalent long-term natural-history studies from watchful-waiting samples and may follow different trajectories. Qualitative reports from parents, clinicians, and some studies indicate short-term reductions in acute distress and improved peer integration following social transition. These short-term associations have been interpreted through minority-stress models in which changes in social presentation (name, pronouns, and clothing matching identified gender) mitigate distress from societal stigma, as well as through competing frameworks that emphasize co-occurring psychiatric and neurodevelopmental conditions, possible social, peer, and online influences (including hypothesized rapid-onset presentations), and potential iatrogenic effects of early social transition on identity persistence (low-certainty evidence per GRADE ratings in Cass/NICE reviews). Systematic reviews such as the Cass Review highlight low-quality evidence overall, suggesting these benefits may partly arise from accompanying psychological support, that social transition is an active intervention that may alter developmental trajectories (particularly in pre-pubertal children), and that long-term persistence of benefits in the absence of further interventions remains unconfirmed.[457][390] For adolescents, systematic reviews such as the Cass Review and NICE assessments reported mixed short-term psychological effects from puberty blockers or cross-sex hormones but no consistent long-term improvements in dysphoria or mental health, while documenting or leaving unexcluded physical and developmental risks including reduced bone-mineral-density accrual, uncertain effects on cognitive, brain, and psychosexual development, and high rates of progression to cross-sex hormones (typically exceeding 90% in clinic follow-up) with associated fertility impairment.[453][397][390] Observational associations from individual studies are rated low-quality and confounded by systematic reviews. Some observational studies have reported positive short-term associations; for instance, Turban et al. (2020) found that access to pubertal suppression during adolescence was associated with lower lifetime suicidal ideation among transgender adults (adjusted odds ratio 0.3, 95% CI 0.2–0.6, after controls; cross-sectional adult survey data, limited long-term data and low certainty per GRADE in systematic reviews),[460][461] and Tordoff et al. (2022) reported that puberty blockers and cross-sex hormones (termed gender-affirming medications in the source) were associated with lower odds of depression (adjusted odds ratio 0.40) and suicidality (adjusted odds ratio 0.27) over 12 months in a prospective cohort of transgender and nonbinary youth (observational data subject to confounders).[462] These associations come from cross-sectional or short-term observational/self-report data subject to selection bias, reverse causation (youth with better-controlled mental health more likely to receive blockers), unreliable self-report on treatment timing, exclusion of those who detransitioned or died by suicide, and inconsistent findings across most suicidality measures; systematic reviews rate the evidence low-certainty and do not support causal claims of reduced suicidality.[463] Short-term observational data from clinics report decreased suicidality and improved functioning during early hormone phases for some adolescents, per USTS and clinic registries, though European systematic reviews rate such evidence as low-quality and confounded by concurrent psychotherapy/social support (low-certainty evidence per GRADE ratings in Cass/NICE reviews). These findings derive from non-randomized designs and are subject to limitations including potential confounders, selection bias, and short follow-up periods, consistent with broader critiques of evidence quality in the field.Adult outcomes
Long-term population-based cohort studies, such as Dhejne et al. (2011) following 324 Swedish individuals after sex-reassignment surgery (1973–2003), find substantially elevated suicide mortality (adjusted hazard ratio 19.1), suicide attempts (aHR 4.9), and psychiatric inpatient care (aHR 2.8) relative to matched general-population controls, even after adjustment for prior psychiatric morbidity.[421] More recent U.S. analyses using the TriNetX database similarly report 4.71- to 12.12-fold higher risks of suicide attempts within five years after sex-reassignment surgery compared with propensity-matched controls.[464] Intra-group observational and survey studies, including Almazan et al. (2021) analysis of the 2015 U.S. Transgender Survey, report lower odds of psychological distress and past-year suicidal ideation among those who received surgery compared with those who desired but had not received it.[465] Turban et al. (2020) and other retrospective surveys similarly associate recalled access to puberty blockers or hormones with lower lifetime suicidality.[460] Bränström and Pachankis (2020) initially associated longer time since surgery with reduced mental-health treatment utilization, but a subsequent correction found no advantage versus individuals with a gender-incongruence diagnosis who did not undergo surgery.[466] Systematic reviews observe that both the population-level and intra-group findings are limited by observational design, absence of randomization, high attrition, residual confounding by comorbidities, social support and selection into treatment, and relatively short follow-up in many datasets. Long-term population-based cohort studies with matched controls and low attrition (such as the Swedish national registry follow-up) generally carry higher weight for long-term outcomes such as suicide mortality than short-term intra-group surveys of self-selected samples. Interpretations of the persistently elevated rates versus the general population include the minority-stress model (chronic stigma and discrimination), unresolved or pre-existing psychiatric conditions, possible adverse effects of the medical interventions themselves, and selection or healthy-user effects. Quality-of-life assessments using validated scales (e.g., SF-36, WHOQOL) in adult cohorts often show statistically significant gains in domains like social functioning, vitality, and emotional role post-hormone therapy or surgery, though improvements are smaller or absent in domains tied to physical limitations or regret (low certainty for long-term effects). Long-term physical outcomes, which enter net-benefit calculations, include an approximately 40% higher overall cardiovascular-disease risk relative to cisgender people of the same birth sex and a pooled venous-thromboembolism relative risk of 2.2 (incidence 1.6%) among natal males receiving estrogen; an 8-year absolute risk difference of 16.7 events per 1,000 versus cisgender men was observed in one large U.S. cohort.[467][468] Bone-mineral-density changes in adults are typically modest, though low bone mass is more prevalent after prolonged estrogen plus gonadectomy; fertility is commonly impaired and often irreversible without prior gamete preservation; sexual-function results are heterogeneous. These observational findings share the methodological limitations already noted for psychiatric data and are detailed further under Adverse events. High reported satisfaction with surgical appearance or short-term dysphoria reduction does not automatically equate to population-normalized mental health or preclude later regret, consistent with persistently elevated suicide and psychiatric-hospitalization rates even after adjustment for pre-existing morbidity. Clinic-based follow-up studies of regret typically capture only patients who remain in contact with the original service; they commonly have high loss to follow-up (20–36% in several series) and short observation windows (often under 5 years), thereby undercounting those who discontinue attendance, die by suicide, or experience delayed regret that can emerge years later.[469] Longer-term population registries and consecutive-discharge audits have produced higher estimates in some analyses (for example, 2.2% legal-gender reversal applications in a Swedish national series spanning 1960–2010 and 6.9% meeting a detransition case definition among 175 patients discharged from a UK adult gender-identity clinic).[470][471] A survey of 100 individuals who had medically or surgically transitioned and subsequently detransitioned found that only 24% had informed their original clinicians; reported reasons included both internal shifts in gender identity (60%) and external pressures as well as medical complications or unimproved mental health.[472] Certain U.S. administrative cohorts report hormone-continuation rates of approximately 70% at four years.[473] Observational data frequently show reductions in gender-dysphoria scores after intervention, but long-term population studies have not demonstrated that overall psychiatric morbidity or suicide mortality converge to general-population baselines. A number of systematic reviews, typically of low or very low GRADE certainty due to selection bias, absence of concurrent untreated controls, high attrition, and self-report outcomes, have reported associations with reduced gender dysphoria, improved psychological functioning, and higher quality of life in the short to medium term. The Cornell University What We Know Project (reviewing 55 peer-reviewed studies published between 1991 and 2017 without GRADE assessment of study quality) concluded that the vast majority of research found reduced gender dysphoria, improved psychological functioning, and higher quality of life following medical transition.[474] A 2023 systematic review of gender-affirming hormone therapy similarly found consistent reductions in depressive symptoms and psychological distress, with inconsistent evidence for quality of life and limited long-term data.[475] These findings have been cited by the American Medical Association and the World Professional Association for Transgender Health as supporting medical necessity. Independent systematic reviews of adult hormone treatment, such as the 2022 Swedish SBU assessment, reported associations with improved short-term psychological well-being but rated the evidence insufficient to assess longer-term effects owing to high risk of bias, residual confounding, and limited follow-up.[476] Assessments of NHS adult gender services linked to the Cass Review have likewise noted a limited evidence base and scarce long-term outcome data.[477] At the same time, long-term population-based studies (for example, the Swedish cohort followed for over 30 years) indicate that suicide rates and psychiatric morbidity remain elevated compared with the general population even after medical transition, and some reviewers note that methodological limitations—including loss to follow-up and lack of randomized controls—apply to both positive and negative findings. Ongoing research continues to examine whether these elevated risks are attributable to pre-intervention psychiatric morbidity, minority stress, possible adverse effects of the interventions, selection effects, or post-intervention experiences. Transgender older adults (aged 50 and above) represent a growing demographic as earlier cohorts age.[478] They often face compounded challenges including higher rates of loneliness, chronic health conditions, and barriers to long-term care facilities that may lack specialized protocols for post-intervention medical monitoring.[479][478] Some studies document resilience factors such as strong chosen-family networks and continued hormone therapy into later life, with reports of maintained quality of life when appropriate medical monitoring is available.[480] At the same time, long-term data indicate elevated risks of osteoporosis, cardiovascular issues, and cognitive decline in this group, partly linked to decades of hormone exposure or prior minority stress.[481][478] Specialized geriatric programs are emerging in a few regions to address these needs.Temperature Detection Thresholds Measured by Quantitative Sensory Testing
Prospective observational cohorts employing quantitative sensory testing protocols have measured temperature detection and pain thresholds in individuals undergoing cross-sex hormone therapy. Baseline data showed lower temperature detection thresholds in females compared with males. After three and six months of estrogen-based therapy, males receiving estrogen showed shifts in thermal sensitivity in the direction of female reference values. No statistically significant changes occurred in females receiving testosterone. These measurements were obtained using standardized thermal probes and repeated at fixed intervals.[482]Listener Gender Attribution Ratings from Voice Recordings
Experimental studies present de-identified voice recordings to naive listeners who rate perceived gender on continuous or categorical scales. In female speakers receiving testosterone (transmasculine individuals), post-treatment samples receive significantly higher rates of male attribution than pre-treatment samples.[483] Resynthesis experiments isolating acoustic parameters consistently identify mean fundamental frequency—a highly sexually dimorphic trait shaped by laryngeal growth under testosterone—as the strongest single predictor of listener gender judgments.[483] For male speakers after behavioral voice training (transfeminine individuals), listener ratings shift toward more feminine or gender-ambiguous categories, though consistent female attribution remains less common than male attribution after testosterone in female speakers, with outcomes quantified across multiple listener cohorts.[484]Regret and detransition
Estimates of regret after sex-reassignment surgery are typically around 1% in pooled analyses of clinic cohorts, while broader measures of detransition or hormone discontinuation range from under 1% to 8–13% (or higher in some short-term discontinuation studies) depending on definition (temporary versus permanent; external pressure versus identity change; medical cessation without identity shift), population (adult versus adolescent-onset), and follow-up length.[485][486] Most low regret figures derive from adult surgical series under older, more restrictive protocols. Data on adolescents receiving puberty blockers or hormones, and on the post-2010s clinical population, are sparser, shorter-term, and show higher rates of treatment discontinuation or identity flux in several series. Long-term outcomes for the current demographic remain largely unknown.[487][488] All figures carry high uncertainty due to short follow-up (often under five years), high loss-to-follow-up (20–36% in key studies), non-standardized definitions, and reliance on clinic-retained patients, which may underestimate prevalence. The Cass Review noted that rates remain unknown, particularly among youth. Even the lower reported rates occur against a background of irreversible effects and low-quality evidence; absolute numbers affected are rising with the increase in referrals.[489][488] Mental-health outcomes are variously attributed to minority stress, high baseline psychiatric comorbidity, or both; disentangling these requires better-controlled longitudinal data that current studies largely lack.[490][491] Long-term outcomes following medical transition interventions include both reported satisfaction and quality-of-life improvements in some cohorts as well as instances of regret, detransition, and persistent mental-health challenges. Reported regret rates after these interventions are under 1% in pooled analyses of thousands of patients (low-certainty evidence per GRADE ratings due to methodological limitations). However, these figures come from studies with short follow-ups (under five years), high loss-to-follow-up rates (20-30%), and reliance on clinic self-reports, which may underestimate true prevalence. Longer-term tracking remains limited, especially given the potential for delayed onset due to irreversible effects like infertility. A 2021 meta-analysis of 7,928 patients found 1% regret but emphasized methodological limitations.[485] A 2024 systematic review of 3,662 patients (predominantly U.S.) reported a pooled prevalence of 1.94%.[492] The Cass Review noted unknown rates among youth amid social influences. Detransition rates range from 0.5% to 8%. Detransition may involve clinical desistance (a post-transition change in gender identity) or medical cessation (stopping or pausing interventions without a change in gender identity). Surveys of currently identifying people (e.g., the 2015 U.S. Transgender Survey of nearly 28,000 respondents) find external pressures (stigma, family, discrimination) cited by a majority of those who temporarily or permanently detransitioned; Turban et al. (2021) reported 82.5% citing at least one such factor.[486] This non-probability sample cannot capture people who fully exited a transgender identity. Clinic-based and detransitioner-focused studies more frequently report internal factors (identity change, resolution of dysphoria after addressing comorbidities, medical complications): a survey of 100 found 60% became more comfortable identifying as their natal sex and 38% attributed dysphoria to trauma or a mental-health condition, while a survey of 237 found 70% realized gender dysphoria was related to other issues.[493][494] Detransition can be temporary, with some studies finding approximately 42% later resuming after addressing external barriers.[495] Both sets of data are limited by selection and loss-to-follow-up; the relative contribution of external versus internal drivers remains uncertain and likely varies by cohort (especially rapid-onset adolescent cases). Measurement challenges include underreporting, varying definitions, and inadequate longitudinal data.[496][492] Detransitioners report varied trajectories, with some describing initial relief from dysphoria followed by factors such as evolving identity, external pressures from family, peers, or online communities, realization of comorbidities, medical complications, loss of fertility, or impaired sexual function as drivers for desistance. Qualitative studies and testimonies highlight themes of grief over irreversible changes, social ostracism from former communities, and delayed realization, often averaging around 5 years post-transition initiation.[497][498] Affirming perspectives frame detransition as rare and often externally driven, advocating continued access to care with improved screening. Evidence-critical views emphasize underreporting due to stigma, potential iatrogenic harm from rapid affirmation, and the need for dedicated psychological support akin to desistance pathways in conditions like anorexia.[499] Emerging peer support networks provide therapy focused on underlying trauma, autism, or sexual orientation exploration. Since 2022, detransitioners have filed an increasing number of medical malpractice lawsuits against providers of gender-related medical interventions, with over 20 documented cases in the U.S. alleging inadequate mental health evaluations prior to treatments such as puberty blockers, hormones, and surgeries.[500] In a landmark 2026 verdict, a New York jury awarded $2 million to Fox Varian for a double mastectomy performed at age 16, finding that the psychologist and plastic surgeon deviated from accepted standards.[501] Most such cases remain pending, but a 2025 peer-reviewed analysis of litigation trends underscores heightened physician exposure to claims related to gender detransition due to insufficient assessments.[502] These developments reflect instances of regret manifesting through legal channels. The minority stress model, widely referenced in public-health research (American Psychological Association, Centers for Disease Control and Prevention), attributes elevated rates of anxiety, depression, and suicidality primarily to stigma, discrimination, rejection, and lack of social support rather than gender incongruence itself. Some studies using validated quality-of-life instruments (e.g., SF-36, WHOQOL) report statistically significant gains in social functioning, vitality, and emotional well-being for many adults after medical transition, although effect sizes vary and long-term data remain limited (low certainty per systematic reviews). Some longitudinal studies and self-reported surveys indicate improvements in quality of life, body congruence, and mental health for many adults following cross-sex hormone therapy or surgery, with reductions in gender dysphoria and depression in certain cohorts. A 2018 systematic literature review by Cornell University's What We Know Project of 55 studies (through mid-2017) found that 51 (93%) reported that gender transition improves overall well-being.[474] Recent large surveys of currently identifying transgender adults, such as the 2022 U.S. Transgender Survey, found that 98% of those who received hormone therapy and 97% of those who underwent surgery reported that the interventions made them more satisfied with their lives.[503] A 2025 cross-sectional study of 946 patients with prior gender-affirming surgery reported 82% high surgical satisfaction.[504] These benefits are often cited in support of gender-affirmative models, though critics note high loss-to-follow-up, selection bias (including that fully detransitioned individuals are typically not captured), and lack of randomized controls limiting causal claims; evidence quality is moderate for short-term outcomes with limited long-term data. Support services for individuals who detransition or experience regret are limited in many areas. Dedicated clinics and peer-led groups have begun offering counseling, medical reversal options (where feasible), and social reintegration assistance. Some detransitioners report relief in exploring underlying factors such as trauma or co-occurring mental health conditions, while others describe ongoing distress from irreversible physical changes. Affirmative care providers increasingly recommend pre-treatment screening and post-transition follow-up to identify those who may benefit from alternative pathways. Availability of these services varies greatly by country, with critics arguing that more systematic tracking and dedicated funding are needed.Adverse events
Systematic reviews and meta-analyses have documented a range of physiological effects and risks associated with pharmacological and surgical interventions, as detailed in the Treatment Approaches section, including reductions in bone mineral density (particularly during puberty suppression or early cross-sex hormone use), impaired fertility that is often irreversible without prior gamete preservation, changes in sexual function, and elevated cardiovascular risks, including an approximately 40% higher overall risk of cardiovascular disease compared with cisgender people of the same birth sex and a roughly twofold increase in venous thromboembolism among transgender women receiving estrogen compared with cisgender men of the same birth sex (pooled relative risk 2.2, 95% CI 1.1–4.5).[505][506][507][508][467] Standard clinical risk-management measures include preference for transdermal over oral estrogen formulations (to lower VTE risk) and routine fertility-preservation counseling before hormone initiation. Residual risks remain after these precautions and vary with age, formulation, duration of exposure, and individual comorbidities.[509][510] Longitudinal research in this area shares methodological challenges common to other fields involving elective interventions and long-term hormone exposure: rapid evolution of diagnostic criteria and treatment protocols, high rates of loss to follow-up, inability to blind participants or assessors, and tension between patient-reported outcome measures and standardized clinical endpoints. These limitations have led to repeated calls for prospective registries, independent audits, and preregistered protocols to improve the reliability of evidence used for clinical guidance and policy.Bone Mineral Density Changes Measured by DXA Scans
Longitudinal studies have tracked bone mineral density using dual-energy X-ray absorptiometry (DXA) scans before and after gender-affirming hormone therapy. Systematic reviews and meta-analyses of prospective DXA studies, of low-to-moderate quality owing to observational designs, small sample sizes, heterogeneity in hormone regimens, short follow-up, and variable vitamin D and calcium status, generally show modest increases or stability in lumbar spine BMD with estrogen therapy in natal males receiving estrogen plus anti-androgen (trans women) (e.g., +0.03 to +0.06 g/cm² at 12–24 months) and little or no change at the femoral neck, with generally neutral or small positive effects from testosterone in natal females receiving testosterone (trans men). Individual studies vary in the magnitude and direction of change at specific sites.[511][512][513] Effects are site-specific and time-dependent. Estrogen therapy in natal males typically preserves or modestly increases trabecular bone (lumbar spine); testosterone in natal females is largely neutral. Prior gonadotropin-releasing hormone agonist use can lower Z-scores, with variable recovery. Long-term fracture outcome data remain sparse. Guidelines recommend monitoring in high-risk individuals.[514][515][516]Lean Body Mass Measured by Dual-Energy X-ray Absorptiometry
In prospective DXA studies, average changes of approximately 1.8 kg (95% CI −3.15 to −0.47) to 2.4 kg (decreases) in natal males receiving estrogen (trans women) and 3.9 kg (95% CI 3.2 to 4.5) to 4.98 kg (95% CI 4.06 to 5.91) (increases) in natal females receiving testosterone (trans men) have been observed after approximately 12 months of hormone therapy, with substantial heterogeneity and low-to-very-low certainty of evidence. Magnitude varies across cohorts; longer-term data are more limited. Individual prospective DXA studies show a wider range of changes, including losses of around 4–5 kg in some natal-male cohorts. Absolute lean body mass typically remains higher among treated natal males than among treated natal females. These shifts move lean mass toward opposite-sex ranges but typically do not eliminate sex-based differences. Residual lean mass in estrogen-treated natal males often remains higher than in untreated natal females.[517][518] Strength and performance outcomes show related but not identical patterns. Measurements in the included studies were generally taken at baseline and 12-month follow-up using standardized whole-body DXA protocols.[519][520][521]Serum Lipid Profile Changes
Serial blood tests in prospective cohorts have documented average changes in total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides during hormone therapy, particularly over periods of 12–60 months; however, there is substantial inter-individual and inter-study heterogeneity, and some longer-term observational data find attenuation or non-significance.[522] Meta-analyses of longitudinal data show that triglycerides often rise, particularly with testosterone and with oral estrogen, although some pooled analyses of feminizing therapy find little overall triglyceride change. Testosterone produces a clearer pro-atherogenic pattern (increased LDL-C, total cholesterol and triglycerides together with decreased HDL-C). Estrogen primarily raises triglycerides, especially oral formulations, with more variable effects on the remaining lipids. Representative effect sizes include, for masculinizing therapy (natal females receiving testosterone), LDL-C increases of 18–26 mg/dL, HDL-C decreases of approximately 8–9 mg/dL, and triglyceride increases of 21–31 mg/dL over 12–60 months; some analyses of feminizing therapy (natal males receiving estrogen) report triglyceride increases of around 32 mg/dL at ≥24 months.[523][524][525] Heterogeneity across studies is substantial, reflecting differences in hormone type, dose, route of administration, duration, and study quality. The clinical significance of these laboratory shifts for cardiovascular events remains uncertain, and evidence linking them to long-term hard cardiovascular endpoints is limited and of low-to-moderate quality. These shifts generally move some lipid parameters toward typical opposite-natal-sex ranges. Testosterone therapy is associated with a more consistently pro-atherogenic lipid profile, while estrogen effects are milder and formulation-dependent. Routine lipid monitoring is recommended in clinical guidelines.[526][527]Alanine Aminotransferase (ALT) Levels from Blood Tests
Longitudinal blood monitoring studies have tracked alanine aminotransferase (ALT) levels at regular intervals during hormone therapy. In adult females receiving testosterone (trans men / transmasculine individuals), ALT levels showed modest but statistically significant increases after starting testosterone treatment (typically ~2 IU/L at 12 months; rarely reaching injury thresholds).[528][529] In adult males receiving estrogen-based therapy (trans women / transfeminine individuals), ALT levels remain stable or show small decreases.[530][531] Values were obtained from standard venous blood draws and laboratory analysis. Absolute changes are small and often transient; the incidence of frank biochemical liver injury attributable solely to hormone therapy is very low (<1%). Other factors such as alcohol use and body mass commonly influence observed values.[529][528][531]Aspartate Aminotransferase (AST) Levels from Blood Tests
Longitudinal blood monitoring studies have tracked aspartate aminotransferase (AST) levels at regular intervals during hormone therapy. In adult females receiving testosterone (trans men / transmasculine individuals), AST levels showed modest but statistically significant increases after starting testosterone treatment (typically ~2 IU/L at 12 months; rarely reaching injury thresholds).[528][529] In adult males receiving estrogen-based therapy (trans women / transfeminine individuals), AST levels remain stable or show small decreases.[530][531] Values were obtained from standard venous blood draws and laboratory analysis. These changes are generally small and often transient, and the incidence of frank biochemical liver injury attributable to hormone therapy alone is very low (<1%).[528][529] Other factors, including alcohol use and obesity, are associated with higher enzyme levels and can contribute to observed elevations.[531] Some large studies conclude that routine liver-enzyme monitoring specifically for the risk of liver injury from hormone therapy is not necessary.[529]Body Fat Distribution Measured by DXA Regional Analysis
Longitudinal DXA scans have assessed regional body fat distribution before and after hormone therapy. Prospective multicenter DXA data show that in trans women (adult males receiving feminizing hormones, typically with concurrent anti-androgens), android (abdominal) fat increased by 18% while gynoid (hip/thigh) fat increased by 34% and leg fat by 42% after 12 months of estrogen treatment, shifting the android-to-gynoid ratio toward a more gynoid-dominant pattern typically observed in adult females; these represented substantial absolute gains (total body fat +28%). In trans men (adult females receiving masculinizing hormones), gynoid fat decreased by 14% and leg fat by 16% with android fat essentially unchanged (+1%) after 12 months of testosterone treatment; hip circumference fell and waist-to-hip ratio rose. Such regional changes are most pronounced in the first 1–2 years. Some MRI studies have reported increases in visceral adipose tissue with testosterone (e.g., +34% at 1 year), and longer-term MRI data indicate additional visceral-versus-subcutaneous shifts; DXA may underestimate visceral changes relative to MRI. Regional fat percentages were calculated from whole-body DXA scans using manufacturer software.[532][533][534]Hand Grip Strength Measured by Dynamometer
In a large prospective multicenter study, hand-grip strength increased by a mean of approximately 18 % (+6.1 kg) after 12 months of testosterone treatment in trans men. In trans women, grip strength decreased by a mean of 1.8 kg (roughly 4 %) after 12 months of estrogen plus anti-androgen treatment. After 12 months, median grip strength of trans women remained in the 95th percentile for age-matched females, while that of trans men fell in the 25th percentile of age-matched males.[535] A systematic review of 15 studies (12 of which assessed handgrip) of muscle-strength outcomes under gender-affirming hormone therapy rated the overall risk of bias as moderate to high and noted heterogeneity, particularly for feminizing regimens; cross-sectional comparisons found transmasculine and transfeminine persons had higher strength than cisgender women but lower than cisgender men.[536][537]Systolic Blood Pressure Measured by Standard Cuff
One longitudinal clinic-based study using standard cuff measurements reported that, within 2 to 4 months of starting hormone therapy, mean systolic blood pressure decreased by 4.0 mm Hg in individuals assigned male at birth receiving estrogen and increased by 2.6 mm Hg in individuals assigned female at birth receiving testosterone. These changes were observed during routine clinical visits and persisted over longer follow-up in that cohort. Individual responses varied considerably: while the majority of individuals assigned male at birth showed decreases, a substantial minority experienced increases of 5 mm Hg or more. Among individuals assigned female at birth, the average rise was modest, but the proportion meeting criteria for stage 1 hypertension increased over time. The authors recommended routine blood-pressure monitoring after initiation of hormone therapy.[538] A systematic review of 14 observational studies found heterogeneous results, with both increases and decreases in systolic blood pressure among those receiving estrogen, most studies of testosterone showing no change, and overall low evidence quality owing to methodological limitations of uncontrolled pre-post designs.[539] Subsequent studies have confirmed that the direction of change can vary, particularly with estrogen-based regimens, depending on anti-androgen type and other factors.[540] These short-term mean changes occur against a background of higher rates of hypertension and other cardiovascular risk factors observed in several studies of transgender populations relative to cisgender comparison groups, together with limited quality and consistency of evidence on long-term cardiovascular outcomes associated with cross-sex hormone therapy.[541][467][542]Epistemological and Methodological Challenges
Research on transgender phenomena highlights core difficulties in generating reliable knowledge across clinical, social, and population sciences. Longitudinal studies frequently encounter high attrition rates, often exceeding 20–30 % and in some clinic cohorts substantially higher.[487][543] Loss to follow-up is rarely random; individuals who discontinue medical transition, detransition, or experience worsening mental health are more likely to drop out, systematically biasing outcome estimates toward more favorable results.[544][545] A nationwide German insurance-data study reported that only 36.4 % of individuals aged 5–24 with a confirmed gender-identity-disorder diagnosis retained the diagnosis after five years.[546] Challenges in establishing appropriate control groups and limitations in blinding participants or clinicians to treatment status also occur. Independent systematic reviews, including the Cass Review, a Swedish evidence review, Finnish COHERE recommendations, and a 2025 U.S. HHS review, have identified high attrition, lack of blinding, and absence of adequate controls as central limitations of the existing evidence base.[547][548][549][440] Diagnostic classification systems have undergone repeated revisions, shifting from 'gender identity disorder' in DSM-IV to 'gender dysphoria' in DSM-5 and to 'gender incongruence' in ICD-11, which was removed from the mental-disorders chapter.[3] These changes were influenced both by clinical observations and by advocacy aimed at reducing stigma, with documented participation by advocacy organizations including WPATH.[550][20] The revisions raise questions about whether rising case numbers and changing demographics primarily reflect true increases in prevalence, greater social acceptance and visibility, lowered diagnostic thresholds, or a combination of these factors. These issues parallel broader debates in psychiatry and psychology regarding the reliability of self-reported identity measures versus observable behavioral or physiological markers. In the case of gender dysphoria/incongruence, diagnosis and outcome measurement rest almost exclusively on self-report; no validated biomarkers or objective physiological criteria currently exist to confirm or refute the identity claim.[551][552] This heavy reliance on subjective declaration poses distinctive challenges for reliability, validity, and causal inference. Scholars across perspectives have called for greater emphasis on preregistered protocols, independent data audits, low-attrition long-term follow-up, and mixed-methods designs that integrate biological, psychological, and social data. Implementation of these standards has been uneven; studies supporting medical transition have frequently suffered from high loss to follow-up and short observation windows, while calls for stricter evidence requirements have sometimes been met with accusations of ideological motivation rather than methodological engagement.[406][547]Emerging Biotechnologies and Future Research Horizons
Advances in reproductive science—including in vitro gametogenesis, uterine transplantation, and gene-editing technologies—raise theoretical possibilities for expanding reproductive options beyond current biological limits.[553][554] Researchers have discussed whether future interventions could allow individuals of one biological sex to produce gametes or gestate in ways not presently possible; however, significant anatomical, hormonal, immunological, developmental, and ethical barriers remain, and no such applications have been demonstrated in humans.[555][556] Parallel developments in neuroimaging, biomarker identification, and personalized medicine may improve prediction of whether gender dysphoria will persist or resolve, and may help identify individuals with co-occurring conditions that require priority treatment. Such tools could support more precise clinical decision-making across a range of approaches, from exploratory psychotherapy to medical intervention where indicated. Calls for large-scale, prospective registries with decades-long follow-up emphasize the need to track not only individual outcomes but also population-level effects of widespread medical transition on developmental trajectories and health systems. Emerging biotechnologies include advances in fertility restoration and tissue engineering for surgical outcomes. Early research explores gamete derivation from stem cells and regenerative techniques to mitigate hormone-related risks.[557] Challenges include ethical questions, long development timelines, and uncertain safety profiles. Future studies are expected to clarify feasibility, with calls for rigorous trials before clinical adoption. In the absence of high-certainty, low-attrition longitudinal evidence spanning decades, clinical practice continues to vary. Jurisdictions and professional bodies that apply stricter evidence thresholds (systematic reviews using GRADE or equivalent methods) have generally shifted toward psychotherapy-first, exploratory approaches for minors.[488][558][440][559] Bodies that place greater weight on expert consensus, patient autonomy claims, or lower-quality observational data continue to support earlier medical intervention after assessment.[395][385][560] Further rigorous, prospective, long-term data are required to resolve these differences. Policy responses illustrate the current divide. The 2025 HHS evidence review and the February 2026 American Society of Plastic Surgeons position statement recommend deprioritizing medical and surgical interventions for minors in favor of comprehensive psychosocial assessment and psychotherapy, citing very-low-quality evidence of benefit, documented risks (including infertility, sexual dysfunction, impaired bone density, and potential cognitive effects), and ethical concerns regarding irreversible interventions in a developmentally vulnerable population.[440][559] Critics of these positions argue that they overstate uncertainties or are influenced by political factors. Supporters note that earlier affirmative guidelines relied on lower-quality evidence syntheses and that systematic reviews from the UK (Cass Review),[488] Sweden,[558] Finland,[561] and other jurisdictions[562] reached convergent conclusions about the weakness of the evidence base.[563]Societal and Cultural Dimensions
Activism and political history
Late 20th-Century Activism and Community Organization: Growth of Transgender Advocacy and Community Networks (1970s–1990s). In the decades following the initial clinical programs, transgender individuals increasingly formed self-organized groups to address exclusion from broader gay and lesbian movements and to advocate for specific needs. Organizations such as the Erickson Educational Foundation (founded 1964, active through the 1970s) provided peer support and information on medical access. Groups such as the Transsexual Action Organization (founded 1970)[564] and the American Educational Gender Information Service (founded 1990)[565] emerged. Figures such as Sylvia Rivera and Marsha P. Johnson (who primarily identified as drag queens, transvestites, or street queens) co-founded Street Transvestite Action Revolutionaries (STAR, 1970) and highlighted the intersection of gender nonconformity with poverty, racism, and housing instability. They are frequently cited in later transgender advocacy histories. Historians note that the terminology and self-understandings of the era differ from modern "transgender" categories; their roles in events such as Stonewall are also debated.[68][69][566] The 1990s saw the founding of national advocacy entities such as GenderPAC (1995) and expanded efforts pursuing anti-discrimination policies and public education amid rising visibility through publications like Leslie Feinberg's Transgender Warriors (1996). The Transgender Law Center was founded in 2002.[567] Peer support and community organizations play a central role for many transgender individuals. Groups offer mentoring, social events, online forums, and crisis assistance, with participants frequently reporting reduced isolation and improved coping skills.[568] National and local networks facilitate resource sharing and advocacy. Some organizations focus on specific demographics (e.g., youth, people of color, non-binary). Availability varies by region, and critics within the community note occasional internal divisions over priorities or approaches, including medical transition, youth care, sex-based rights, and the inclusion of detransitioners.[569][570] Quantitative evaluations of these programs remain limited.[571] Relations with broader LGBTQ movements involved both collaboration and documented tensions. Early transgender advocacy groups in the 1970s frequently operated separately due to exclusion from some gay and lesbian organizations; by the 1990s and 2000s, joint platforms emerged under umbrella LGBTQ frameworks while preserving distinct transgender-specific priorities such as access to medical care and legal recognition. International networks, including ILGA World and regional affiliates, coordinated advocacy on decriminalization and anti-discrimination measures across more than 100 countries. In the late 20th century, transgender concerns shifted from medical models to identity politics, influenced by queer theory. Judith Butler's Gender Trouble (1990) argued that gender is a repetitive performance shaped by social norms, not an innate essence. Activists used this framework to challenge binary sex categories as social constructs, prioritizing social recognition over clinical treatment.[572][573]
Coalition Tensions
Stonewall, originally focused on lesbian, gay and bisexual rights, expanded its remit in the mid-2010s to include transgender issues under a gender-identity framework. This produced both greater shared visibility and resources and internal and external tensions over priorities and definitions.[590][591] In 2019, the UK's LGB Alliance was founded by lesbians, gay men and bisexuals (including former Stonewall supporters and Stonewall co-founder Simon Fanshawe) to advocate for sex-based definitions of sexual orientation—i.e., that homosexuality is attraction to the same biological sex—and to resist what they viewed as the subordination of those rights to gender-identity policies.[592][577] LGB Alliance faced strong public and institutional opposition from Stonewall and other gender-identity-focused organizations.[593] Notable related litigation included the employment tribunal claim by LGB Alliance co-founder Allison Bailey (who succeeded against her chambers on discrimination grounds related to her gender-critical beliefs; claims against Stonewall were dismissed)[594] and a later unsuccessful attempt by Mermaids and others to remove LGB Alliance’s charitable status.[595] Similar divisions appeared at Pride events, including protests by lesbian groups asserting sex-based boundaries.[596] Between 2020 and 2021 a number of UK public bodies and employers—including the Equality and Human Rights Commission, Ofcom, the BBC, and several government departments—withdrew from Stonewall’s Diversity Champions scheme, citing concerns over value for money, impartiality, or perceived bias on sex and gender issues.[597][598][599][600][601]Sociocultural Relationships
Transgender advocacy has maintained complex relationships with the broader LGBTQ community, characterized by historical coalition-building alongside persistent inclusion and exclusion tensions. Early efforts to integrate transgender issues into gay and lesbian movements met resistance from groups prioritizing sexual orientation, leading to separate organizing before eventual inclusion in the LGBTQ framework. Ongoing frictions include debates over resource allocation and ideological alignment. Some lesbian and gay organizations and researchers maintain that sexual orientation is defined by biological sex (same-sex attraction), and therefore view inclusion of opposite-sex-attracted transgender people under the same umbrella as conceptually and politically distinct.[602][603] Relations with feminism have undergone significant shifts. Radical second-wave and gender-critical (sex-realist) feminists argue that male-to-female transition can reinforce sex stereotypes and that single-sex spaces require biological-sex criteria for physical safety and privacy.[604][605] Many third- and fourth-wave and intersectional feminists prioritize gender-identity inclusion in women’s categories and spaces. Support organizations play comparative roles: transgender-specific entities like the Transgender Law Center emphasize legal recognition of gender identity and access to medical transition, whereas broader LGBTQ organizations such as Human Rights Campaign integrate these with advocacy for sexual minorities, sometimes leading to divergent priorities in policy campaigns. Surveys report elevated rates of harassment of transgender people by non-transgender LGB peers and, in the opposite direction, complaints by lesbians and gay men of pressure, exclusion, or violence when asserting sex-based boundaries. Both patterns are documented in community surveys and qualitative studies.[606][607] Transgender individuals often describe coming out as a multi-stage process involving disclosure to family, friends, employers, and institutions.[608] Longitudinal and cross-sectional studies show that family rejection is associated with higher rates of depression, suicidality, and homelessness. Family acceptance is associated with lower rates of those outcomes; however, most studies define acceptance as affirmation of the young person’s gender identity (including support for social transition), and evidence quality on long-term outcomes of social transition remains limited. High rates of co-occurring autism, trauma, and same-sex attraction are well-documented confounders.[10][609][610] "Stealth" (non-disclosure of transgender history) and "passing" are individual strategies for privacy or safety.[611] Some clinicians and researchers note that early social transition can increase the likelihood of persistence into medical pathways;[10][612] others view it as low-risk and reversible.[348] Empirical data on both persistence rates after social transition and long-term mental-health trajectories remain incomplete.[10] Transgender individuals experience distinct interpersonal dynamics in family, romantic, and parenting contexts. Family acceptance profoundly influences mental health outcomes; research from the Family Acceptance Project indicates that family rejection correlates with an approximately eightfold increase in suicide attempt rates among LGBTQ youth, including transgender subsets.[613] Romantic relationships present challenges such as dating difficulties and heightened risks of intimate partner violence. One U.S. survey of transgender adults reported a 42% lifetime prevalence of physical intimate-partner violence.[55] Large population and clinic studies find elevated IPV victimization rates relative to the general population; some samples also report elevated perpetration, and methodological limitations (convenience sampling, self-report) apply.[614][615] In parenting, transgender individuals encounter issues including custody disputes influenced by gender identity, barriers to fertility preservation prior to hormone therapy or surgery, and obstacles in adoption processes due to discriminatory policies or perceptions. Transgender youth in foster care systems or engaging in family therapy models are recommended interventions designed to enhance familial support and mitigate rejection-related trauma, such as those incorporating behavioral acceptance strategies, though quantitative outcome data remain lacking.[616][617] Transgender individuals often navigate family and partner relationships, including raising children. They form families through adoption, surrogacy, assisted reproduction, or prior relationships, with fertility preservation (sperm/egg banking) prior to medical transition enabling biological parenthood in many cases. Small-scale studies report developmental outcomes for children of transgender parents that are broadly comparable to those of children in cisgender families on measures of adjustment and gender identity.[618][619] Sample sizes are typically modest, follow-up periods short, and parental mental-health and relationship stability are rarely fully controlled.[620] Larger, longer-term population studies are still lacking.[424] Many parents report strengthened family bonds through increased honesty and communication. Some studies highlight positive adaptation when partners are supportive, citing improved relationship satisfaction in affirming environments. However, transitions can lead to strain in existing partnerships, custody challenges, or family rejection, with some ex-partners describing adjustment difficulties or legal conflicts over parental roles. These dynamics are influenced by external societal attitudes, and longitudinal data remain limited. Employment discrimination remains a documented issue for transgender individuals, with some population surveys reporting higher unemployment and poverty rates compared to the general population.[55] At the same time, legal protections (such as those following the U.S. Bostock ruling) have been associated with improved hiring outcomes and workplace retention in jurisdictions where they are enforced.[621] Self-reports of improved authenticity and career progress after transition exist alongside population data showing persistently higher unemployment, poverty, and disability rates relative to the general population even after legal gender recognition.[622][623][624]Discrimination, Violence, and Victimization
Large surveys such as the 2015 U.S. Transgender Survey report high lifetime rates of sexual assault (47%), physical assault (25–50% across family, partner, school and other aggregates), employment discrimination (20–40%), and poverty (29%, approximately twice the U.S. average) among respondents.[55] The USTS is a non-probability convenience sample of respondents reached primarily through community networks and online outreach; results cannot be generalized to all people who identify as transgender, and reported rates may be elevated relative to probability-based samples.[56][625] Minority-stress models constitute one prominent explanatory framework attributing these primarily to stigma and discrimination. Alternative or complementary accounts emphasize elevated baseline rates of psychiatric comorbidities, autism-spectrum traits, childhood trauma, substance use, and behavioral risk factors such as sex work, which are documented in clinic and survey data and may operate independently of or interact with external stigma.[8][626][627] Analyses of population-based cohort studies and prison statistics that record natal sex find that natal-male patterns of violent and sexual offending largely persist after transition. In the Dhejne et al. (2011) Swedish population-based cohort of 191 post-surgical male-to-female individuals, conviction rates were comparable to natal-male controls (any-crime aHR 0.8, 95% CI 0.5–1.2) but substantially elevated versus natal-female controls (aHR 6.6, 95% CI 4.1–10.8), indicating retention of male-typical patterns of criminality including violent crime; female-to-male individuals showed a shift toward male-typical rates.[610] Prison statistics report comparable residual male-pattern risks.[628] Rates among post-transition males more closely resemble natal-male than natal-female baselines. Both self-report surveys and official statistics have recognized limitations (sampling bias, under- or over-reporting, confounding by comorbidities and lifestyle). Policy responses therefore diverge between expanded identity-based protections and retention of sex-based categories in high-risk settings such as single-sex prisons, shelters, hospital wards, and sports.[629] This divergence reflects competing claims of protecting transgender-identified people from discrimination versus protecting natal females from residual male-pattern physical and sexual violence risks. Elevated self-reported victimization and socioeconomic disadvantage are consistently found in available surveys, but the degree to which these are caused by external stigma versus internal comorbidities, selection effects, or other factors remains unresolved in the literature. Longitudinal data remain limited and contested, with both perspectives represented in peer-reviewed literature and government reports; no consensus exists on causation or optimal mitigation strategies.Representations in Media and Culture
Early cinematic depictions of transvestism, cross-dressing, and sex-change subjects, such as the 1953 film Glen or Glenda, portrayed these as pathological or tragic, aligning with then-prevailing psychiatric classifications of transvestism as a sexual deviation and transsexualism as a disorder rather than solely as prejudice.[91] Contemporaneous clinical literature, including Harry Benjamin’s research distinguishing these conditions and supporting hormonal and surgical interventions, was itself evolving.[217] The umbrella term “transgender,” with its current identity-based meaning, developed in the 1980s and 1990s; modern analyses often reframe such earlier works under that later category.[37] The 1999 film Boys Don't Cry dramatized the 1993 murder of Brandon Teena (born Teena Renae Brandon), who lived as a man, and is frequently cited in discussions of violence against people who cross gender presentation. Teena’s self-identification and the applicability of modern transgender categories remain subjects of historical and activist debate.[630][631][632] Television representations emerged sporadically in the late 20th century. An analysis of over 90 transgender characters from 2002 to 2012 found 40% depicted as victims of violence or discrimination and 21% as villains or killers, reflecting persistent tropes such as tragedy and deception.[633] Transgender visibility increased markedly in media since the mid-2010s. Later media increased the volume and range of depictions relative to earlier portrayals, which were frequently framed through the psychiatric diagnoses and tropes of their era. High-visibility media events in the mid-2010s, including Time magazine's 2014 cover featuring actress Laverne Cox with the headline "The Transgender Tipping Point" and Caitlyn Jenner's 2015 public transition announcement and Vanity Fair cover, increased public attention to transgender experiences.[634] These events prompted contemporaneous criticism, such as from conservative outlets, as well as subsequent arguments that certain portrayals understated medical risks of interventions, overstated the permanence of gender identity in youth, or contributed to social contagion effects hypothesized in rapid-onset gender dysphoria cases among adolescents.[635][636] Subsequent representations in television, film, and digital media have included diverse narratives, increasing the volume of depictions of transgender topics, though transgender characters accounted for less than 0.5% of speaking roles in major media audits.[637] Advocacy organizations such as GLAAD view the increased visibility as reducing stigma and fostering acceptance.[638] Population prevalence estimates of transgender identification vary by definition and age group, from under 0.03% for those with gender-dysphoria diagnoses or seeking medical transition to 0.5–0.8% of adults and 1.4–3.3% of youth in self-report surveys.[6][639] Some researchers have questioned whether media volume tracks or contributes to identification rates, as hypothesized in studies of rapid-onset gender dysphoria.[272] Platforms like TikTok and Instagram have further amplified visibility through influencer content and user-generated stories circulating narratives about people who identify as transgender.[640] Laverne Cox's portrayal of Sophia Burset in Orange Is the New Black (2013–2019) achieved milestones, including her 2014 Primetime Emmy nomination as the first openly transgender nominee.[641] The series Pose (2018–2021) featured transgender actors in prominent roles, depicting the ballroom culture and lives of transgender people of color.[642] The 2020 documentary Disclosure examined transgender portrayals in film and television history. In video games, The Last of Us Part II (2020) included Lev, a transgender character. In literature, Virginia Woolf's Orlando (1928) is retrospectively viewed as exploring gender fluidity via a protagonist who changes sexes over centuries.[643] Art and literature have portrayed transgender themes through works such as Alison Bechdel's graphic memoir Fun Home (2006, exploring gender nonconformity and family dynamics), Torrey Peters' novel Detransition, Baby (2021, examining relationships and parenthood), and Casey Plett’s fiction, which grapples with transition, community, and the daily realities of trans women's lives. Visual arts include photography series by artists like Zanele Muholi (documenting Black transgender lives in South Africa), performance art by Cassils using the body to interrogate gender transformation and endurance, and installations addressing identity fluidity. Filmmakers have contributed through works like The Danish Girl (2015), depicting early medical transitions, and Tangerine (2015), portraying trans experiences amid social pressures, balancing celebration of identity with critiques of medicalization and societal constraints. These contributions foster dialogue on lived experiences across genres.[644][645][646] In comics, DC Comics introduced Alysia Yeoh in 2013 as Batgirl's transgender roommate in Batgirl issue #19, marking an early mainstream superhero inclusion.[647]Debates on Representation
Cultural Visibility and Practices
Transgender coming-out processes involve disclosing a transgender identification to others, frequently first in online environments. Self-identified transgender people and advocacy organizations commonly report that such disclosure can build support networks and reduce isolation in some cases. Non-probability surveys of self-identified transgender respondents report elevated rates of subsequent social rejection, familial estrangement, workplace discrimination, and physical violence, with higher figures often noted among those from marginalized racial, ethnic, or socioeconomic backgrounds.[55] These surveys have recognized methodological limitations, including self-selection, sampling bias, and limited generalizability.[625] In addition to minority-stress models attributing outcomes primarily to stigma, competing or complementary frameworks include high rates of pre-existing psychiatric comorbidities and behavioral risk factors such as involvement in sex work.[664] These issues receive fuller treatment in the Discrimination, Violence, and Victimization section. Strategic visibility encompasses living openly ("out") to raise awareness and advocate for rights, or maintaining a "stealth" mode by aligning presentation with identified gender without revealing transgender history. These practices are reported to facilitate social integration and privacy in some cases and are described by advocacy groups as supporting community building, solidarity, and education on transgender experiences.[665][666] Documented criticisms and hypothesized risks include possible social reinforcement of dysphoria or identity through social transition and online peer influence, family conflict, and uncertain long-term mental-health outcomes.[10][272][665][666] Practices such as coming out, living “out,” or remaining “stealth” vary widely among individuals who identify as transgender, and community responses to these choices are not monolithic. Some individuals and subgroups, particularly those emphasizing medical transition and dysphoria, criticize aspects of high-visibility activism as overly confrontational or social-transition norms as insufficiently focused on clinical criteria.[667][668][669] Key symbols include the Transgender Pride Flag, designed by Monica Helms in 1999 and first publicly displayed in 2000, consisting of light blue, pink, and white horizontal stripes. Helms described the colors as symbolizing traditional baby colors for boys and girls, those who are transitioning, and those who identify outside the binary. The flag has become a widely recognized symbol within transgender advocacy and community events.[670] Awareness events include Transgender Awareness Week (November 13–19), organized by advocacy groups as a period of education and advocacy that leads into Transgender Day of Remembrance; the Transgender Day of Remembrance (November 20, founded 1999 by Gwendolyn Ann Smith following the 1998 murder of Rita Hester and originating from her “Remembering Our Dead” project), which commemorates transgender-identified people who have been killed via annual lists compiling reported killings of people identified as transgender, predominantly in Latin America and often involving Black or Latina transfeminine individuals; advocacy organizations attribute many of these deaths to anti-transgender bias, while analyses of case details indicate that many cases involve sex work, interpersonal disputes, or other criminal contexts, with anti-transgender bias claimed by advocacy groups but not always established by investigation and hate-crime classification varying by jurisdiction; absolute numbers and relative risk remain debated due to data limitations.[582][73][583][72][671] and the International Transgender Day of Visibility (March 31, founded 2009 by Rachel Crandall-Crocker of the advocacy organization Transgender Michigan) as a counterpart emphasizing living transgender people. These events are organized by advocacy organizations and have stated aims of raising awareness and commemorating lives; public reception and their impact on attitudes remain subjects of debate.[672][652][673]Cross-cultural perspectives
Cross-cultural anthropological studies document traditional gender-variant roles predating modern Western transgender concepts. These were typically culturally specific social, ritual, or spiritual categories involving prescribed occupations, community functions, or initiation rather than a subjective internal gender identity independent of biological sex. They differ in etiology, social function, and embodiment from modern Western transgender identification (which centers on personal gender identity and frequently involves medical intervention) and are not historical precedents or equivalents for contemporary self-identification or medical models.[674] These roles operated within specific cosmologies and social structures that maintained binary sex distinctions for the majority population and did not typically involve claims of an innate cross-sex identity requiring bodily modification to align with an internal sense of gender. Ethnographic accounts distinguish traditional institutionalized roles from cases in which modern individuals in the same cultures adopt Western transgender frameworks.[675][676] In South Asia, hijras form hierarchical communities of typically biological males or intersex individuals organized around guru-chela (mentor-disciple) kinship, often involving ritual castration (nirvan) as an initiation rite (though not universally required). They perform ritual blessings at ceremonies but, despite legal third-gender recognition, commonly experience socioeconomic marginalization including begging and sex work. Ethnographic accounts distinguish these traditional institutionalized roles from contemporary self-identified transgender identities, with some Indian transgender women emphasizing differences from hijras. Approximate population estimates, limited by census undercounting, stigma, and varying definitions that may include broader gender-nonconforming populations, indicate 0.04% in the 2011 census, with surveys suggesting 0.1–0.5%; these do not measure the same phenomenon as modern Western transgender identification rates.[677][678][76][679] In Thailand, kathoey denote male-bodied individuals exhibiting feminine traits, commonly participating in entertainment, with approximate estimates of 0.1–0.5% of the population based on limited urban observational and informal data.[680][681] Similar roles include individuals in certain Indigenous North American societies who occupied gender-variant or mixed-role statuses (later sometimes referred to under the modern pan-Indigenous umbrella term Two-Spirit, coined in 1990), who blend gender and spiritual attributes in community and ceremonial capacities, and muxe among the Zapotec of Mexico, typically biological males occupying socially recognized female-associated roles in domestic and festive contexts.[151] In Latin America, particularly Brazil, Argentina, and Uruguay, travesti constitute a longstanding cultural category of typically biological males adopting feminine presentation and roles, with roots in pre-colonial and colonial-era performance traditions, with approximate prevalence estimates from limited urban surveys at 0.1–0.4%, which may include broader gender-variant groups and are not equivalent to Western transgender identification rates. Travesti, typically biological males, historically participated in carnival, street theater, and religious processions, especially during Candomblé and Umbanda ceremonies, where feminine presentation allowed ritual expression of both masculine and feminine spiritual forces. Unlike modern Western transgender frameworks, travesti identity often combines feminine embodiment through hormones, breast implants, or silicone with rejection of full genital surgery, maintaining a distinct cultural position. In Brazilian street culture and nightlife, travesti have long served as visible performers, sex workers, and community organizers, with roots traced to 19th-century theatrical cross-dressing and earlier indigenous gender-variant practices. The role carries both prestige and marginalization: travesti are central to carnival parades and popular festivals yet face high violence rates. Scholars note that travesti represent a uniquely Latin American synthesis of indigenous, African, and European influences, emphasizing social role and public performance over private medical transition.[682] In pre-colonial Philippine societies, male-bodied ritual specialists known as asog (Visayas) or bayoguin/bayog (Tagalog regions) occupied recognized gender-variant roles among various ethnolinguistic groups. These individuals, typically biological males, often served as babaylan (shamans or spiritual leaders) in animist rituals. Historical accounts from early Spanish chroniclers (late 16th–17th centuries) describe them wearing feminine attire and mannerisms and participating in healing rites and ancestor veneration.[683][684] The roles combined spiritual authority with functions such as healing and preservation of ritual knowledge. They were frequently regarded as unsuited to conventional marriage with women and instead formed relationships with men while occupying community and ritual positions. Colonial records document persecution of babaylan, including gender-variant ones. Elements persisted and later influenced modern Filipino gender expressions such as bakla (or bayot), a distinct 20th-century social category. Scholars distinguish the indigenous ritual roles from both later Western categories and contemporary bakla identity; the historical positions centered on spiritual and ritual functions rather than a subjective internal gender identity independent of sex.[685] In Indonesia, particularly Java and other islands, waria (a portmanteau of wanita "woman" and pria "man") emerged as a recognizable gender category by the early 19th century. Waria, typically biological males, historically adopted feminine presentation, speech, and roles, often participating in urban entertainment, street performance, and community events, serving functions such as performers in theater and dance, caretakers in nightlife, and informal mediators in disputes. Ethnographic accounts describe waria as embodying a "male femininity" blending traditional practices with modern urban life, typically avoiding surgical changes due to cultural and religious influences rather than pursuing medical transition. Unlike ritual roles like bissu in Sulawesi, waria emphasize social performance and urban adaptation, maintaining ties to Islamic or syncretic traditions amid marginalization in colonial and post-independence records.[686][687] In Oman and parts of the Arabian Gulf, the xanith (also khanith) represent a socially recognized third gender. Xanith, typically biological males, adopt feminine dress, mannerisms, and speech while retaining certain masculine legal rights (e.g., inheritance). They often work as musicians, matchmakers, or domestic attendants at weddings and celebrations, roles that blend feminine presentation with ritual and social mediation. Ethnographic studies describe xanith as neither fully male nor female in everyday life; they may marry women yet are permitted to engage in same-sex relations without the stigma attached to other men. Ethnographic studies describe a recognized intermediate status under religious and tribal customs, permitting participation in aspects of both male and female social spheres. Unlike hijra or galli, the xanith role did not typically involve castration and was reversible in some cases. Contemporary accounts note that the tradition persists in rural and coastal Omani communities, though modernization and stricter interpretations of Islamic law have reduced visibility. Anthropologists view xanith as a pragmatic cultural adaptation that accommodates gender variance within conservative Arabian social structures.[688] Among Zulu communities in South Africa, some sangoma (traditional healers/diviners) experience ancestral possession (ukungenwa idlozi) by spirits of the opposite sex, which may lead to adoption of corresponding attire, mannerisms, or behaviors during rituals as a cosmological and spiritual practice rather than an expression of personal gender identity. Ethnographic and autobiographical accounts describe the spirit's influence on the healer's presentation and roles in specified ritual contexts. Sangoma of this type often perform divination, healing ceremonies, and community rituals requiring both masculine and feminine spiritual energies (e.g., "dancing like a woman" or "slaughtering like a man"). This mechanism, rooted in Zulu cosmology where ancestors can transcend biological sex, allows liminal status within a respected spiritual position without permanent physical change; same-sex attraction or partnerships are sometimes framed as spirit-directed. While not all sangoma exhibit such presentation, ethnographic accounts describe these as ritual contexts serving specified spiritual functions rather than general gender variance.[689]Non-Western Modern Developments and Policy Variations
Selected examples of contemporary developments in non-Western contexts illustrate diverse policy approaches to legal recognition of gender variance, gender incongruence, and transgender status. These range from medicalized facilitation of transition and administrative self-declaration to non-recognition of gender change, restrictions or bans on gender-affirming interventions for transgender persons, and criminalization of gender-nonconforming expression. Policies rest on differing rationales, including medical treatment of gender dysphoria, cultural third-gender categories, self-identification, religious doctrine, and social conservatism. In several Middle Eastern, African, and Asian jurisdictions, gender expression is criminalized under laws targeting impersonation, cross-dressing, or public morality, with no pathway for legal gender recognition; human rights reports document such regimes in countries including Saudi Arabia, Oman, Malaysia, and parts of Nigeria.[690][691] In India, the 2014 National Legal Services Authority (NALSA) v. Union of India Supreme Court judgment recognized hijras and eunuchs as a third gender and upheld the right of transgender persons to self-identify as male, female, or third gender, while directing that they be treated as a socially and educationally backward class entitled to reservations in education and public employment along with welfare schemes.[692] Subsequent legislation, including the Transgender Persons (Protection of Rights) Act, 2019, introduced a certification process through district magistrates that has been criticized by activists for imposing requirements at odds with the judgment's emphasis on self-identification, and implementation has been uneven.[693] In Iran, Ayatollah Khomeini’s 1980s fatwa permitted sex-reassignment surgery when recommended by physicians, leading to state-subsidized procedures under a medical model that requires psychiatric diagnosis of gender dysphoria and medico-legal approval. Homosexuality remains illegal, and reports describe pressure on some gender-nonconforming or homosexual individuals toward transition as an alternative to punishment; post-surgery legal recognition of sex markers is possible, but social stigma, family rejection, and constraints outside the approved pathway persist.[694][695][696] Thailand's kathoey, a culturally specific third-gender category of male-bodied individuals with feminine presentation that is not identical to Western transgender identities, maintain visibility in media and entertainment. High volumes of gender-affirming surgeries and hormone therapy have made the country a hub for medical tourism in Asia, yet legal change of sex markers on identity documents remains unavailable and social visibility coexists with discrimination in employment, military conscription, and family contexts.[697][698] In Mexico, muxes, a socially recognized third-gender category among Zapotec communities of Oaxaca consisting of typically male-bodied individuals in traditional feminine social and economic roles, include some who engage in contemporary politics and advocacy for LGBTQ+ rights.[699] Some scholars and activists interpret muxe traditions as challenging colonial gender binaries, though anthropological accounts describe muxes as occupying a distinct indigenous social category not equivalent to Western transgender identities.[700] Argentina's 2012 Gender Identity Law allows adults to change their legal gender marker and name through administrative self-declaration without medical or judicial requirements, enabling updates to official documents. The United Nations Office of the High Commissioner for Human Rights described the law as pioneering in the region.[701][702] Individuals identifying as transgender from certain African and Asian countries seek asylum citing persecution or discrimination. Recognition rates and evidentiary standards vary by host country, and asylum systems balance protection claims against verification challenges common to identity-based claims.[703][704]Liminality and Rites of Passage in Transition Practices
Some scholars and activists analogize modern gender transition to a contemporary rite of passage using Arnold van Gennep’s tripartite model (separation–liminality–incorporation),[705] later elaborated by Victor Turner. In this interpretive framework the process is described as separation from the social role associated with their biological sex, a prolonged liminal phase of ambiguity, and reincorporation into a new social or embodied status, with the threshold said to generate transformative power through suspension of prior norms. Anthropologist Anne Bolin’s 1988 ethnography applied the model to male-to-female transsexuals, emphasizing rituals of symbolic death and rebirth.[706] Later qualitative studies have likewise invoked liminality for gender-nonconforming experiences.[707] The parallel remains an analogy rather than an empirical anthropological consensus. Traditional rites of passage are typically culturally prescribed, time-limited, and collectively regulated, with defined sequences and ritual authorities, and they mark socially recognized status changes rather than biomedical alteration of sex characteristics.[708] Contemporary medical and social transition, by contrast, is frequently individualized, involves potentially irreversible cross-sex hormones and surgeries, and occurs in a context of ongoing clinical debate over long-term benefit (especially for minors) together with elevated psychiatric comorbidity. Anthropologist Laurence Hérault has questioned the analogy, arguing that the tripartite schema can mask the risks, uncertainties and difficulties of sex-change procedures and is sometimes applied too loosely.[709] Recent sociological analyses emphasize that trans trajectories often involve recursive, open-ended or prolonged liminality rather than completed reincorporation into a stable new status.[710] These processes are also interpreted through competing clinical frameworks, including minority-stress models that attribute distress primarily to stigma versus developmental and comorbidity models that emphasize pre-existing psychiatric conditions, neurodevelopmental factors, and possible social-reinforcement effects of early social transition, as well as between gender-affirming approaches and exploratory or watchful-waiting models. High-quality longitudinal data on long-term outcomes remain limited. Systematic reviews of the evidence are summarized in the Evidence on Treatment Outcomes section.[10] Many transgender individuals describe transition as a personal rite of passage involving distinct stages of self-discovery, social coming-out, medical steps (when chosen), and integration into a new embodied and social identity. Anonymous accounts collected by transgender advocacy and support organizations frequently highlight moments of relief after legal name/gender marker changes, the emotional significance of first public presentation in affirmed clothing, and the formation of chosen-family networks that replace or supplement biological family ties. These narratives often emphasize agency, resilience, and improved daily functioning, while also acknowledging periods of grief over lost relationships or physical irreversibility. Support-organization samples are self-selected and tend to over-represent individuals who remain affiliated with transgender communities, introducing selection bias; qualitative studies of detransitioners document additional themes of regret, unresolved mental-health conditions, medical complications, and difficulties reintegrating after interventions.[472] Lived-experience accounts of both persisting and desisting trajectories appear in qualitative research across cultures and constitute one data type among others. They complement but do not substitute for systematic reviews and longitudinal clinic and population data on desistance, detransition, and post-transition psychiatric morbidity, which are summarized in the Evidence on Treatment Outcomes section.[10]Religious Perspectives
Philosophical Perspectives
Philosophical inquiry into transgender phenomena engages ontology (what gender identity is), epistemology (how it is known), and ethics (normative implications), yielding divergent frameworks. These perspectives remain contested, with no consensus on whether gender identity is fundamentally constructed, biologically grounded, existentially authoritative, or something else. Debates influence broader questions of recognition, rights, and human ontology. Language itself is one site of contestation. An illustrative case is the term “gender-affirming,” which is widely used in clinical and advocacy literature to describe interventions that aim to align secondary sex characteristics or social presentation with an individual’s self-described gender identity.[395][385] Proponents regard it as accurately reflecting the goal of supporting the person’s identity;[735] critics regard the term as value-laden because it presupposes that the interventions affirm an innate identity rather than modify the body. Critics therefore prefer descriptive alternatives such as “cross-sex hormone therapy” or “surgeries that approximate opposite-sex anatomy.”[736][737] Cyborg, posthuman, and transhumanist readings interpret medical transition as a deliberate blurring of organism/machine or biology/technology boundaries and, in stronger versions, as a prototype for decoupling identity from reproductive biology.[738][739] Proponents describe this as emancipatory self-creation or a form of evolutionary advancement;[740] critics argue that the interventions remain dependent on unaltered biological substrates, create new forms of medical dependency and unequal access, and may disrupt biologically grounded reproductive and psychological patterns that have long characterized human societies.[741][306] These remain philosophical thought experiments rather than empirically settled claims.Ontological Foundations of Sex and Gender
Philosophical inquiry into transgender experiences engages fundamental questions about the ontology of gender and sex: whether gender identity constitutes an inherent essence, a social construction, or something emergent from biological, psychological, and cultural factors. These debates intersect with feminist theory, queer studies, and ethics, often without consensus. Main philosophical camps on these questions include sex-realist / materialist views, social-constructionist / performative views, first-person-authority views, and pluralist / emergent views. Sex-realist / materialist views (e.g., Kathleen Stock in Material Girls, 2021; Holly Lawford-Smith in Gender-Critical Feminism, 2022) defend sex as a binary, immutable biological category (gametes, reproductive roles) while viewing gender as socially constructed roles/expectations layered atop it. Essentialist perspectives, drawing from biological dimorphism and reproductive anisogamy, treat sex as an objective, immutable category rooted in observable developmental pathways (e.g., gamete production, chromosomal influences). Gender, in this view, is seen as closely tied to or reflective of sex, with some materialist feminists arguing that prioritizing subjective identity over biological realities risks undermining sex-based categories in law, policy, and feminism (e.g., critiques of self-declaration of gender identity overriding material sex differences). Critics of biological essentialism argue that it under-weights first-person reports and cultural variation; sex-realist critics reply that first-person reports are not incorrigible and must be weighed against biological and material evidence. Proponents argue that gender identity claims are subjective self-perceptions that may conflict with material reality and that self-identification overriding sex-based protections (e.g., in single-sex spaces or sports) raises ethical concerns. Advocates of these views contend that they prioritize sex realism to safeguard women's rights and materialist feminism.[742][743] Philosophers associated with these views, such as Holly Lawford-Smith, reject identity-based overrides of sex categories. They argue that conflating sex and gender weakens sex-based protections and disregards materialist foundations of human dimorphism.[744] Philosophical critiques argue for the primacy of biological sex over subjective gender identity. These views contend that social constructivism of gender undermines itself by necessitating physical interventions to align the body with internal feelings, suggesting gender's entanglement with biological realities.[745] Social-constructionist / performative views (most influentially Butler's Gender Trouble, 1990) treat gender as the repeated enactment of social norms rather than an inner essence or direct expression of biological sex. Proponents argue that transgender identities can be understood as subversive or resignifying performances that expose the contingency of the binary. Critics reply that the same framework struggles to explain why medical alteration of the body is sought if gender is purely performative, and that it risks dissolving the material basis for sex-based rights and protections.[746][747] Philosophers such as Judith Butler argue that gender is performative, constituted through repeated social acts rather than fixed by biological sex, which are taken by proponents to support the validity of transgender identities decoupled from biological determinism.[748] Intersections with feminist theory included second-wave critiques of gender roles (e.g., Simone de Beauvoir's 1949 work on constructed femininity) evolving into third- and fourth-wave emphases on intersectionality and inclusivity, though debates persisted on topics like single-sex spaces.[749] Queer theory, as advanced by Judith Butler (1990), framed gender as performative, influencing social-constructionist / performative views while contrasting with sex-realist / materialist views prioritizing biological sex, including critiques from philosophers such as Kathleen Stock and Helen Joyce, as well as analyses of social influences on the rapid-onset gender dysphoria hypothesis from Lisa Littman.[746][750][272] First-person authority / identity-primacy approaches (e.g., Talia Mae Bettcher's work on trans epistemology) treat an individual’s sincere avowal of gender identity as epistemically and ethically primary. Proponents argue that third-party disagreement constitutes a form of "testimonial injustice" or failure to accept a self-declared gender identity. Competing approaches hold that sincere first-person reports are important data but not incorrigible; they may be mistaken, influenced by social factors, or in tension with observable biological facts, and that overriding sex-based categories on the basis of self-identification can itself produce harms to others (privacy, safety, fairness).[742][743] Some integrate phenomenological accounts (e.g., Gayle Salamon on embodiment) or relational ontologies to ground identity in social recognition.[751][752] Pluralist and emergent trans philosophy (e.g., Perry Zurn, Robin Dembroff) seeks to transcend binary debates, exploring trans lives as sites presented as occasions for re-examining personhood, identity, and metaphysics beyond essentialism/constructivism dichotomies. It critiques assumptions in traditional philosophy that treat sex as the primary category while advocating intersectional analyses.[753] Natural-law accounts describe the identification as a mismatch between psychological state and metaphysical (hylomorphic or dualist) essence of the sexed body. These perspectives prioritize causal realism, viewing sex as rooted in developmental biology, over autonomy-driven redefinitions of identity.[754] Christian philosophical perspectives include J.P. Moreland's hylomorphism, which posits the soul as the animating principle unifying a specific body, rendering a sex mismatch conceptually impossible. William Hasker's emergent dualism holds that the self emerges from the body's biological complexity, inherently tied to its sex.[755][756] Semiotic perspectives examine gender as a system of signifiers (pronouns, names, presentation, legal markers). Use of a prior name or sex-based pronouns is described in first-person authority / identity-primacy readings as disrupting the sign–referent relation, while self-chosen language re-stabilises meaning. These readings view this as resignification claimed to expand linguistic and social possibility.[757] Critical readings argue it risks decoupling signs from material referents (biological sex), creating unstable or circular signification where social validation overrides observable biology.[758] Related identity categories such as non-binary, genderfluid, agender, and bigender were positioned within broader debates as extensions or alternatives to binary frameworks, prompting discussions on whether these constitute distinct phenomenological experiences or variations along a spectrum of self-perception. Drag performance and occasional cross-dressing without identity change were distinguished as cultural or theatrical practices rather than indicators of transgender identity, with historical precedents in theater traditions noted in separate cultural analyses. Philosophical approaches diverge on the relative weight of individual autonomy, bodily integrity, and collective considerations of sex-based categories. Perspectives drawing on liberal individualism prioritize self-determination in identity and medical decisions, while those informed by materialist or natural-law traditions stress observable biological realities and potential third-party effects in shared social spaces. Evolutionary biology provides an additional lens, examining transgender phenomena through reproductive fitness and sexual selection frameworks, often as evolutionary mismatches in modern environments.[306] These diverse traditions, including materialist feminism's critiques of eroding sex-based categories in law and policy, generate competing normative claims without consensus, illustrating how empirical findings on etiology, outcomes, and social impacts are interpreted through prior philosophical commitments. Ethical dimensions include youth autonomy vs. precautionary principle: liberal individualist views prioritize self-determination in identity claims, while precautionary or natural-law perspectives stress biological integrity, potential long-term harms from interventions, and third-party effects (e.g., on sex-based rights). These ontological disagreements underpin broader controversies over recognition, medical access, and social policy, with no unified resolution across philosophical traditions.Diachronic and Narrative Perspectives on Personal Identity
Philosophers of personal identity have long asked how a self remains numerically the same across radical change. Transgender transition presents a live test case for these puzzles. Some existentialist readings frame transition as an exercise in authenticity, in which the individual confronts a felt mismatch between body and sense of self and pursues self-creation. Existentialist analyses have applied the concept of bad faith both to the denial of bodily givenness and to the refusal to act on a strongly felt identity, depending on the author.[759] The main competing criteria of diachronic identity are psychological continuity, biological or organismic continuity, and narrative coherence. No single framework commands consensus. Psychological continuity theories hold that psychological connectedness is what matters, so a transitioned person can remain “the same self” in the relevant sense; biological-continuity theories hold that identity tracks the persistence of the human organism even through somatic alteration; narrative approaches treat transition as potentially repairing or rupturing the self-story; existentialists locate value in the authentic choice itself rather than metaphysical sameness. These diachronic debates remain distinct from ontological sex/gender questions, yet they directly inform ethical issues of consent, persistence of obligations, and the phenomenology of “becoming” versus “remaining.” The case of medical and social transition therefore raises sharp questions about the criteria of personal identity over time. Psychological continuity theories treat identity as psychological connectedness (memories, intentions, character traits) rather than bodily sameness. Derek Parfit’s reductionist view holds that what matters is Relation R—psychological continuity and connectedness—rather than strict numerical identity; a transitioned person can be “the same self” in the sense that matters even if the body is altered. Biological-continuity criteria (animalism) hold that identity tracks the persistence of the human organism. Critics applying these criteria argue that radical somatic change (hormones, surgery, gamete alteration) severs the organismic thread, rendering post-transition identity a successor rather than the original person, with implications for legal continuity, parental rights, and regret attribution. Narrative-identity approaches (Marya Schechtman, Paul Ricoeur) view the self as a self-constituting story. Transition can be an authentic chapter that repairs a felt rupture between body and self-conception, preserving diachronic coherence through reinterpretation of the past. Skeptics counter that such retrospective rewriting risks self-deception: the pre-transition child or adolescent may become a “different character” in the story, raising questions of whether the narrative is freely authored or shaped by external social scripts.Consciousness, Qualia, and the Phenomenology of Gender Identity
Debates in philosophy of mind and phenomenology concern whether reports of gender identity reflect a distinct, persistent, embodied qualia — the "what it is like" to feel male, female, or neither — claimed to be distinct from observable behavior or biology.[756][760] First-person accounts describe it as an irreducible subjective feeling, sometimes alleviated by transition, sometimes not. Philosophical positions range from dualist (identity as non-physical essence) to materialist (emergent from brain-body-environment loops). Other case series and clinical reports have linked similar reports to dissociation, social influence, or other factors, with some subsets of youth showing resolution under exploratory approaches that prioritize investigation of underlying factors without immediate social or medical transition. Both sets of observations are limited by methodological constraints such as small samples, selection bias, and lack of controls. Evidence from virtual reality avatar embodiment studies and psychedelic research (reporting mixed effects on gender dysphoria and identity) has been interpreted in both directions.[428][761] No consensus exists on measurement or causation; both perspectives appear in the literature on consciousness and philosophy of mind, though empirical operationalization of ‘gendered qualia’ remains limited and contested.Aging and Elderly Experiences
Surveys of transgender older adults report elevated rates of physical disability, depression, and social isolation compared with age-matched general-population peers.[479] Researchers have proposed multiple contributing factors, including cumulative experiences of stigma and discrimination,[762] higher rates of pre-existing mental-health conditions,[763] effects of long-term medical interventions, and smaller social networks. The relative weight of each factor remains uncertain. Causal inference remains limited by cross-sectional designs and non-representative sampling.[764] Barriers reported by transgender older adults include limited provider familiarity with the long-term effects of hormone therapy, incomplete medical histories, and reluctance to seek care. Some researchers and advocacy organizations call for training programs and protocols that prioritize gender identity in care planning, such as the proposed Trans-specific Geriatric Health Assessment, which adapts comprehensive geriatric assessment to include trans-specific elements (urogenital health, psychiatric evaluation, hormone-therapy monitoring, anatomy-based cancer screening, and advanced care planning) together with culturally sensitive communication training.[765] An observational analysis of National Transgender Discrimination Survey data associated recent gender-affirming medical treatment with higher self-reported quality of life, the difference being larger among respondents aged 60 and older.[766] Others emphasize the need for clinicians to apply standard geriatric risk assessment (cardiovascular, bone, oncologic, thromboembolic) regardless of identity, given the known physiological effects of long-term hormone regimens.[478][767] Evidence that identity-focused geriatric protocols produce better outcomes than individualized standard assessment remains limited, consisting mainly of reviews, qualitative reports, and cross-sectional associations rather than comparative trials. Long-term hormone therapy in this population necessitates ongoing monitoring. Observational studies of limited quality report that natal males receiving estrogen (often described as transgender women) frequently exhibit low bone mineral density prior to treatment and show elevated fracture risk relative to other males not receiving cross-sex hormones among older adults, together with increased venous thromboembolism and certain cardiovascular events in cohort studies; natal females receiving testosterone (often described as transgender men) exhibit distinct metabolic and cardiovascular patterns including erythrocytosis and adverse lipid changes. Evidence quality is generally low to moderate because of observational designs, limited sample sizes, loss to follow-up, and confounding by lifestyle and comorbidities. Clinical guidelines therefore recommend individualized risk assessment and monitoring rather than uniform identity-based protocols.[105][768][769][508] Some qualitative studies and community reports also describe resilience factors, including support networks; quantitative evidence on the prevalence and impact of such factors is limited.[770][771] Studies document disparities in financial security, housing, healthcare access, and overall well-being among this demographic.[772]Economic and Workplace Experiences
Transgender individuals show elevated rates of unemployment, underemployment, and poverty in surveys. Researchers attribute these disparities to a combination of factors, including reported experiences of discrimination and stigma, as well as differences in mental-health profiles, educational patterns, and other variables; the relative contribution of each remains debated. In the United States, the 2020 Bostock v. Clayton County decision held that Title VII of the Civil Rights Act of 1964 prohibits employment discrimination on the basis of gender identity.[621] Unadjusted figures from convenience-sample surveys such as the 2022 U.S. Trans Survey report unemployment of 18% and poverty of 34% among respondents, versus contemporaneous general-population rates of roughly 3–5% and 11–15%.[622] Other surveys place transgender unemployment at 12–14%.[274] Nationally representative Household Pulse data show employment and poverty gaps relative to otherwise similar cisgender individuals after demographic controls (the gaps typically attenuate but remain).[773] Administrative records of individuals who legally changed gender markers indicate residual earnings penalties of 6–13 log points in within-person, sibling, and coworker comparisons.[623] Unadjusted household-income data find transgender or nonbinary households earning about 70 cents per dollar of non-LGBTQI+ households; educational attainment was comparable or higher, but respondents were younger on average and the comparison was not fully adjusted for observables.[774] Definitions of transgender versus nonbinary categories differ across surveys, which affects comparisons with cisgender LGB respondents. In a 2024 Williams Institute survey of LGBTQ employees (transgender subsample n=86), 82% of transgender respondents reported lifetime workplace discrimination or harassment (fired, not hired, denied promotion, or verbally/physically/sexually harassed) that they attributed to sexual orientation or gender identity; 53% reported discrimination in the past five years and 31% in the past year. These rates exceeded those for cisgender LGBQ employees and, on most measures, nonbinary employees. Self-report studies of this type are subject to sampling and response biases.[775] Recent public sector data indicate similar patterns, with elevated rates of lifetime discrimination or harassment among LGBTQ workers, including transgender individuals.[776] Occupational patterns include higher part-time work rates and underemployment (overqualified or temporary roles), alongside barriers like hiring bias (mismatched documents/appearance), on-the-job harassment (invasive questions), disputes over single-sex facilities that have been cited both as barriers for transgender employees and as privacy or safety concerns by some other employees,[777][778] and retention issues (67% reported having left a job because of how they were treated based on LGBTQ status, and 29% had considered leaving their current job).[775] Corporate responses vary: Companies scoring highly on the HRC Corporate Equality Index (an advocacy ranking) have reported stronger revenue growth, net income, and talent retention, with 98% of rated companies including gender identity in nondiscrimination policies and many offering employer-provided coverage for gender-related medical interventions.[779] An independent observational study of U.S. firms from 2003 to 2016 found LGBT-friendly policies, as measured by CEI scores, associated with higher profitability and stock-market valuations; causal identification of these specific policies remains limited.[780] However, recent surveys indicate that 51% of C-suite executives are considering rolling back aspects of their DEI programs; the effects of these shifts on transgender employment outcomes are not yet clear.[781]Demographic, Fertility, and Intergenerational Modeling
Peer-reviewed economic studies have estimated the healthcare costs of hormone therapy and surgery; they have not modeled population fertility, cohort size, or intergenerational sex ratios. A 2015 U.S. societal Markov model of insurance coverage for medically necessary transition-related care estimated an incremental cost-effectiveness ratio of $9,314 per quality-adjusted life year over a 10-year horizon and a budget impact of about $0.016 per member per month; it did not incorporate fertility loss and drew adverse-outcome probabilities largely from a convenience-sample survey.[782] A U.S. commercial-claims analysis reported that in 2019 gender-affirming hormones and surgeries cost on average $1,776 per identified transgender enrollee, equivalent to $0.06 per member per month across the insured population.[783] Using Australian administrative data on 32,313 people who initiated gender-affirming hormones, a 2026 difference-in-differences analysis estimated additional government expenditure over six years of AUD$3,119 after testosterone initiation and AUD$8,348 after estradiol initiation; for testosterone regimens, reductions in mental-healthcare spending exceeded ongoing hormone costs by year six.[784] These estimates vary with assumptions about uptake and which other services are included, and they have been cited in debates over insurance coverage and resource allocation. Gender-affirming hormones and gonadectomy can reduce or eliminate gamete production, and puberty suppression begun before gamete maturation can make standard fertility preservation unavailable; preservation uptake among transgender adolescents is low, and long-term fertility and parenthood after early medical intervention remain sparsely documented.[785] Swedish administrative data on people with a gender-incongruence diagnosis found parenthood prevalence of 11.4% in 2020 (10% among trans men and 13% among trans women), roughly half the age-specific rates among cisgender peers, with many trans women becoming parents before medical transition.[786] Claims that high-transition cohorts will alter sex ratios at birth in later generations are not supported by longitudinal demographic evidence.Digital Embodiment and the Virtual Self
The digital revolution of the 2010s and 2020s has created new arenas for gender exploration decoupled from physical bodies. Platforms such as VRChat, Roblox, and Second Life allow users to inhabit avatars whose presentation differs from the user’s biological sex, potentially providing self-reported relief from distress associated with sex-gender incongruence through virtual embodiment without medical intervention.[787] Immersion in these environments may intensify both positive subjective experiences and negative social exposures.| Platform | Avatar Freedom | AI Features | Reported User Impact | Evidence type / limitations and reported risks |
|---|---|---|---|---|
| VRChat | High customization for gender-fluid avatars | AI-assisted workflows and third-party tools for avatar generation | Users report self-reported relief from gender-related distress through virtual embodiment[787] | Small qualitative study (survey n=29, interviews n=7 of transgender and genderqueer users); 26 reported relief; no control group or long-term follow-up. Social VR associated with hate speech (over 44%), bullying (37.6%), harassment (35%) and sexual harassment (nearly 19%); girls experienced sexual harassment and grooming more frequently than boys[788] |
| Roblox | Customizable avatars with gender options | Limited platform-native AI; emphasis on user-generated customization | Users report identity exploration and expression | Limited dedicated empirical studies on transgender users; observational/anecdotal accounts. Youth-oriented user-generated platform with typical risks of bullying, grooming and exposure to inappropriate content |
| Second Life | Extensive customization including gender flexibility | AI Character Designer for crafting virtual characters[789] | Users report gender flexibility and virtual self-presentation | Observational reports of identity play; similar social-interaction and harassment risks as other persistent virtual worlds |
Controversies and Debates
Debates concern the relative weight of biological sex (defined by gamete type and reproductive anatomy) versus gender identity, the quality of evidence for medical interventions (especially in minors), and policy trade-offs in sports, prisons, and single-sex spaces. Perspectives range from gender-identity-affirming / affirmative-care models that prioritise self-identified gender (citing observational studies reporting associations with improved mental-health metrics such as reduced depression and suicidality, reduced minority stress, and support from major medical associations and advocacy guidelines)[462][395][385][795] to approaches that prioritize biological sex and exploratory / psychotherapy-first models (citing independent systematic reviews and European health-authority assessments, and data on desistance, comorbidities, and male-typical performance advantages).[10][558] The relative strength, quality, and applicability of the respective bodies of evidence remain contested, and interpretations of that evidence differ. Clinical and legal policies have shifted rapidly in several jurisdictions after independent evidence reviews. Positions that gender identity should determine category access are presented alongside positions that biological sex should determine access for fairness and safety. Social construct theories (e.g., spectrum models) are critiqued by sex-realist perspectives for underemphasizing biological realities like reproductive dimorphism; this informs opposition to expansive policies. Ethical concerns are contested: affirmative approaches emphasize patient autonomy, access to care, and mitigation of minority stress, while cautionary approaches highlight the potential for medical interventions applied to distress that may have social origins, the role of psychosocial support versus irreversible treatments, and balancing patient autonomy with safeguarding vulnerable groups.Speech Disputes and Harassment
Free speech debates have centered on social media platforms, where both holders of gender-critical views (those that prioritize biological sex and sex-based rights) and transgender individuals have reported facing harassment and inconsistent moderation. Definitions of prohibited speech—such as targeted misgendering versus statements distinguishing biological sex from gender identity—remain contested and have produced inconsistent enforcement across platforms and over time. Twitter's 2018 policy explicitly prohibiting targeted misgendering and deadnaming of transgender individuals was removed in April 2023 after the ownership change, coinciding with independent analyses of rises in certain anti-transgender content and a sharp decline in account suspensions for hateful conduct in subsequent transparency reports; gender-critical users had previously cited parliamentary evidence of over-enforcement against discussion of sex-based rights.[796][797][798][799][800] Scottish MP Joanna Cherry reported that she endured sustained abuse on Twitter (before Elon Musk's acquisition) for her positions on transgender issues and sex-based rights, claiming the platform's uneven enforcement of rules failed to protect speakers who distinguish biological sex from gender identity.[801][802][803][804] Philosopher Kathleen Stock resigned from the University of Sussex in October 2021 following campus protests, posters demanding her dismissal, and a student campaign accusing her of transphobia over her gender-critical writings; university officials later stated she had been subject to bullying and harassment, and she reported police advice on safety measures.[805][806] Quantitative data on harassment specifically targeting gender-critical individuals remains limited and is drawn largely from self-selected surveys. A 2021 survey by the Woman is This collective of 2,943 women who reject gender identity ideology found that 68.9% reported being threatened or subject to verbal or physical abuse because of their views (including 60.7% on social media) and 77.8% had been called a TERF or other derogatory names.[807] Broader conflicts involve reports of institutional sanctions against holders of gender-critical views criticizing policies that allow access to single-sex spaces or sports on the basis of self-identification, underscoring tensions between inclusion initiatives and open discussion of biological sex differences. Institutional pressures including employment disputes and professional complaints have likewise been reported by individuals who publicly affirm gender-identity policies or criticize gender-critical positions, with documented cases such as the 2025 firing of Texas A&M lecturer Melissa McCoul after teaching about gender identity[808] and the removal of University of Oklahoma instructor Mel Curth from teaching duties after failing a student essay arguing traditional gender views.[809] Transgender individuals and advocates have also reported high rates of online harassment, including slurs, misgendering, and threats. Transgender influencer Dylan Mulvaney reported facing stalking, personal attacks, death threats, and a bomb threat directed at a partnered company after a 2023 social media advertisement, describing the experience as involving more bullying and transphobia than she could have imagined.[810] A 2025 Williams Institute analysis of 2022 U.S. Transgender Survey data found that 42% of California respondents experienced online harassment in the prior year.[811] A 2025 TGEU survey of 30 trans content creators in 16 European countries reported that all experienced hate speech (35% daily), commonly including denial of existence (67%), slurs (63%), misgendering (57%), and death threats (50%), with respondents describing inadequate platform responses.[812]Fairness in Sports and Physical Competitions
The debate over participation of transgender women (biological males) in women's sports (biological females) centers on physiological advantages conferred by male puberty, which hormone therapy does not fully reverse. Reviews drawing on studies of mostly non-elite clinical and military populations have reported mixed findings. A 2021 review by Hilton and Lundberg concluded that transgender women retain performance advantages of approximately 9% in endurance running, 17-25% in jumping and throwing, and 20-30% in strength after at least 12 months of testosterone suppression, with skeletal advantages (height, limb length) persisting indefinitely.[517][813] Estrogen therapy reduces muscle volume by 5–10%; the reductions do not bring values into the female reference range.[814] A 2021 U.S. Air Force study of 46 transgender women found that after two years of therapy, push-up and sit-up differences versus biological females disappeared but they remained 12% faster in the 1.5-mile run.[815] Haemoglobin typically falls to the female range within four months.[816] A 2026 meta-analysis of 52 studies (very-low to low GRADE certainty, mostly non-elite samples) found no statistically significant differences in upper- or lower-body strength or VO2 max after 1–3 years despite higher lean mass.[518] A 2025 longitudinal study of nine transgender women runners and one swimmer reported 14.6% and 5.2% slower race times, respectively, after 2–3 years, with age-graded competitiveness remaining similar after training adjustment.[817] Early puberty suppression may limit some advantages, but elite-athlete data remain scarce on both sides of these findings.[818] World Rugby excluded transgender women from elite women's contact rugby in 2020, citing 20–30% higher projected tackle injury forces from retained size and strength.[819] World Athletics (2023, updated 2025) requires SRY-gene testing and restricts the female category to biological females (no Y chromosome, with limited exceptions such as complete androgen-insensitivity syndrome).[820] World Aquatics (2022) permits transgender women only if they experienced no male puberty beyond Tanner stage 2 or age 12 and thereafter maintain testosterone below 2.5 nmol/L. In March 2026 the IOC replaced its 2021 sport-specific framework with a policy limiting female-category eligibility at Olympic events to biological females, determined by once-in-a-lifetime SRY-gene screening (with limited exceptions such as complete androgen-insensitivity syndrome).[821] Outcomes vary by intervention timing, therapy duration, training and sport demands.
Longitudinal Changes in Athletic Race Times and Performance Metrics
Longitudinal studies of transgender women (biological males) athletes have measured changes in competitive running and swimming performance before and after cross-sex hormone therapy using official race times and point-score systems. In a 2025 cohort of nine runners, average race times increased by 14.6 % (standard deviation 5.6 %) after a mean of 31 months (range 5–86 months) of hormone therapy, with testosterone concentrations falling to female-typical levels (1.10 nmol·L⁻¹); decrements were larger in longer-duration events. These absolute changes occurred against typical male–female gaps of 10–12 % in comparable middle- and long-distance running events.[826] In one competitive swimmer, race times increased by 5.2 % after 34 months while FINA scores rose by 65 points. Changes in training volume were positively associated with changes in age-grade scores (p = 0.008), helping to attenuate the observed decrements. After adjustment for training-volume changes, runners’ age-grade scores (comparing an athlete’s time with the best recorded performance for the same age and sex) did not differ significantly pre- versus post-therapy (p = 0.304). The cohort was a small, self-selected sample of athletes who continued competing (not restricted to elite performers) and combined retrospective self-reported training data with verified race times. The authors noted the small sample size, heterogeneous therapy durations, and that event demands and training may influence outcomes, and stated that further research is required. These studies rely on self-reported training data cross-checked against verified competition results and serial blood testosterone measurements.[827]Access to Sex-Segregated Spaces
Criminality Data
Available studies examine patterns of criminal convictions and offending among transgender women (biological males who identify as women) relative to male and female comparison groups. The Dhejne et al. (2011) Swedish cohort of 191 post-surgical male-to-female individuals reported conviction rates similar to male controls and elevated versus female controls (any crime aHR 6.6; 95% CI 4.1–10.8) over the full 1973–2003 follow-up. In analyses of the combined male-to-female and female-to-male sample versus birth-sex controls, elevated conviction risk for any crime was statistically significant only for the 1973–1988 period.[610] Lead author Cecilia Dhejne later stated that crime-rate differences disappeared in the 1989–2003 cohort, coinciding with better mental-health care and lower stigma, although the published tables did not fully stratify the later period by sex.[830] Small samples, low event counts and wide confidence intervals (violent crime aHR 1.5; 95% CI 0.8–3.0) limit power; the design compared post-transition rates with matched cisgender controls rather than tracking the same persons before and after transition. A 2026 New Zealand analysis linking 2023 census gender-identity data to police and court records (ages 18–39) found transgender women had lower odds of recorded offending than cisgender men (odds ratios approximately 0.55–0.69 across assault and other categories) after age, ethnicity and deprivation controls, though still higher than cisgender women; those with gender-marker changes or hormone therapy showed still lower rates.[831] The analysis was limited to a young-adult sample, relied on self-reported gender identity in the census rather than confirmed medical or legal transition, used contemporaneous record linkage rather than tracking the same persons before versus after identification, and cannot be generalized beyond New Zealand or to rare offences. United Kingdom prison statistics, drawn from small transgender cohorts selected for incarceration, show sexual-offence conviction shares of about 40–62% among prisoners identifying as women—higher than male prisoners (~17%) and far above female prisoners (~2–3%).[832][833] Canadian correctional research reported sex-offence histories in 37% of gender-diverse offenders (86% of whom were transgender women), compared with about 30% of the in-custody population in men's institutions and 6% in women's institutions; in a related CSC analysis, 94% of gender-diverse offenders with sexual-offence histories had committed those offences while living as their birth sex.[834][835] These samples cannot be extrapolated to the non-incarcerated population and do not permit inference about changes in offending associated with transition. Transgender women also show elevated rates of certain non-violent offences (e.g., sex work, theft), which some analyses attribute in part to economic marginalization and others to broader patterns of male-typical offending; U.S. lifetime incarceration estimates from non-probability surveys are around 21% versus <3% in the general population.[836] Large, high-quality longitudinal studies of representative samples that track offending before versus after transition do not exist. Males account for approximately 90% of homicide perpetrators globally and for the large majority of intimate-partner and sexual violence against women.[837][838] Parallel research documents significantly elevated victimization rates among transgender people, particularly for trans women of color, with higher reported incidences of violence, hate crimes, and sexual assault compared to the general population.[55] Some analyses interpret both higher victimization and certain offending patterns (for example survival crimes) through a minority-stress lens; alternative interpretations emphasize residual male-pattern risk factors.[839] Policy implications remain contested. One interpretation holds that the cohort and prison data support maintaining sex-based placement for safety. An alternative interpretation holds that self-identification combined with individualized risk assessment better balances protection of transgender individuals with residual risk management.Non-binary Identities
Non-binary identities encompass gender experiences outside the male–female binary, such as agender, genderfluid, bigender, and others. Some individuals include them under the transgender umbrella when incongruence with assigned sex at birth exists; others regard them as distinct. The specific constellation of non-binary labels in current Western usage has become far more visible since the 2010s; cross-cultural and historical analogues exist but often map onto different social roles.[840][841] One set of views treats non-binary identities as valid expressions of gender diversity that warrant recognition and accommodation, emphasising self-determination, reduced minority stress through recognition, and the need for inclusive language, third-gender markers, and accommodation in binary-oriented systems. Longitudinal data on the stability of non-binary identities remain limited, particularly over periods extending into adulthood.[21] Another set of views questions their long-term stability, suggesting many adolescent-onset cases may reflect social influence, identity exploration, or resolution of comorbidities (autism, trauma, same-sex attraction) rather than a fixed, innate cross-sex or non-binary identity. They highlight strong correlation with recent youth referral surges and argue non-binary identification can serve as a temporary or socially reinforced stage, potentially benefiting from extended exploratory assessment.[488] Some individuals report persistent non-binary identification into adulthood.[842] Prevalence estimates vary widely (roughly 0.1–0.5% in broader population surveys; substantially higher in some youth and clinical samples), reflecting differences in survey design, age group, and definition of non-binary identification.[842][843][844] No consensus exists on whether non-binary identities constitute a distinct category, an extension of transgender experience, or a culturally contingent phenomenon. Legal and medical accommodation remains inconsistent, reflecting broader disagreements over whether non-binary identities should be treated as equivalent to binary transgender identities for purposes of markers, facilities, and clinical care.Youth Transitions and Safeguarding Concerns
Referrals to gender identity clinics for children and adolescents have risen sharply, as noted in the Demographic Trends and Increases Among Youth subsection. Medical interventions for youth with gender dysphoria often start with puberty blockers, followed by cross-sex hormones, though guidelines vary; evidence and outcomes appear in the Treatment Approaches and Evidence on Treatment Outcomes sections. There is debate between two main approaches. Arguments for early social and medical transition / identity-affirming approaches, advanced by the American Academy of Pediatrics, Endocrine Society and WPATH, hold that these interventions after multidisciplinary assessment reduce gender dysphoria, minority stress and suicide risk. One observational study (Tordoff et al., 2022) reported associations with 60 % lower odds of depression and 73 % lower odds of suicidality among youths receiving puberty blockers or hormones; systematic reviews have rated the overall evidence base, including this study, as low or very low certainty due to methodological limitations. Some clinicians recommend prompt social transition (name, pronouns, clothing) to support identity development.[795][385][462] Arguments for exploratory psychotherapy and caution / watchful-waiting approaches note that pre-2010 follow-up studies of clinic-referred children found desistance rates of 60–90 % by adulthood without social or medical transition. Cass-commissioned systematic reviews graded 24 of 50 puberty-blocker studies as low quality and only one as high quality, concluding that benefits for dysphoria and mental health remain uncertain while risks to bone density, fertility and sexual function are documented. High comorbidity rates (autism, ADHD, depression, anxiety, trauma) and the rapid-onset gender dysphoria hypothesis (still debated, based primarily on parent-report studies) of peer and online influences, especially among adolescent natal females, support thorough differential diagnosis. Some clinicians recommend a period of exploratory psychotherapy before social or medical steps.[845][846][10][491] Addressing these issues and surging referrals, several European nations have tightened medical policies for youth gender dysphoria, favoring extensive psychological assessment and non-medical options. The UK's 2024 Cass Review found weak evidence for routine puberty blockers, prompting their indefinite ban for those under 18 outside trials.[847][10] Sweden, Finland, Norway, and Denmark similarly restrict hormones to rare instances, stressing therapy due to uncertainties in benefits and risks.[261] Comparative international reviews, such as Finland's Council for Choices in Health Care (2020) and Sweden's National Board of Health and Welfare (2022), aligned with the Cass Review by recommending restricted access to puberty blockers for minors outside research settings due to insufficient long-term data, while contrasting with U.S. Endocrine Society guidelines (2017) that endorse individualized affirmative care with multidisciplinary evaluation. These variations highlighted policy divergences based on evidence interpretation.[436] Evolution of policy responses to evidence reviews (2019–2026):- 2020: Finland's Council for Choices in Health Care recommends restricting hormonal interventions for minors with gender dysphoria, prioritizing psychosocial support and deeming medical treatments experimental.[848]
- 2021: Sweden's Karolinska Institute discontinues routine puberty blockers and cross-sex hormones for minors outside clinical studies.[849]
- 2022: Sweden's National Board of Health and Welfare restricts youth gender transitions to research settings, citing insufficient evidence of benefits outweighing risks.[850]
- 2021–2024: Over 20 U.S. states enact bans or restrictions on medical interventions for gender dysphoria in minors, beginning with Arkansas in 2021.[851]
- 2024: United Kingdom imposes indefinite ban on routine puberty blockers for under-18s following the Cass Review.[847]
- 2025: Argentina bans hormone therapy and gender surgery for minors.[852]
- 2025–2026: Approximately 27 U.S. states had enacted restrictions or prohibitions on medical interventions for minors.[851]
Legal and Policy Landscape
In this section, sex-based refers to categories or legal protections grounded in biological sex. Self-declaration models (also termed self-ID) describe legal gender recognition based solely on personal declaration without medical or surgical requirements. Medically gated or diagnosis-based models describe legal gender recognition that requires medical diagnosis, hormone therapy, surgery, or judicial approval. Models that retain biological-sex criteria treat legal sex as grounded in biological sex (chromosomes, gametes, or recorded sex at birth) regardless of self-identification. Jurisdictions differ along a spectrum ranging from pure self-declaration systems to systems that require medical diagnosis, surgical intervention, or that retain biological-sex criteria for legal sex. These differences reflect ongoing debates over whether legal sex should track self-identified gender, biological sex, or a combination of medical and judicial criteria.[854]Gender Recognition Laws
The late 20th and early 21st centuries marked the emergence of initial legislative steps toward formal legal recognition and anti-discrimination protections for transgender individuals. In 1993, Minnesota became the first U.S. state to enact statewide anti-discrimination protections including gender identity in employment, housing, and public accommodations. Internationally, the United Kingdom's Gender Recognition Act (2004) allowed legal changes of gender upon medical diagnosis, granting amended birth certificates and marriage rights in the affirmed gender.[855] Gender recognition laws outline procedures for changing sex or gender designations on official documents, such as birth certificates, passports, and driver's licenses. Requirements differ widely, with some jurisdictions mandating medical or surgical criteria and others relying on personal declaration. Policies vary by jurisdiction; some allow legal marker changes on the basis of self-declaration, while others require medical diagnosis, hormone therapy, or surgery.[855][856] Historically, many required evidence such as surgery, hormone therapy, or a diagnosis of gender dysphoria. Japan's 2003 law required diagnosis and sterilization; the Supreme Court struck down the sterilization requirement in 2023, and subsequent lower-court rulings have further eased genital-surgery conditions, though diagnosis, age, marital, and parental-status requirements continue.[857] Self-declaration models (change based on personal statement with minimal or no medical evidence) include Argentina's 2012 law allowing changes via declaration, as well as similar frameworks in Malta in 2015 and Denmark in 2014. As of 2026, 12 European countries base legal gender recognition on self-determination.[856] Legal gender recognition varies globally: Argentina (2012) and several European countries permit self-declaration without medical requirements, while others (e.g., parts of Eastern Europe) mandate surgery or sterilization (though increasingly challenged, as in Japan where courts have eased such requirements). Proponents of self-declaration emphasize autonomy and reduced administrative barriers. Proponents of medically gated or biological-sex models emphasize record integrity, fraud prevention, and alignment with sex-based legal categories.[858] Employment and housing protections often fall under broader anti-discrimination laws, with varying enforcement and exemptions (e.g., religious organizations). The following table provides a summary of gender recognition processes in selected jurisdictions, reported as of October 2026. Entries are drawn from legislative texts, court rulings and official announcements; several remain subject to ongoing litigation or further amendment.| Jurisdiction | Self-ID Allowed | Age Minimum | Medical/Surgery Requirement | Recent Changes (2020–2026) | Notes |
|---|---|---|---|---|---|
| Argentina | Yes | 18 | No | None | Declaration-based processes |
| Denmark | Yes | 18 | No | None | CPR gender change at 18 with six-month reflection; limited under-18 exceptions; reduced youth hormone approvals |
| UK | No | 18 | Yes (diagnosis) | Post-Cass restrictions on youth medical | Ongoing litigation on recognition |
| USA (varies) | Partial | Varies | Varies | State bans on youth care upheld in some courts | Federal redefinition of sex as biological (2025) |
| India | Partial | 18 | Yes (medical board proposed) | Amendment drops self-perceived (2026) | Third-gender recognition; welfare rights but medical hurdles; enforcement inconsistent |
| Iran | No | 18 | Yes (surgery) | None | State-supported surgeries; disputes tied to criminalization of same-sex activity |
| Japan | No | 18 | Diagnosis (surgery/appearance relaxed by courts) | Court rulings 2023–2025 relaxing physical requirements | Diagnosis, unmarried, no minor children; legal change at 18 |
| Brazil | Yes | 18 | No | None | Judicial self-declaration |
| Germany | Yes | 14 (with consent) | No | Self-ID Act (2024) | Non-binary recognized; three-month wait; under-14 via legal representative |
| Malta | Yes | None specified | No | None | Full depathologization; non-binary; minimal disputes noted |
| Norway | Yes | None specified | No | None | Conservative youth guidance; research-only restrictions |
| Sweden | No | 16 (with consent) | Healthcare certificate | Lowered age, no dysphoria diagnosis (2025) | Certificate from licensed clinician required; ILGA-Europe does not classify as self-determination; youth medical care restricted |
| Finland | Yes | 18 | No | Shift to self-ID (2023) | 30-day confirmation period; psychotherapy first-line for youth medical care |
| Canada | Yes (provincial) | Varies | No | None | Assessment-based; self-declaration in some provinces |
| Australia (varies) | Varies | Varies | Varies | State updates (e.g., NSW 2025) | Patchwork eligibility |
Transgender Refugees and International Migration
Transgender individuals seeking asylum or refugee status may face risks linked to both their gender identity and their displacement status, including discrimination, violence, and barriers to documentation or services.[864] Comprehensive global statistics on the number of transgender asylum seekers remain limited, as most states and UNHCR official statistics do not systematically disaggregate refugee or asylum data by gender identity.[865][866] Where national figures exist, transgender-specific claims typically form a small share of SOGI claims. In Canada, Immigration and Refugee Board data for 2013–2021 recorded approximately 80 claims categorized as transgender (about 1% of sexual-orientation claims and 0.07% of all claims), with a 97% recognition rate compared with 77% for sexual-orientation claims and 70% overall; researchers note that transgender claims were often placed in other categories before 2019.[867] Most EU+ countries do not publish SOGIESC-specific asylum statistics, and no centralized EU-level figures exist.[866] UNHCR guidelines interpret the 1951 Refugee Convention’s “particular social group” ground to encompass persecution based on gender identity in appropriate cases; many (but not all) states have adopted this interpretation.[868] Barriers persist in legal gender recognition, detention conditions, and access to services. Transgender asylum seekers may face elevated risks of violence in transit and in detention, as documented in multiple reports. Recognition rates and reception conditions vary significantly by host country; some jurisdictions have issued dedicated SOGI guidelines,[869] while others apply standard evidentiary thresholds that can result in higher refusal rates when claims lack corroboration.[870] As with other asylum claims, success depends on demonstrating a well-founded fear of persecution; decision-makers assess credibility, consistency, and country-of-origin information, which can present particular challenges in gender-identity cases.[704] Host countries differ in detention practices, access to hormone therapy or identity documents, and housing of transgender detainees (some by self-identified gender, others by biological sex or risk assessment).[871][872] UNHCR and some national authorities have issued specialized guidance, yet implementation gaps and reports of violence or medical interruption persist.[873]Administrative Requirements and Processing Times for Legal Marker Changes
Policy analyses, including compilations in the ILGA World Database of legal gender recognition procedures, and participant-reported data document the sequential steps required to update legal name and gender markers on identity documents. Typical processes involve court petitions or administrative applications, submission of supporting medical or court documentation in certain jurisdictions, notary verification, and separate updates across agencies such as vital records, motor vehicle departments, and social security administrations. Processing times vary widely even within the same legal model due to administrative backlogs; studies report averages ranging from several weeks to many months (for example, a mixed-methods study of name-change petitions among transgender people in Florida found a mean of 64 days from filing to grant, with a range of 26 to 136 days), with associated compliance costs including application fees and legal assistance.[863][874] Processing times and documentation standards varied internationally: some jurisdictions (e.g., Argentina since 2012, Malta since 2015) base changes on self-declaration with minimal or no medical criteria; others (e.g., Japan, South Korea, and several Eastern European countries as of 2025) require psychological evaluation, surgery/sterilization, or court approval. Japan's 2003 law required diagnosis, sterilization, and genital-appearance criteria plus family-court approval; the Supreme Court ruled the sterilization provision unconstitutional in 2023, and 2024–2025 lower-court decisions relaxed or found the appearance requirement unconstitutional in individual cases, though the statute remained unamended as of 2026 and diagnosis plus court petition continued to apply.[875][857][876] South Korea and several Eastern European countries as of 2025 still typically required psychological evaluation or court processes, with mixed or evolving surgery/sterilization rules, resulting in timelines ranging from several months to over two years. In the United States, federal policy under Executive Order 14168 (2025) requires government-issued identity documents to reflect biological sex at birth; state-level rules for driver’s licenses and birth certificates continue to vary, with some permitting administrative changes and others prohibiting them or requiring medical evidence.[861] Age restrictions and parental consent rules further differentiated minor applications in most systems. Applicants report repeated disclosure requirements and temporary inconsistencies across documents. Jurisdictions that retain medical or judicial gates cite needs for record integrity, fraud prevention, and alignment with biological-sex classifications in law.[877][878]Regulations on Medical Interventions
Regulations for medical interventions, including puberty blockers, cross-sex hormones, and surgeries, vary by age, diagnosis, and evidence standards. The World Professional Association for Transgender Health's Standards of Care version 8 (2022) endorses a multidisciplinary, informed-consent model.[395] Independent systematic reviews, including the UK's Cass Review (2024) and subsequent GRADE analyses, have rated the evidence base for puberty blockers and cross-sex hormones in minors as very low certainty, prompting restrictions in several European countries and U.S. states.[10][442]
Prisons and Facilities Policy
Policies on transgender access to sex-segregated facilities, such as prisons, domestic violence shelters, and public bathrooms, vary by jurisdiction. Some permit access based on declared gender identity, while others base access on biological sex (or recorded sex at birth) or case-by-case risk assessments.[888]
Military Service Policies
Policies on transgender individuals serving in the military differ across countries. In the United States, open service was permitted under a 2016 Department of Defense policy. Eligibility was restricted from 2017 to 2021, generally disqualifying individuals with gender dysphoria from service except by waiver, restored in 2021 under President Biden,[897] and again restricted under Executive Order 14183 of January 27, 2025, which set standards treating gender dysphoria as generally incompatible with service requirements and provides that high standards for troop readiness are inconsistent with the medical, surgical, and mental-health constraints on individuals with gender dysphoria.[898] Implementation began in early 2025; the policy remains subject to ongoing litigation (including Talbott v. United States), with the Supreme Court allowing enforcement to proceed pending further review.[899] Policies range from open service with medical-stability requirements (e.g., Canada, Israel, several European nations) to restrictions or disqualification based on gender dysphoria or transition status (e.g., Russia, and as of 2025 the United States).[900] Some transgender service members have reported discrimination or harassment;[901] other reports and military surveys describe successful integration under supportive policies.[902] Systematic data on prevalence remain limited. In the U.S., as of 2025 the Department of Veterans Affairs is phasing out coverage of cross-sex hormones and related interventions for gender dysphoria (with limited grandfathering for those already receiving care or who received it while in service), while continuing other medical and mental-health services.[903] Policies on transgender military service vary by country. Several nations permit open service with provisions for medical care and stability requirements. Proponents of open service cite internal surveys and studies (e.g., RAND 2016 and later scoping reviews) reporting minimal effects on readiness and cohesion when clear policies are in place.[902][904] Opponents cite concerns about temporary non-deployability during medical transition, residual physical differences, unit cohesion, and the medical demands of gender dysphoria; long-term, large-scale U.S. data remain limited.[815]Sports Regulations
Education and School Policies
Jurisdictions diverge on whether school policies should follow a student’s stated gender identity or their biological sex for names/pronouns, facility access, and related curriculum. Policies on social transition (changes in name, pronouns, clothing, or presentation to match a student’s stated gender identity), pronouns, facilities, and curriculum in schools thus differ sharply by jurisdiction. Some systems (e.g., certain Canadian provinces, California, and parts of Australia) permit or encourage treatment according to a student’s stated gender identity with minimal parental notification, allowing name/pronoun changes and identity-based facility access,[913][914][915] while others (e.g., UK post-Cass Review guidance, Florida, several U.S. states, and some Canadian provinces) require parental consent for social transition, restrict facility access according to biological sex, or limit curriculum content on gender identity.[916][917][918] One set of observational studies reports associations between identity-affirming school policies and lower self-reported distress and suicide-attempt rates,[919][920] while another body of literature (including desistance studies and analyses of rapid-onset cases) raises concerns about social influence, parental rights, and privacy and fairness considerations for other students.[921][387] Both sets of studies have substantial limitations: identity-affirmation–suicidality associations are typically cross-sectional and self-selected and cannot establish causation, while desistance estimates vary widely with diagnostic criteria, follow-up completeness, and whether samples comprise clinic-referred children managed with watchful waiting or youth who have already socially transitioned.[922][375][491] International bodies (e.g., Council of Europe) generally recommend policies that accommodate students according to gender identity,[923] while national clinical reviews in the UK and several Nordic countries emphasize caution and evidence limitations, and UK school guidance prioritizes biological-sex categories for facilities and sports. Outcomes data remain observational and methodologically debated.See Also
Medical and Diagnostic Terms
- Autogynephilia
- Body integrity dysphoria
- Cass Review
- Center of Expertise on Gender Dysphoria
- Desistance of gender dysphoria
- Gender dysphoria
- Gender dysphoria in children
- Gender incongruence
- Gender-affirming hormone therapy
- Gender-affirming surgery
- Puberty blocker
- Rapid-onset gender dysphoria
- WPATH Standards of Care
Related Identities and Genders
- Cisgender
- Genderqueer
- Hijra
- Non-binary gender
- Third gender
- Trans man
- Trans woman
- Transsexual
- Two-spirit
Legal and Policy Topics
- Bell v Tavistock
- Legal status of transgender people
- LGBTQ rights
- Sex-based rights
- Sex-segregated spaces
- Transgender people in sports
- Transgender rights
Cultural and Historical Aspects
- Feminism and transgender topics
- Timeline of transgender history
- Transgender Day of Visibility
- Transgender flag
- Transgender history
- Transgender people and religion
Other Related Concepts
- Androphilia and gynephilia
- Attraction to transgender people
- Biological sex
- Detransition
- Gender expression
- Gender identity
- Gender role
- Gender transition
- Intersex / Disorders of sex development
- Minority stress
- Outline of transgender topics
- Regret (decision-making)
- Transphobia
- Transmisogyny
External Links
Professional Guidelines and Standards
- World Professional Association for Transgender Health (WPATH) – Standards of Care Version 8 (2022, latest)
- Endocrine Society – Clinical Practice Guideline: Gender Dysphoria/Gender Incongruence (2017)
National and Independent Reviews
- Cass Review – Final Report (Independent Review of Gender Identity Services for Children and Young People, April 2024)
- National Institute for Health and Care Excellence (NICE) – Evidence review: Gender-affirming hormones for children and adolescents with gender dysphoria (2020–2021)
- NICE Evidence Review: Gonadotrophin Releasing Hormone Analogues for Children and Adolescents with Gender Dysphoria (October 2020)
- Swedish National Board of Health and Welfare – Care of children and adolescents with gender dysphoria (updated 2022 policy, restricting youth interventions)
- Swedish National Board of Health and Welfare – Care of Children and Adolescents with Gender Dysphoria (Summary of National Guidelines, December 2022)
Diagnostic and Educational Resources
- American Psychiatric Association – DSM-5 Gender Dysphoria Criteria
- American Psychological Association – Understanding transgender people, gender identity and gender expression
Further Reading
Historical and Cultural Perspectives
- ''The Transsexual Phenomenon'' by Harry Benjamin (1966) — Foundational historical text on medicalization and early transsexual treatment frameworks.
- ''Before We Were Trans: A New History of Gender'' by Kit Heyam (2022, paperback 2024) – Global historical exploration of gender nonconformity across cultures and eras.
- ''Histories of the Transgender Child'' by Jules Gill-Peterson (2018) – Archival history of transgender youth and medical interventions from the early 20th century onward.
- ''Transgender History: The Roots of Today's Revolution'' by Susan Stryker (revised edition 2017) – Overview of American transgender movements, activism, and cultural shifts.
- ''Material Girls: Why Reality Matters for Feminism'' by Kathleen Stock (2021) — Philosophical critique of sex/gender distinctions and implications for women's rights/spaces.
Youth and Development
- ''Free to Be: Understanding Kids & Gender Identity'' by Jack Turban (2024) – Research-based overview of gender identity development, youth treatments, and scientific debates in pediatric care.
- ''Gender Born, Gender Made: Raising Healthy Gender-Nonconforming Children'' by Diane Ehrensaft (2011) – Guidance for parents and clinicians on supporting gender-nonconforming youth.
- ''Irreversible Damage: The Transgender Craze Seducing Our Daughters'' by Abigail Shrier (2020) – Investigative examination of rapid rises in adolescent female identifications, social influences, and detransition concerns.
- ''When Kids Say They’re Trans: A Guide for Parents'' by Lisa Marchiano, Sasha Ayad, and Stella O’Malley (2023) – Practical parental guidance emphasizing exploratory approaches over rapid affirmation.
- ''The Cass Review and Gender-Related Care for Young People in Canada: A Commentary on the Canadian Paediatric Society Position Statement on Transgender and Gender-Diverse Youth'' by Kulatunga Moruzi et al. (2025) — Critique of affirmative guidelines in light of international evidence retreats.
- ''Gender Detransition: A Critical Review of the Literature'' by Pablo Expósito-Campos et al. (2023) — Systematic examination of detransition prevalence, factors, and definitions.
- ''Interventions for Gender Dysphoria and Related Health Problems in Transgender and Gender-Expansive Youth: A Systematic Review of Benefits and Risks to Inform Practice, Policy, and Research'' (2025) — Updated synthesis of intervention outcomes, benefits, and risks for TGE youth.
- ''Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices'' (U.S. HHS/OPA comprehensive report, 2025 peer-reviewed version) — Broad evidence synthesis highlighting risks, weak benefits, and ethical concerns in youth interventions.
- ''Stability and Change in Gender Identity and Sexual Orientation Across Childhood and Adolescence'' (Trans Youth Project monograph, 2025) — Longitudinal data on identity persistence/change in supported vs. cisgender youth.
Personal Narratives and Fiction
- ''Becoming a Visible Man'' by Jamison Green (2004) – Autobiography and analysis of female-to-male transition experiences, family dynamics, and community building.
- ''Stone Butch Blues'' by Leslie Feinberg (1993, anniversary editions) – Seminal novel/memoir blending fiction and lived experience of gender nonconformity and working-class trans life.
- ''Detransition, Baby'' by Torrey Peters (2021) — Fictional exploration touching on detransition themes and identity complexities.
Medical and Health Approaches
- ''Trans: When Ideology Meets Reality'' by Helen Joyce (2021) — Analysis of transgender rights activism, policy impacts, and ideological shifts in society.
- ''An Evidence-Based Critique of the Cass Review on Gender-Affirming Care for Adolescent Gender Dysphoria'' by Meredithe McNamara et al. (2024/2025) — Counter-critique defending affirmative models against Cass conclusions.
- ''Transgender Health and Medicine: History, Practice, Research, and the Future'' by Dana Jennett Bevan (2019) – Single-author overview of transgender medical history, theories of causation, treatment procedures, side effects, outcomes, and future research directions.
- What We Know Project (Cornell University meta-analysis/update) — Compilation of studies on positive post-transition well-being outcomes.